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SUMMARY
A cellular protein, EBP1, was Identified, which bound to the “core" region of the SV40 
enhancer. The DNA sequences requirements for specific EBP1 binding distinguished this protein 
from a number of previously reported enhancer binding proteins. Multiple copies of the EBP1 
binding site could serve, in vivo, to enhance transcription. The In vivo transcriptional activity of wild 
type and mutant SV40 enhancers correlated with EBP1 binding. Mutations that abolish EBP1 
binding also severely reduced transcription, indicating that this protein may be important for
SV40 enhancer activity.
Nuclease protection and chemical probing studies Identified purine bases and backbone 
phosphate groups which participate In the formation of a specific EBP1/DNA complex. 
“Footprinting” with hydroxyl radicals revealed deoxyribose residues In the binding site which are 
protected from cleavage by EBP1. Computer graphics were used to display this information 
indicating that EBP1 made specific base and backbone contacts over one complete turn of the DNA 
double helix, supporting a model whereby the protein makes sequence-specific contacts in the 
major groove, although binding may also be influenced by Interactions In the minor groove.
Competition and contact point analyses revealed that EBP1 bound similarly to sites present in 
several other viral and cellular enhancers. Mutational analysis of EBPI binding sites Identified base 
pairs important for specific EBP1/DNA complex formation. All high affinity binding sites contained 
the sequence 5'-GG{N)6CC-3'. Although single base pair changes In the region between the 
conserved guanines and cytosines can generally be tolerated, it Is clear that the central six base 
pairs contribute to binding affinity. Mutations In the recognition site which could lead to gross 
structural changes in the DNA abolish EPB1 binding.
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INTRODUCTION
Transcription is the process whereby genes,. 
are selectively located, recognised and transcribed into RNA by DNA-dependent RNA 
polymerases. At each step In RNA synthesis, transcription is regulated via a complex series of 
interactions of the RNA polymerase, DNA, nascent RNA, a variety of regulatory proteins 
(transcription factors) and small molecule ligands: this control of gene expression Is critical to cell 
function and differentiation throughout the lifetime of the cell (reviewed by von Hippel et al., 1984).
Genes determine the structures of the molecules that constitute living cells. At any one time, 
each cell uses only a subset of its genes to direct the synthesis of other molecules - these 
expressed genes are “switched on” whereas those not expressed are “switched off” (reviewed by 
Ptashne, 1986b). Although genes are transmitted essentially unchanged from parental to daughter 
cells, their expression may vary In different cell types. How are these genes “switched on” and “off" 
and what are the molecular mechanisms controlling gene expression?
In an attempt to answer these questions gene expression In the bacterium £  coll, Its 
bacteriophage and various animal viruses has been extensively studied, and what emerges Is that 
essentially the same molecular principles are used in prokaryotic and eukaryotic systems.
At a glance, It would appear that DNA plays a somewhat passive role in these control 
mechanisms, and, that it Is only through the interactions of proteins with specific sequences In the 
DNA that the messages encoded In DNA are read and acted upon. Consequently, of prime 
importance In the control of gene expression, is the study of DNA-protein complexes. Identifying 
proteins which bind to specific sequences in DNA will provide us with a better understanding of the 
mechanisms controlling gene expression; understanding the chemistry of how genetic “switches” 
are controlled will require detailed structural information on these DNA-protein complexes.
The aim of this introduction is to provide a background to the initiation of transcription in both 
prokaryotes and eukaryotes, and to provide some insight Into to the various mechanisms controlling 
gene expression, with particular emphasis on the interactions of regulatory proteins with 
transcriptional control elements.
1. Control of Gene Expression in Prokaryotes and their Bacteriophages
Gene expression involves the sequential flow of information from DNA to protein. The first 
stage of this process, transcription, Involves the synthesis of an RNA chain representing one strand 
of the DNA duplex, the template strand. In contrast to DNA replication, the genome is not copied in 
its entirety but rather as defined units of genetic Information which are transcribed Into RNA 
molecules. These messenger RN As (mRNAs) are then used in the process known as translation to 
direct the synthesis of proteins.
Control of initiation of RNA synthesis by DNA-dependent RNA polymerase appears to occur at 
two distinct levels: the frequency and the site of initiation. Initiation of transcription Involves the 
binding of RNA polymerase to double stranded DNA which then unwinds to make available the 
template strand. Local unwinding of the DNA occurs In the region of bound RNA polymerase. 
Initiation Is generally regarded as Including the primary recognition of double stranded DNA, 
unwinding of the DNA helix and incorporation of the first few nucleotides In the RNA chain. The 
entire nucleotide sequence necessary to facilitate such an Interaction is called the promoter. The 
site of incorporation of the first nucleotide is known as the mRNA start site (reviewed by Lewin, 
1985).
The sites of control of transcriptional Initiation, the promoters, are segments of conserved DNA 
sequence that bind RNA polymerase, and which are located upstream (5') of the initiation or mRNA 
start site (Rosenberg and Court, 1979; Siebenllst et a!., 1980). These features In the DNA, 
necessary for RNA polymerase binding, were Identified by comparing the sequences of different 
promoters. If a particular nucleotide Is essential for promoter function then theoretically it should be 
conserved In all promoters. However, this base need not be conserved at every single position; 
some variation may be permitted. Putative DNA recognition sites can be defined with regard to an 
optimum sequence that represents the base most often present at each position. A consensus 
sequence is defined by aligning all known examples so as to maximise their homology. Such 
conserved sequences have been located approximately 10 bp and 35 bp upstream of the Initiation 
sites of E. coii promoters (reviewed by Lewin, 1985). In addition to these constitutive promoter 
elements, sequences governing negative and/or positive regulation have been identified.
Negative regulation of transcription involves the binding of a repressor protein to operator DNA 
(which often overlaps with the RNA polymerase binding site). Positive regulation, on the other 
hand, involves binding of an activator protein to a specific DNA sequence upstream of the promoter 
and stimulating transcription, presumably by making contact with RNA polymerase (Hochschild etai, 
1983). The structure of a typical prokaryotic promoter Is shown In Figure 1.
RNA chain Initiation by bacterial RNA polymerase is dependent on the ability of the enzyme to 
act as a sequence-specific DNA binding protein (often in concert with other proteins), to then effect 
unwinding of DNA and strand separation over a limited region, and finally to act as an RNA 
synthetase. In addition. Initiation Is regulated by both general and promoter-specific means 
facilitated by the direct Interaction and response of RNA polymerase to low molecular weight 
effectors and other regulatory proteins (reviewed by Travers, 1987a).
The relationship of structure to function Is central to understanding the biological processes 
governing transcription initiation. Detailed structural information on promoters is now widely 
available but for RNA polymerase structural information Is not quite so abundant. However, a rather 
simplified model involving only three overall steps, has for a number of years been Invaluable In the 
investigations of transcription initiation (reviewed by McClure, 1985). This scheme, outlined in 
Figure 2, was suggested as a result of observations by Walter and coworkers (1967) and Involves 
the Initial binding of RNA polymerase and the promoter to form an Inactive Intermediate referred to 
as the closed complex (RPc)- This closed complex subsequently Isomerlses to form the 
transcriptionally active open complex (RPo)* Both binding and Isomérisation Involve noncovalent 
Interactions. The energy available in nucleoside triphosphates is not utilised until the subsequent 
binding of the template-directed nucleoside triphosphates occurs and RNA chain elongation 
begins, eventually leading to promoter clearance (reviewed by McClure, 1985).
1.1 RNA Polymerase
The eubacterlal DNA-dependent RNA polymerase Is a complex multisubunit enzyme which is 
structurally and evolutionarily related to the RNA polymerases of archaebacteria and eukaryotes 
(reviewed by Travers, 1987a). The best studied prokaryotic RNA polymerase is that isolated from E.
Figure i. Structure of Prokaryotic (eubacterial) promoters
The -35 box and TATA (or Pribnow) box Interact with RNA polymerase. Positive regulation can be 
mediated via neighbouring upstream elements binding activator proteins which in turn contact 
RNA polymerase. Spacing of these control elements is quite strict -  the distances of the various 
elements from the transcription Initiation site are indicated. In addition, prokaryotic promoters are 
often regulated by a repressor protein binding to an operator sequence near the transcription 
start site (not shown on this diagram).
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Figure 3.. Mechanism of transcription initiation
This scheme involves the initial binding ot RNA polymerase (R) to promoter DNA (P) with a binding 
constant, K b , to form an inactive intermediate known as the closed complex (RPc)* This complex 
subsequently isomerises, with rate constant kf, to form the transcriptionally active open complex 
(RPo). Binding of template-directed nucleoside triphosphates (NTPs) occurs and RNA chain 
elongation commences.
co li. The enzyme can be functionally separated into two macromolecular components, the core 
polymerase and a sigma {«- ) factor (Burgess et ai, 1969). The structure of the enzyme is 
understood only at relatively low resolution from neutron and X-ray small angle studies 
(Meisenberger, 1980). However, it is well established that the core enzyme, which has the subunit 
composition ot.2 BB'« 2  with individual molecular weights of 155.6, 150.6, 13.5 and -10 Kdaltons 
respectively (Chamberlin, 1982), contains the catalytic machinery necessary for the synthesis of an 
RNA chain. The genes encoding the«(, B and B' subunits {rpoA, rpoB, and rpoC respectively) have 
been cloned and shown to be essential for polymerase function; the involvement of thew subunits 
still remains to be determined. The sigma factor associates with the core polymerase to form the 
holoenzyme which can bind specifically to promoter sites to effect correct initiation of RNA chains at 
the majority of E.coli promoters. The major sigma factor In E. coll is the vegetative sigma of 
molecular weight 70.2 Kdaltons encoded by the rpoD gene (Burton et ai, 1981) and which is 
present in the form of RNA polymerase active in the selection of the majority of E. coli promoters. 
Transcription of other sets of genes, for example those activated by heat shock or genes required 
for nitrogen fixation, require sigma factors encoded by the rpoH and rpoN {ntrA ) genes 
respectively (Grossman et ai. 1984; Kustu e ta i, 1986). However, the structures of the different 
sigma factors are similar and all contain two regions of “helix-turn-heilx" motif, characteristic of a 
variety of sequence-specific DNA binding proteins, as well as a conserved region postulated to be a 
site of contact between the core polymerase and the sigma factor (Stragieref a/., 1985, Doi and 
Wang, 1986).
Investigation of RNA synthesis in Bacillus subtllis (B. subtllls ) has demonstrated the presence 
of at least five sigma factors one of which has been shown to be involved In transcriptional specificity 
during the early stages of sporulation development (Losick and Youngman, 1984). In addition, 
SP01, a B, subtllis bacteriophage (phage), encodes two factors that are responsible for temporal 
expression of its genes (Losick and Pero, 1981). Phage-induced RNA polymerases display a very 
high degree of specificity for their promoters on the corresponding phage DNA. Moreover, these 
polymerases appear to recognise a contiguous sequence of DNA near the transcription start site 
(reviewed by McClure, 1985), Diverse strategies are exhibited by the various phage which is
reflected In the finding that some phage use the host enzyme early and then use a phage encoded 
enzyme for the intermediate and late transcription units. Other phage use a modified form of the 
host RNA polymerase throughout their development.
Very little is known about the detailed three dimensional structure of the RNA polymerase
holoenzyme. However X-ray scattering and electron microscope studies have provided some
insight into the overall shape of the molecule in solution (Hawley and McClure, 1983) -  details on
the precise of the DNA around the enzyme in the polymerase-promoter complex remain to be A
elucidated.
1.2 Promoter Structure
The nucleotide sequence of a promoter site should reflect not only its capacity to act as a 
specific recognition site for DNA binding proteins, but also to facilitate strand separation. The DNA 
sequences of more than 200 promoters utilised by RNA polymerase from E. coli and the closely 
related Salmonella typhimurlum have now been determined (Hawley and McClure, 1983 for 
sequences up to 1982). Comparison of these sequences suggest that the characteristics of the 
different classes of promoter allows differential recognition by DNA binding proteins and the 
subsequent enzymatic manipulation which results in strand separation. However, when functional 
parameters of an individual promoter are to be derived from structural information alone, such DNA 
sequences are of little predictive value. A better understanding of how the complex functional 
make-up of a promoter is stored in the nucleotide sequence requires quantitative information on the 
function of defined promoter sequences.
Differential recognition of promoters by RNA polymerase containing different sigma subunits is 
the principal determinant for the separation of promoter sequences into discrete classes (reviewed 
by Travers, 1987a). In general, a promoter can be defined as the segment of DNA that contains 
signals which direct the proper binding of the RNA polymerase holoenzyme and its subsequent 
activation to a form capable of specific RNA transcription initiation. Additional DNA sequences 
controlling the specific binding of accessory repressor or activator proteins often lie within or 
immediately adjacent to the promoter (Pabo and Sauer, 1984)
The efficacy with which a particular promoter competes for and activates RNA polymerase will 
determine how often that promoter is used. The relative transcriptional effectiveness of different 
promoters is often referred to as “promoter strength"; a parameter which is determined by the 
intrinsic DNA sequence of the promoter itself and by accessory proteins which may modulate certain 
promoter-RNA polymerase interactions (von Hippel etai., 1984).
The most abundant class of promoters is that recognised by the vegetative holoenzyme Earyo. 
Within each promoter class two regions of strong DNA sequence homology are normally apparent. 
The two most highly conserved regions, with consensus sequences TTGACA and TATAAT, are 
centred approximately 33 and 10 bp, respectively, upstream of the mRNA start site and are usually 
termed the “-35” and “-10" boxes (Hawley and McClure, 1983). In each motif, three bases are highly 
conserved: the TTG at -35 and the TA—T near -10. However, the -35 and -10 hexamers are 
generally referred to as the principal features in each region, even though conserved sequence 
homologies exist on either side of the hexamers. The structural features of prokaryotic promoters 
are shown in Figure 1. Surprisingly, no wild type E. coll promoter has been identified that 
completely matches the consensus promoter, even in highly conserved hexamer regions, 
suggesting that promoter function is ordinarily optimised in vivo and not maximised (reviewed by 
McClure, 1985). The distance between the two regions can vary but for the majority of these 
promoters it is 16 to 18 bp, with 17 bp occurring most frequently. Similarly, the separation between 
the -10 region and the start site varies between 4 and 8 bp (reviewed by Travers, 1987a). However, 
it should be stressed that the sequence arrangements of other promoter classes recognised by 
different holoenzymes show significant deviation from this pattern. The promoters used by E. coli 
E«*32 during heat shock response have similar spacing between the two conserved major regions 
but the -10 region sequences differ substantially from those recognised by B r  jq (Cowing et al.,
1985). In addition, the RpoN protein, which acts as a sigma factor for genes involved in nitrogen 
metabolism, has two conserved regions separated by one turn of the DNA double helix at -25 and 
-16 (Ausubel, 1984; Benyon etai., 1983). In contrast, promoters utilised by the T4 bacteriophage 
gp55 sigma factor contain only a single region of conserved sequence similar in position to the -10
box of E. coli Eo“ 7o promoters (Elliot and Geiduschek, 1984). In spite of this diversity of promoter 
structure, one structural motif appears to be common to ail classes of promoters in eukaryotes, 
eubacteria and archaebacteria -  the TATA sequence, which Is normally located at ~-10 in 
eubacterial promoters.
Since most genetically defined promoter mutations fall within the conserved regions at -10 and 
-35, it is likely that these sequences will define the strongest interactions between the promoter 
DNA and RNA polymerase. Recent experimental data has shown, however, that promoters which 
exactly match or fit very closely to the consensus sequence in these conserved regions, 
demonstrate only moderate activity with respect to the most active promoters (Deuschle et a!.,
1986). It would seem then that additional sequence constraints determine promoter strength. 
Deuschle and coworkers (1986) were able to measure accurately the In vivo strength of well 
defined promoter sequences and to endeavour to interpret this sequence data based on functional 
information. A system was developed in which promoter activity was measured at the RNA level, 
with respect to an internal standard, independently of translation effects or gene dosage. In all, 
fourteen promoters were characterised and up to 75-fold differences in promoter strength were 
observed. The most efficient signals were seen using promoters from the coliphages T7 and T4. 
The activity of these promoters was very close to the strength of fully induced promoters of rRNA 
opérons, which may approach the functional optimum of a single sequence. This contrasts the 
results obtained using a synthetic “consensus” promoter which generated less efficient signals. It 
appears then that optimal promoter strength can be achieved by alternate structures, strongly 
suggesting that information outside the “classically” defined promoter region contributes to 
promoter activity.
Functional dissection of E. coli promoters by Kammerer and coworkers (1986) led to the 
definition of a promoter as a 70 bp sequence containing a "core" of 35 bp (from positions +1 to -35), 
an upstream region of 15 bp and a downstream region of 20 bp. They could demonstrate that the 
downstream region of a promoter (Pn25 of T5) contained information which could increase the 
strength of at least some promoters. In addition, the “core region" of the promoter contained the 
essential elements necessary for the early steps of the interaction between a promoter and RNA
polymerase including recognition of a nucleotide sequence by the enzyme and isomérisation of the 
initial complex into a state capable of Initiating RNA synthesis. This in turn would suggest that the 
downstream regions contain signal functions required at a later stage of the overall process. The 
data of Kammerer et ai, (1986) show that the strength of a given promoter can be limited at different 
levels of the overall process and as a consequence, promoters of identical strength can exhibit 
different structures due to an alternate optimisation of their pathway to transcription initiation.
The actual location per se of a promoter on the DNA may play a regulatory role in initiation of 
transcription. Hawley and McClure (1983) compiled the sequences of 112 E  coli promoters and 
found that more than one third were situated close to other promoters. The geometry associated 
with these closely spaced promoters suggests three different classes. In the first class two or more 
promoters are orientated in the same direction and transcribe the same gene or operon as is the 
case with the gal and lac genes. The second class comprises the divergently orientated promoters 
which are capable of binding two RNA polymerase molecules with a common region and which 
transcribe separate genes or opérons in opposite directions, for example the araBAD operon and 
araC gene. Thirdly, a less common class are the convergent promoters where RNA polymerase 
molecules actually oppose one another and transcribe both strands of the DNA over a common 
interval, for example in phage lambda promoters Pr  and Pr m - In many of the aforementioned 
cases, the close proximity of the promoters has been shown to be an important component of the 
regulatory function displayed by these promoters (reviewed by McClure, 1985). It is possible that 
promoter juxtaposition could also result in an enhancement of transcription from one or both sites -  
possibly mediated through protein-protein interactions.
1.3 DNA Bending and Bendability
DNA-protein Interactions often involve imposing a curvature on the DNA molecule along a 
precisely defined route on the surface of a protein complex, for example in the interaction between 
E. coli DNA gyrase and DNA (Klrchhausen et al., 1985). This curvature is dependent on two 
factors; bendability and intrinsic bending of the DNA.
The bendabiiity of a DNA molecule is its ability to adopt a preferred direction of curvature when
constrained in a tight loop on the surface of a protein or in the form of a small circle. This bending of 
the DNA double helix means that the external circumference of the circle or loop will be significantly 
greater than the internal circumference. As a consequence of this, the average widths of the major 
and minor grooves must be greater on the outside than on the inside such that particular 
sequences will adopt a preferred orientation with respect to the direction of curvature (Drew and 
Travers, 1984). Yet another parameter to be considered is that the direction of the helical axis must 
change. This change is correlated with the angle between the long axis of the base pair planes 
termed "roll". Rotational positioning of DNA about the histone octamer in nucleosomes appears to 
be determined by such sequence- dependent modulations of DNA structure (Drew and Travers, 
1985). In nucleosomal DNA the variation In groove width is correlated with the appearance of 
particular short sequences such that, e.g., the trinucleotide AAA or TTT is more frequently found 
where the minor groove points inwards towards the histone octamer, whereas GGC or GCC prefers 
to be situated in an outward facing minor groove (reviewed by Travers and Klug. 1987). Any 
preferred direction of curvature of promoter DNA in the polymerase-promoter complex should 
subsequently be reflected in the preferred occurrence of sequences correlated with rotational 
orientation at particular positions in the DNA. This has indeed been shown to be the case by 
analysis of available promoter DNA whereby sequences associated with an outward facing minor 
groove are enriched at positions separated by -10 bp -  a value resembling the helical twist of DNA 
free in solution (reviewed by Travers, 1987a).
Intrinsic bending is the selection of a highly preferred direction of bending of the DNA double 
helix. This unusual property has been attributed to the presence of homopolymer (dA).(dT) 
stretches usually greater then 4 bp in length (Koo et al., 1986). Such stretches tend to assume, in 
solution, a highly characteristic structure with a helical screw of 10 bp per turn and a relatively narrow 
minor groove (Nelson etai., 1987). However, the intrinsic bending associated with such 
sequences is probably due to the stacking of immediately flanking base pairs on highly 
propeller-twisted (dA).(dT) base pairs which themselves are maintained in a relatively inflexible stack 
(reviewed by Travers, 1987a). Base stacking, in particular purine- purine stacking, is a very 
significant force in stabilising homopolymer structures. This is maximised by poly(dA).poly(dT)
through the high degree of propeller twist which rotates the bases around their longitudinal axis 
thereby facilitating more Interactions between neighbouring bases (Nelson et al., 1987). The 
propeller twist causes the major groove to point towards the 3'-end of its DMA strand which In turn 
pushes the N-6 atom of adenine, which lies In the major groove, towards the 0-4 atom of thymine on 
the 3'-slde of It. This allows the formation of a three-centred bifurcated H-bond consisting of a non- 
Watson-Crlck H-bond diagonally across the major groove as well as the two normal Watson-Crlck 
H-bonds. The distinctive features of poly(dA).poly(dT), that Is additional H-bonds and good base 
stacking, are such as would confer a rigidity greater that that expected from base pairs with two 
H-bonds. Runs of about 5 bp of the homopolymer phased every helical repeat effect an overall 
bend to the DMA configuration (reviewed by Nelson et al., 1987). The basis of this bending may be 
due, in part, to the contrast between the special geometry of the oligo(dA). ollgo(dT) tract and 
abrupt change at the DNA sequence junctions, or a gradual change over the Intervening region, or 
perhaps a combination of both (Nelson eta!., 1987). So, It would appear that the distribution of 
dA:dT blocks within promoters can define, in part, by the Intrinsic bend, the potential pathway of 
DNA on the polymerase and also determine the limits (by their rigidity) of the regions which can be 
bent.
1.4 RNA polymerase-promoter interactions
Classically, the Initiation of transcription by RNA polymerase has been regarded as essentially a 
two step process, described by the greatly oversimplified equation shown In Figure 2, which 
Involves binding. Isomérisation and promoter clearance. This model Is based on the assumption 
that the first step In the process is the formation of a complex between RNA polymerase and the 
double stranded promoter DNA. This “closed" complex (RPc) is In rapid equilibrium with free 
polymerase. A subsequent step which requires DNA strand separation results in the formation of a 
more stable “open” complex (RPo) in which one to one and a half turns of the DNA double helix in 
the vicinity of the Initiation site are no longer base paired (reviewed by Travers, 1987a).
Extensive investigations of this bipartite model have been carried out. Abortive initiation 
assays, template competition assays, filter binding assays and various “footprlnting” techniques
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have now been employed to quantitate a particular species of the pathway (reviewed by Buc,
1987).
The Initial step In the formation of a closed complex Is the location of the specific promoter site 
by RNA polymerase. RNA polymerase, like other DNA binding proteins, has a significant 
non-specific affinity for DNA (Strauss et ai, 1980). This means that when DNA and RNA polymerase 
are mixed in solution, an Individual RNA polymerase molecule will be In close association with the 
DNA for a substantial proportion of the time. This effectively increases the target size for an Initial 
Interaction due to the number of non-specific sites on a given DNA molecule greatly exceeding the 
number of specific sites. Once bound non-speclflcaiiy, a polymerase molecule could then migrate 
along the DNA In an essentially one-dlmenslonal, diffusion-limited manner. RicchettI etal., (1988) 
have reported such a mechanism to facilitate promoter location. Four A l promoters of phage T7 
were polymerised head to tall and the length of the DNA upstream from the first promoter, or 
downstream from the last promoter, varied. The relative occupancy of the promoters was measured 
by quantitating the relative amounts of the corresponding transcripts. In this way they could 
demonstrate that Increasing the length of the downstream region led to a positive gradient of 
occupancy from sites one to four, Indicating a polarity In the process of promoter search. Since RNA 
polymerase and the promoter are asymmetric structures. It Is possible that only those molecules 
bound In the correct orientation with respect to the direction of transcription are able to successfully 
Initiate transcription. In addition, one has to consider that only those polymerase molecules that 
approach the promoter from downstream are successful. A possible explanation for these findings 
Is that a potential barrier, at the DNA level, could be created by a set of base pairs upstream of the 
promoter preventing RNA polymerase from sliding through -  this Idea requires further Investigation.
Another view of promoter location (or indeed the recognition of any sequence specific protein 
binding site on the DNA) Is dependent on the observation that the external topography of the DNA 
double helix Is not uniform but Is a reflection of the Internal relationships, between the bases (Drew 
and Travers, 1984). This means that the protein must first find the appropriate external structure 
characteristic of Its binding site, for example, local variations In groove width or overall curvature of 
the double helix. Irrespective of the precise structures comprising such a recognition site, promoter
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location requires one-dimensional sliding along the DNA until the protein encounters a feature 
which Is In close proximity to, or coincides with, a sequence- specific binding site perhaps allowing 
the protein to adopt a sequence-specific binding conformation (Drew and Travers, 1985b). Details 
of the recognition of RNA polymerase and promoter DNA are unknown but It is presumed to Involve 
an Interaction of the “helix-turn-hellx” domain of the polymerase sigma subunit with either the -10 or 
-35 regions -  strongly favoured Is the major groove of the -35 region (reviewed by Travers, 1987a).
It Is possible that a common multlstep sequential process operates at all promoters during 
Initiation of transcription -  the rate-limiting steps being different and quite sequence-specific. 
Several competing mechanisms may be at work and, depending on the sequence of the promoter, 
one particular pathway may be more efficient than the others. Different sets of sequences could 
lead to the optimisation of different mechanisms for open complex formation. In this case, hybrid 
promoters from two optimal sequences would prove to be weaker -  such context-dependent 
effects have been described by Bujard et al., (1986). Two general features of the DNA structure 
have been Implicated In these multistep processes.
The first of these Is the spontaneous tendency of free promoter DNA to unwind slightly 
upstream of the Pribnow box. When certain promoters are Inserted Into negatively supercoiled 
DNA templates they become particularly sensitive to single stranded nucleases In this region, 
others do not. In one particular case, the loss of sensitivity to nuclease SI In this region, as seen 
when one base pair of the Pribnow box Is mutated, correlates with the Inability of the altered 
promoter to form an open complex with RNA polymerase (Drew et a!., 1985; Travers,1986b). In 
addition, the remarkable sensitivity of strong lactose promoters, not complexed with RNA 
polymerase, to the nuclease action of the OP/Cu+ complex, could also “signal” to the RNA 
polymerase the region where nucléation should be Induced (Sigman eta!., 1985; Spassky and 
SIgman, 1985).
The second feature of the DNA structure, resulting from detailed studies performed at the lac 
UV5 promoter, suggest that the bendabllity of the whole promoter region could assist the 
nucléation process. Data from several laboratories (reviewed by Buc, 1987) Indicate that upstream 
elements having an Intrinsic curvature, increase the promoter strength when correctly positioned
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with respect to the -35 region.
Another important point of note is that promoter strength does not rely solely on the ability of 
RNA polymerase to rapidly lead to formation of an open complex, but also on Its ability to exit from 
this stable complex and to carry out the first translocation steps. This promoter clearance step has 
been found to be rate-limiting, and. In some cases, suggested to be the target of regulation 
(reviewed by Buc, 1987). Bujard et al., (1986) have provided data which support the idea that 
Improvement of the rate of open complex formation could impair the overall process. Including the 
first translocation and the transition from an Initiating to an elongating complex. They conclude that 
regions upstream and downstream of the promoter are Involved In optimising the last steps.
1.5 Structural Transitions in Promoter DNA
Prior to transcription initiation, the product of the Interaction of RNA polymerase with promoter 
DNA Is the separation of the DNA strands over -12 bp in the region of the transcription startpolnt. 
The extent of the region over which this occurs has been estimated by chemical modification of the 
open complex on the lac UV5 promoter at 37°C. Bases In the region from —9 to +3 were shown to 
have the reactivity characteristic of single stranded DNA. This melted region does not Include the 
TATA box which has already been shown In both the tyrT and lac UV5 promoters to be the region of 
the promoter at which unstacking Is most readily Induced by negative superhelical stress or thermal 
changes (reviewed by Travers, 1987a). This suggests that the TATA region serves as the 
nucléation point for untwisting and that the untwisted region Is subsequently propagated to the 
transcription start site (Figure 3). For this to happen would require that untwisting occurs prior to 
open complex formation and that any mutation which blocks untwisting may trap the 
polymerase-promoter complex at an early step In the Initiation pathway. AtT to A transversion 
converting the tyrT -10 region from TATGAT to TATGAA resulted In at least a 50-fold decrease in 
the rate of Initiation both in vivo (Berman and Landy, 1979) and in vitro (Travers et ai., 1983), It Is
cFvcïvrv
likely that the T to A transversion blocks polymerasoyjextenslon and the polymerase promoter 
complex remains In the closed state. This block may be due to the lack of a crucial contact with the 
most highly conserved position of the -10 region or, alternatively, from failure to untwist the DNA In
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Figure 3. Nucléation of unwinding at the f y r T p r o m o t e r
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(redrawn from Travers, 1987)
this region. It Is possible that untwisting of the DNA to form additional or altered contacts with the 
polymerase which in turn triggers a conformational change resulting In polymerase extension 
(reviewed by Travers, 1987a). Since untwisting by itself does not necessarily Involve strand 
separation, at what stage of the Initiation process does strand separation first become detectable? 
To address this point, studies on cytosine reactivity to DMS were carried out (Spassky et ai, 1985b). 
Results from these studies showed that cytosine residues close to the Initiation site were 
methylated at 37®C (that Is, In the open complex) but not at 17"^ C (in the Intermediate complex 
where promoter DNA Is double stranded) suggesting that strand separation occurs between 17®C 
and 37®C on formation of the open complex. In both the Intermediate and open complexes the 
distal limit of protection by RNA polymerase was positioned at +20. In a similar set of experiments, 
Straney and Crothers (1985) separated two "open" transcription complexes at the lac UV5 promoter 
(by native gel electrophoresis) which were Interconvertible, one predominating at 16°C, the other at 
higher temperatures. In both cases DNA/RNApolymerase complexes were protected from DNase 1 
digestion to position +20 and both were transcriptionally active in vitro. The relationship of the low 
temperature "open" complex of Straney and Crothers and the 17°C complex of Spassky et ai., Is 
unclear at the present time -  It Is possible that It represents an additional type of complex.
Topological unwinding during closed complex formation at the lac UV5 promoter might take the 
form of "wrapping" the DNA In a tight left-handed supercoil about the polymerase molecule. At the 
other extreme, the unwinding of 1.3 turns of DNA could In theory be accommodated by untwisting, 
distributed either across the whole polymerase binding site or locally in the -10 region. For either of 
these alternatives to occur would require a reduction In the local twist to 18® In the case of the 
former, or In the formation of a 6-8 bp stretch of left-handed DNA In the latter case (reviewed by 
Travers, 1987a).
1.6 Models for Transcription initiation in Prokaryotes
The pathway to open complex formation Involves structural transitions In both the DNA 
template and RNA polymerase occurring, to a certain extent, Independently of any direct interaction 
between the enzyme and promoter DNA (Travers, 1987)a. Kinetic and thermodynamic data
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suggest that at least two mechanistically distinguishable pathways exist leading to open complex 
formation. These pathways are exemplified by the lac UV5 and lambda Pr  promoters, respectively 
(reviewed by Travers, 1987a). In the case of the lac UV5 promoter, RNA polymerase would Interact 
with partially unwound promoter DNA In the -10 region to form an Initial complex. This state Is then 
followed by an Intermediate complex where the DNA remains in the unwound state but with no 
detectable strand separation. At this stage RNA polymerase covers -60-70 bp of the promoter 
from positions +20 to -40 or -50. The final step In Initiation Involves strand separation in the region 
of the start site, that is there has been migration of the untwisted region from -10 with the RNA 
polymerase remaining extended -  the polymerase now becomes competent to Initiate RNA 
synthesis. In the lambda Pr  promoter a crucial difference is that the Initial Interaction of RNA 
polymerase is with unstressed DNA. In the initial complex RNA polymerase remains compact with no 
unwinding of the DNA. This Is followed by a concerted transformation to an Intermediate complex 
whereby DNA unwinding and RNA polymerase extension take place resulting In the formation of an 
equivalent complex to that observed on the lac UV5 pathway. Transition to the open complex 
would then be common in both pathways (Travers, 1987a).
To what extent the observed differences leading to open complex formation on different 
promoters relate to an intrinsic variability In promoter function, or simply reflect assay conditions 
which are not fundamentally comparable, remains to be elucidated. However, If as suggested by 
Travers (1987a) that the structure of free RNA polymerase Is a determinant of the pathway leading to 
open complex formation, then defined variation In reaction conditions should uncover alternative 
pathways to open complex formation from the same promoter.
1.7 Regulation of Transcription in E. coli
The rate of transcription Initiation at the majority of bacterial promoters Is regulated in concert 
with the cellular requirement for the expression of particular genes. In general, this regulation 
occurs at two levels, the first of which Is a direct modulation of the specificity and overall affinity of 
RNA polymerase for a particular class of promoter mediated by sigma factor substitution and by 
Interaction with regulatory nucleotides. The second level of control Is governed by regulatory
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proteins which Interact primarily with additional sequence- specific DNA binding sites, usually In 
close proximity to the polymerase binding site, which can act either positively or negatively to control 
transcription on particular transcription units (Hochschild etal., 1983).
Repressors of transcription Initiation bind to specific DNA sites (operators) In the vicinity of the 
promoter. These operator sequences have been found In regions as far upstream as -60 and 
downstream as far as +12. and have also been shown to overlap physically the promoter in their 
DNA sequence (reviewed by McClure, 1985). In addition, there appears to be a wide spectrum of 
repressor-operator affinities ranging from a dissociation constant of ~10-11 M for E. coll lac (Barklay 
and Bourgeois, 1978) to 10-7 m for the Arc repressor of phage P22 (A.D. Vershon and R.T. Sauer, 
unpublished observations). Thus the most tightly binding repressors could result In total shutoff of 
transcription Initiation (on a physiological time scale). More weakly binding repressors, on the other 
hand, could contribute simply to a down modulation of transcription -  this might be advantageous to 
the cell In that reduced expression from a particular promoter could then be affected by other 
cellular or phage products.
1.7.1. The Lactose Operon
One of the best studied models for negative control of gene expression Is the lac operon of E. 
coll (Jacob and Monod, 1961: Miller and Reznlkoff, 1980). The expression of lac appears to be 
dependent on two factors -  the presence In cells of an Inducer and cAMP (reviewed by Beckwith, 
1988). In this system, the lactose repressor protein (the product of the lad  gene) binds as a 
tetramer to the operator DNA, physically blocking RNA polymerase/promoter DNA interactions and 
hence transcription Initiation of the lactose metabolic enzymes. Induction of transcription by binding 
of Inducer sugars to the repressor causes a conformational change In the repressor resulting in a 
lowered operator DNA binding affinity. RNA polymerase can now bind to the lac promoter region 
and transcription of the lac gene cluster occurs.
From studies Involving chemical and enzymatic probing techniques, proteolysis, as well as 
mutagenesis of both the repressor and Its operator site (Straney and Crothers, 1987 and 
references therein), a great deal is now known about the structure of the lac repressor, and how It
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binds DNA. Kinetic and equilibrium studies of repressor-operator Interactions have also been 
carried out (Fried and Crothers, 1981) and a detailed picture of the binding of lac repressor to its 
operator site is now emerging. The main features resulting from these studies are a high equilibrium 
binding constant (Keq ~10-13 M; Winter and von HIppei, 1981) and two regions of the protein which 
contribute to specific binding. The first of these regions, the N-terminal region, contains a putative 
"helix-turn-helix” motif (Weber etal., 1982) and the remaining "core" region which Is required for 
binding In a specific Inducer-sensitive manner (Manley etal., 1983).
Experiments to determine the stoichiometry of operator sequences/repressor tetramers 
suggest that the repressor protein occupies two operator sites on the DNA simultaneously 
(reviewed by Hsieh etal., 1987). Fried and Crothers (1984) have also demonstrated, by 
electrophoretic analysis of repressor/DNA complexes In direct transfer experiments of repressor 
protein between operator and non-specific DNA, results consistent with the binding of repressor at 
two operator sites. In addition, Barbler et al., (1984) found two non-specific DNA binding sites on 
the lac repressor by cross-linking small DNA fragments to the protein.
In the lac operon two regions of DNA sequence (pseudooperators), in addition to the primary 
operator, have been found which bind the repressor, albeit with a lower affinity to that of the primary 
sequence (reviewed by HsIeh et al., 1987). The specific function of these pseudooperators Is 
unclear at present but Winter and von HIppel (1981) have pointed out Increased binding affinities 
when pseudooperators accompany the primary operator sequence on DNA fragments. A role for 
these sequences In stabilising binding via an Intramolecular ternary complex of 
operator-repressor-pseudooperator, forming a looped double stranded structure, has recently 
been suggested (Whitson et al., 1986). Hsieh and coworkers (1987) examined the influence of 
sequence and distance between two operators on lac repressor binding and obtained results 
consistent with the formation of operator-repressor-pseudooperator ternary complex to generate a 
looped structure -  complex formation was not observed when the two operators were too distant 
(>400 bp) or too proximal (<100 bp). Ternary complex formation was found to be dependent on the 
energy required for DNA binding to form the complex, phasing of the sequences along the DNA , 
local concentration of the second site and the relative affinity of the repressor for the DNA
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sequence at the second site. The mechanism by which the protein searches for the second 
binding site once It Is bound at the first site has not been determined but It will clearly be of great 
Interest.
The three-dimensional structure of DNA under the Influence of negative supercoiling has 
been found to be critical In the modulation of gene expression in both prokaryotes and eukaryotes 
(reviewed by Gellert, 1981). Whitson and coworkers (1987), using a variety of 
operator/pseudooperator-containIng, negatively supercoiled plasmid DNAs, examined the 
dissociation of the repressor-operator complex as a function of the sequence context, orientation 
and spacing. Their finding s were consistent with formation of an Intramolecular complex with a 
looped DNA segment stabilised by the combination of Increased local concentration of binding sites 
and torsional stress on the DNA which favour binding In supercolled DNA. Comparison of these 
results with observations In more complex systems, where effects of enhancer sequences on 
transcription occur at large distances from the transcription Initiation site, should prove most useful.
Straney and Crothers (1987) demonstrated that the lac repressor can bind to the L8UV5/ac 
promoter at the same time as RNA polymerase and that the contacts with the DNA In such a ternary 
complex were different from those made by either protein alone. Another surprising finding, which 
contrasts with most models of prokaryotic repression for lac repressor as well as others (Majors, 
1975; Ptashne et ai, 1980), was that the repressor exerted its effect at the isomérisation step and 
not at the Initial binding step. It should be stressed however that just as Individual activators such as 
CAP and lambda repressor have been shown to act at different steps (Hawley and McClure, 1982) 
there Is no reason why different repressors cannot repress at different steps. It Is likely that 
repressors Inhibit RNA synthesis by a variety of mechanisms and that it cannot be presumed that the 
overlap of polymerase and repressor binding sites will simply exclude polymerase binding In the 
presence of repressor.
Yet another major finding of Straney and Crothers (1987) Is that the lac repressor can act as a 
transient gene activator. They could show that at low polymerase concentrations the presence of 
lac repressor (and then the gratuitous Inducer IPTG) increased the rate of the first round of 
productive transcription thereby allowing the system to respond rapidly to the release of repression
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and making the repressor a more efficient regulator in the cell. A somewhat analogous situation has 
been described In eukaryotes (Gilmour and Lis, 1986) in which RNA polymerase I! has been found 
to bind to a heat shock promoter In the absence of activating factors -  transcription does not occur 
but polymerase Is stably bound waiting to be activated.
The catabolite gene activator protein (CAP), or cAMP receptor protein (CRP), together with 
Its cofactor cAMP, regulates the expression of several catabolite-sensitive opérons In E. coli (Adhya 
and Garges, 1982). This regulation Is brought about by the specific binding of CAP-cAMP to sites 
within catabolite sensitive promoters. The sequence of these sites Is somewhat variable, as is their 
location relative to the transcription start site among different promoters, suggesting that the 
influence of the CAP/DNA complex on the RNA polymerase open promoter complex is variable 
(DeGrazia et al., 1985). However, the ability of CAP-cAMP to act as a repressor of transcription for 
some promoters (Alba, 1983) must also be taken Into account when formulating any mechanism of 
CAP-cAMPs enhancement of transcription.
An initial model, put forward to explain the mechanism of activation of CAP-cAMP, proposed 
that CAP-cAMP, when bound to the DNA, interacts directly with RNA polymerase (Gilbert, 1976). A 
more recent model to elucidate CAP activation, indicates that CAP-cAMP stimulates mRNA 
expression of the gal and lac opérons by blocking RNA polymerase from binding to a strong 
binding but weak transcription site, thereby allowing RNA polymerase to bind a nearby productive 
initiation site (reviewed by DeGrazia etal., 1985). DeGrazia and coworkers (1985) examined the 
effect of CAP on the thermal stability of DNA and results from their studies Indicate that site-speclfic 
CAP-cAMP binding stabilises the promoter site. This physical behaviour Is consistent with CAP 
functioning as a repressor by blocking RNA polymerase interaction at strong Initiation sites, and as 
an activator by displacing RNA polymerase from poor Initiation regions to good initiation regions. It Is 
also possible that the Influence of CAP-cAMP on RNA polymerase may Involve other Interactions as 
a consequence of DNA bending and/or proteln-protein contacts -  the Idea of a transmitted change 
In the DNA has still to be established.
The CAP protein contains 209 amino acid residues and can be divided Into two distinct 
domains (Figure 4). The C-terminal domain binds DNA while the N-termlnal domain binds cAMP and
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Figure 4. The CAP monomer and the proposed Interaction between the 
C-termlnal domain of CAP and Its binding site In the lac operon
A digramatic representation of the CAP monomer Is shown In A. The position of each domain Is 
Indicated, as well as their primary functions (McKay etal., 1982). The proposed Interaction 
between the C-termlnal domains of a CAP dimer and the CAP binding site in the lac operon Is 
outlined In B. Filled dots Indicate phosphate groups in the DNA backbone contacted by the 
protein (Steitz and Weber, 1983).
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provides a surface for most of tfie CAP dimer contacts, in soiution, CAP forms a stable dimer and it is 
tills dimer wiiich is the active DNA binding species (reviewed by Pabo and Sauer, 1984). The 
N-terminai domain comprises 135 amino acids which consist of two short helices (A and B), an 
eight-stranded antiparallei B-roli and a long alpha-helix (C). The C-terminal domain includes amino 
acid residues 136-209 and contains three alpha helices (D, E, and F) and two pairs of short 
antiparallei B-strands as shown In Figure 4A. The CAP dimer contacts, which are in the N-terminal 
domain, involve a pairing of the C-heiices as well as some additional contacts between the C-heiix of 
one subunit and the B-roil of the other subunit. Part of this dimer interface is also occupied by the 
cAMP which is completely buried within the interior of the N-terminai domain but it forms H-bonds 
which span the dimer interface (McKay etal., 1982).
The sequence of the CAP binding site in the lac promoter exhibits marked two fold symmetry 
which is mirrored by the pattern of CAP-induced protection against chemical attack indicating that 
the dimeric CAP molecule binds symmetrically (reviewed by Busby, 1986). Current data suggest 
that CAP binds to right-handed B-DNA using the N-terminai portions of its F helices to contact the 
major groove. Each of the DNA binding regions in the two CAP subunits appear to bind to one of 
the symmetric sequence elements of the CAP binding site and based on these findings a plausible 
molecular model has been proposed for CAP-DNA interactions (Weber and Steitz, 1984). In this 
model, residues in the "helix-turn-helix" motif on the two subunits bind to bases that appear In two 
adjacent major grooves (Figure 4.B). The centre of symmetry in the DNA binding site corresponds 
approximately to the centre of symmetry in the protein. Mutational analysis confirms that DNA 
binding is determined by the correct juxtaposition of two “helix-turn-helix” motifs and that the 
specificity of binding depends on the exact amino acid sequence in this zone.
1.7.2 The Tryptophan Operon
The synthesis of L-tryptophan in E. coli is regulated in part by repression of the biosynthetic 
operon {trpEDCBA ) for L-tryptophan, and aroH whose gene product catalyses the first step in 
amino acid biosynthesis (ZurawskI etal., 1981 ; Kelley etal., 1982). Repression of these opérons is 
regulated by a straight forward negative feedback loop -  as the concentration of L-tryptophan
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increases two molecules of L-tryptophan bind to the inactive trp aporepressor (a dimer of two 
identical 107 amino acid subunits) forming the active trp repressor which binds as a dimer in a 
sequence-specific manner to operator DNA of these opérons (Joachimlak etal., 1983a). In the 
same way, the trp repressor is also autoregulatory since it decreases transcription of the tipR gene 
which encodes the trp aporepressor polypeptide.
In addition to regulation by repression, a second control mechanism -  transcription attenuation 
-  is used to regulate the structural genes of the trp operon. The transcription start site in the trp 
operon is separated from trpE (the first major structural gene) by a leader region of -160 bp 
(Yanofsky et al., 1984). This region is responsible for attenuation control, which provides the option 
for transcription termination. This leader RNA segment contains a coding region for a 14 amino acid 
peptide, the most significant feature of which is the presence of two Trp codons, in tandem, near its 
distal end (Das et al., 1983). The inability to translate these Trp codons results in the relief of 
termination at the attenuator, leading to continuation of transcription of the structural genes. 
Transcript segments that can form a stable hairpin loop, followed by a run of Us, are located just 
downstream of the leader coding region (Kuroda and Yanofsky, 1984). When transcription 
terminates in the trp operon leader region, the transcript ends with a run of Us. There is a growing 
body of evidence (reviewed by Yanofsky, 1988) to suggest that the transcribing RNA polymerase 
molecule recognises this structure as a Rho-independent termination signal.
The leader transcript can form two additional hairpin structures, the pause and antiterminator 
structures, each of which plays a crucial role in attenuation. The promoter proximal hairpin causes 
transcription pausing which may be responsible for synchronising transcription of the leader region 
with translation of the peptide coding region (Kuroda and Yanofsky, 1984; Winkler and Yanofsky, 
1981). It may be that polymerase pausing introduces a transcription delay allowing time for a 
ribosome to load onto the leader transcript and begin synthesis of the leader peptide. The moving 
ribosome may in turn disrupt the pause complex thus restoring active transcription. When the 
translating ribosome completes synthesis of the leader peptide, the terminator structure 
presumably forms and transcription termination occurs. If however the translating ribosome stalls at 
either of the Trp codons (as a consequence of inadequate levels of charged tR N A T r p )  then the
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antiterminator hairpin forms (Kuroda and Yanofsky, 1984). Thus the availability of charged tRNATrp 
determines which RNA hairpin wlli form in the leader transcript which in turn controls transcription 
termination in the trp operon.
The determination of the three-dimensional structure of DNA binding proteins (Pabo and 
Lewis, 1982: McKay and Steitz, 1981) has provided a general framework with which to understand 
the interactions of proteins with regulatory sequences in DNA. Of special interest is the structural 
basis of trp repressor's function because its regulatory role is modulated by binding of the small 
molecule, L-tryptophan. Altered patterns of crystallisation (Joachimlak et al., 1983b) and proteolysis 
(Tsapakos etal., 1985) have suggested that the binding of L-tryptophan produces a conformational 
change that may be responsible for the activation of the aporepressor to the repressor.
The crystal structure of the E  coli trp repressor has been solved to atomic resolution by 
Schevitz and coworkers (1985). They deduced that 77 of the 107 amino acid residues form six 
alpha helices connected by short runs and all but one of the helices of one subunit make contact 
with some part of the opposing subunit. This makes the dyad-reiated subunits so completely 
interlinked that it would be difficult to disengage them without significantly altering their tertiary 
structures. The crystal structure described by Schevitz et al., (1985) is of the active repressor and 
contains two equivalent molecules of L-tryptophan per dimer. Both subunits of the repressor 
contribute to each of the two symmetrical tryptophan binding sites which are located in a natural 
cavity near the surface of the trp repressor. The DNA surface which interacts with the repressor was 
indicated by several observations. First, it contains as a prominent surface feature the "helix-turn 
helix” motif that has both sequence and structural homology to the DNA binding proteins cro 
(Anderson etal., 1981), lambda repressor (Pabo and Lewis, 1982) and CAP (McKay and Steitz, 
1981). This presumed interactive surface is separated from its dyad-reiated counterpart by one full 
turn of the DNA double helix. Second, this interactive surface holds the pocket containing the 
L-tryptophan site. Figure 5A shows the overall appearance of the modelled repressor/operator 
complex. In addition to the interaction of the “helix-turn-helix" elements (helices D and E) with the 
major groove, there is a more central contact surface in which the DNA backbones on either side of 
the minor groove approach the repressor surface close to the common dyad of the complex, but,
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Figure 5. Models for the Interaction of trp repressor with operator DNA
A. Schematic representation of the docked Trp repressor dimer with B-form DNA. The ochelices 
of trp are represented by cylinders and the operator DNA is shown as a ladder with the rungs 
representing base pairs. The 4 bp In each operator half site critical for binding are indicated by the 
bold rungs; dots in the centre of each molecule define dyad axes (Bass et al., 1988).
B. Schematic view of the upper half of trp operator as “viewed” by trp repressor showing 
phosphates (circles with numbers) and repressor’s functional groups (shown by arrows) that form 
direct H-bonds (Otwinowski etal., 1988).
C. Schematic view of the amino acid positions (circled amino acid numbers) in the 
“helix-turn-heiix” substructure that make direct H-bonds to the operator (shown by arrows). The 
Figure stresses that the second helix, or E-helix, of the bi-heiicai motif Is “pointed into” the major 
groove with its helical axis almost perpendicular to the global DNA axis. The E-helix does not lie 
in the major groove with its axis parallel to the groove (Otwinowski et al., 1988).
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the bases in the minor groove do not appear to be in contact with the repressor {Schevitz et al., 
1985). It would seem that the “helix-turn-helix" motif of the trp repressor is related to its operator in 
a similar manner to that of lambda repressor (Lewis etal., 1983) rather than that of cro (Ohlendorf et 
al., 1982). The much shorter D helix of trp repressor fits across the major groove between the 
sugar-phosphate backbone.
The roles of bound tryptophan appear to be at least two-fold (Schevitz et al., 1985). Since 
L-tryptophan is wedged against the side of helix E, the ligand stabilises the functionally critical 
orientation of the "helix-turn-helix" substructure that is responsible for the operator-specific 
contacts. The second role is more local and results from interactions of the bound tryptophan’s 
carboxyl and amino groups with functional groups of the repressor near its DNA binding surface.
Mutant trp repressors with new DNA binding specificities have been identified (Bass et al., 
1988). Thirty-six mutant repressors (each with single amino acid changes) were analysed for their 
ability to bind to each member of a set of 28 different operators closely related to the tip operator 
consensus sequence. Mutations that create new binding specificities create new contacts 
between the repressor and operator. Or, alternatively, they could eliminate negative interactions 
between the wild type amino acid and wild type operator. In vivo interaction of wild type Trp 
repressor with the mutant operators revealed that four adjacent base pairs of a half-site are critical for 
binding (Bass et al., 1987). The new specificities indicate that the hydroxyl group of Thr^i makes a 
specific contact with one of the four critical base pairs and the methyl group of Thr^l determines the 
specificity at a second critical base pair. Unlike lambda repressor, lambda Cro protein and coliphage 
434 repressor, the Trp repressor does not appear to use the first two hydrophobic amino acids of its 
“recognition alpha-helix", lle^Q and AlaSO, to make sequence specific contacts with the DNA. 
Instead, specific contacts between Trp repressor and its operator occur via amino acid side chains 
from both the first alpha-helix (D) and the second aipha-helix (E) of the "helix-turn-helix" 
substructure (Bass etal., 1988).
Zhang and coworkers (1987) have reported the crystal structure determination and refinement 
of trp aporepressor to a nominal resolution of 1.8Â and have contrasted this with the partially refined 
model of the trigonal crystal form of the repressor described above (Schevitz et al., 1985). Their
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findings sfiow that binding of L- tryptophan activates the repressor dimer 1000-fold by moving two 
symmetrically-disposed flexible bihelical motifs. These flexible "DNA reading heads" flank a highly 
inflexible core domain formed by an unusual arrangement of interlocking alpha-helices from both 
repressor subunits. It would appear that the appropriate shape and orientation of the repressor's 
reading head is a crucial feature for operator-specific binding and that it is this conformation that is 
modulated in the aporepressor-repressor transition. The structural changes in the flexible reading 
heads involve two alternative arrangements of buried residues in the hydrophobic brace (a cluster of 
hydrophobic residues in the repressor), in the active conformation of the repressor, the indole ring 
of bound tryptophan is a fundamental part of the brace that stabilises what would be an otherwise 
unstable conformation. However, in the inactive conformation of the aporepressor, an alternative 
arrangement of buried hydrophobic side chains forms a stable compact brace in the absence of 
tryptophan. This conformation of the DNA reading heads in the aporepressor produces a surface 
non-complementary to the recognition surface of the operator.
The crystal structure of the trp repressor/operator complex, refined to 2.4Â resolution, has 
recently been determined (Otwinowski e ta l, 1988). The co-crystal shows an extensive contact 
surface between the Tpr repressor and its operator which includes 24 direct and six 
solvent-mediated H-bonds to the phosphate groups of the DNA. These water-mediated H-bonds 
to six bases have been demonstrated, in vivo , to be important in specifying the operator as the 
target sequence for the trp repressor (Bass etal., 1987). There are 14 direct H-bonds between the 
half-repressor/half-operator and all but two of these are involved in the unesterifled oxygens of the 
six phosphate groups. The exceptions are the two direct H-bonds between A rg69 and the 
functional groups of G-g (Otwinowski etal., 1988). Of the 14 direct contacts to the half-operator, 
four are made by amino acid residues which do not form part of the "helix-turn-helix" motif implying 
that specificity in this instance is not due to direct H-bonded contact of the major groove's polar 
groups by the H-bonding groups of the protein (von Hippel and Berg, 1986). It is believed that in 
the trp repressor/operator system, a primary mode of sequence-specific recognition is that the 
operator sequence enables the DNA to adopt a characteristic conformation that will make 24 direct 
H-bonds to the protein through its phosphate groups and increase the solvent- excluded surface
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(Otwinowski et ai, 1988). Since four of the H-bonded phosphates in the promoter accept more that 
one H-bond and two of these are caged by three direct H-bonds, means that the DNA backbone 
must adopt a very precise geometry. This in turn permits the formation of a stable interface. Figure 
5.B and C show residues involved in direct contacts between trp repressor and operator. 
Specificity in the trp repressor/operator system appears to be independent of a simple 
complementarity between the repressor amino acid side chains and operator bases. Rather, it is 
dependent on a combination of solvent mediated interactions with crucial bases and as yet poorly 
understood principles governing the way nucleotide sequence restrains the conformation of B-form 
DNA (Otwinowski etal., 1988).
1.7.3 The LexA Repressor
E. coll has developed a system of -20 genes involved mainly in the repair of DNA damage and 
enhanced mutagenesis known as the “SOS system". The “SOS” genes are expressed upon 
induction of the SOS machinery by chemical and/or physical carcinogens (reviewed by Little and 
Mount, 1982). These DNA modifications in vivo lead to the production of an “SOS signal” which in 
turn activates the existing cellular pool of RecA protein which catalyses the specific cleavage of the 
LexA protein, the common repressor of all the SOS genes including the recA and lexA genes.
LexA can essentially be viewed as a two domain protein with a flexible hinge region linking the 
two structural domains (Little and Hill. 1985). At alkaline pH, LexA undergoes a self-cleavage 
reaction at the Ala-84-Gly-85 bond within the hinge region, generating the same two protein 
fragments as in the RecA-mediated cleavage reaction. The two fragments have been purified and 
the N-terminal fragment shown to harbour the DNA binding site of the protein (Hurstel etal., 1986). 
It has also been shown that the C-terminal domain dimerises in the same way as the entire protein 
(S. Hurstel, M. Granger-Schnarr and M. Schnarr, unpublished observations). No high resolution 
structural information is available as yet for LexA, and it remains to be determined whether the 
protein contains the common “helix-turn-helix” motif found in many other regulatory proteins 
(reviewed by Pabo and Sauer, 1984). However, there is some evidence that the N-terminal 
fragment of LexA contains a substantial amount of alpha-helical structure(Hurstel etal., 1986). To
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compare the overall positioning of LexA on the DNA double helix with that of other repressors with a 
known three-dimensional structure, Hurstel and coworkers (1988) carried out hydroxyl radical 
footprlnting and éthylation Interference experiments to determine the backbone contacts of the 
entire LexA repressor and its N-terminal fragment, with recA operator DNA. Both these methods 
are complementary in that hydroxyl radicals primarily attack the deoxyribose residues (Tullius and 
Dombroski, 1986) whereas ethylnitrosourea reacts mainly with phosphate groups of the DNA 
backbone (Siebenlist and Gilbert, 1980), enabling non-identical but closely related parts of the DNA 
backbone to be probed. These techniques revealed essentially the same contacts between both 
proteins and one side of the DNA double helix (assuming that the DNA stays in the normal 
B-conformation). This result was somewhat unexpected since méthylation protection studies 
(Hurstel et al., 1986) suggested a somewhat twisted recognition surface. In an attempt to reconcile 
the two sets of data (that Is, backbone and major groove contacts), Hurstel et al., (1988) propose a 
model whereby the bulk of the protein body sticks to one face of the DNA helix through contacts 
with the DNA backbone, and a protruding “reading head" probes the bottom of the major groove 
(where recognition takes place) slightly sideways. The backbone contacts are symmetrically 
disposed with respect to the centre of the operator indicating that the operator binds two LexA 
monomers. A comparable, but non-identical, relative disposition between backbone contacts and 
recognised base pairs has been demonstrated in the case of lambda repressor (Ptashne et al., 
1980; Tullius and Dombroski, 1986). Obviously this similarity is insufficient to conclude that LexA 
contains the structural “helix-turn helix” motif, but it is certainly an argument in favour of this 
possibility.
Another slight difference between the backbone contacts of LexA and lambda repressor 
concerns the relative "weight” of the protected regions in that LexA has a greater number of 
contacts in the outer part of each operator half site whereas lambda repressor shows the opposite 
behaviour (Hurstel et ai, 1988). One might speculate at this stage that if LexA contained the 
common “helix-turn-helix” substructure, the roughly inverted backbone contact pattern could arise 
from an ~180® rotation of the “helix-turn-helix” motif upon insertion into the major groove -  such a 
rotation has recently been suggested by Boelens et al., (1987), in the case of the lac repressor.
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1.7.4 The Galactose Operon
Three of the enzymes involved in the galactose metabolism pathway in E  coli are encoded by 
the galK, gall and galE genes which constitute the galactose {gal) operon. The induction of the gal 
genes by galactose or fucose is inhibited by the presence of glucose in the growth medium 
(Dreyfus etal., 1985; Monod, 1947). The gal operon contains two promoters, Pgi and Pq2. the 
first of which requires cAMP and CRP, and the second which is normally inhibited by cAMP and CRP 
(this promoter functions in cells devoid of cAMP or functional CRP, under which conditions the 
original promoter becomes defective) (reviewed by Adhya, 1988). The presence of two promoters 
and their opposing controls, mediated by cAMP, ensures that the enzymes are available in both 
normal physiological conditions and catabolic repression.
The two gal promoters overlap slightly residing within the -52 to +19 region. Both promoters 
have their own -35 and -10 consensus sequence regions and it is likely that RNA polymerase has 
the option to form a closed complex and then an open complex at Pqi or Pq2 in a mutually 
exclusive way (reviewed by Adhya, 1988). It is believed that binding of a single molecule of 
cAMP.CRP at the -37 region inhibits Pq2 activity by steric hindrance of the corresponding closed 
complex formation by RNA polymerase at the -40 to +10 region (McClure, 1980). The mechanism of 
cAMP.CRP activation of Pqi remains to be elucidated.
Regulation of the two gal promoters is mediated through the Gai repressor, the product of the 
unlinked gaIR gene (Buttin, 1963). Inactivation of the repressor by the addition of galactose or 
fucose derepresses the operon. Genetic and biochemical studies have shown that the gal operon 
contains two operator loci, Oe and 0|, which show strong sequence homology and are located at 
-60 and +55 respectively (reviewed by Adhya, 1988). Each homologous sequence contains a dyad 
symmetry. Mutation at either site may cause derepression of Pqi and Pq2- The Gai repressor has 
been shown to bind specifically to the two operators (Majumdar and Adhya, 1984; Adhya and 
Majumdar, 1987). Active Gal repressor is a dimer in solution and as such each symmetrical 
sequence in Oe and 0| is probably recognised by the dimer (Nakanishi et al., 1973). The N-terminal 
domain of Gal repressor binds DNA and makes specific contacts, through the second alpha helix of
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a "helix-turn-helix” motif, in the major groove of the DNA; the C-terminal domain is responsible for 
dimérisation and inducer contact (von Wllcken-Bergmann et al., 1982). Binding of the inducer to 
the C-terminal domain inactivates specific DNA binding ability of the N-terminal domain by ailosteric 
alteration of the protein.
A striking feature of the organisation of the gal operon is the existence of the two essential 
operators separated by more than 100 bp which flank, but do notoverlap, the promoters (reviewed 
by Adhya, 1988). Several models have been proposed to explain the mechanism by which the Gal 
repressor acts, neither of which are exclusive, nor mutually exclusive (Irani, etal., 1983; Majumdar 
and Adhya, 1984; Adhya, 1988). Repressor action is thoughj'to be brought about by steric 
hindrance of RNA polymerase. Gal repressor bound to O e , because of its close proximity to the 
promoter, may hinder RNA polymerase or CRP entry to, or activity at, the promoters, or both (this is 
assuming that repressor binding to Oe is weak and thus that repressor bound to 0; interacts with 
repressor at O e  and prevents dissociation of repressor from O e ). Alternatively, RNA polymerase 
could enter the gal promoters from outside the 0 e - 0 |  DNA segment and gain access to the 
promoters. Repressor occupation of both O e  and 0| (which do not overlap the promoters) could 
block rapid access of RNA polymerase to the promoters. In a third model, repressor bound to Oe 
and 0| could form a complex via protein-protein interactions generating a DNA loop with a 
topologically independent DNA domain containing the promoter region. This DNA domain could 
have an altered promoter conformation which does not support RNA polymerase activity. Finally, 
binding of repressor to Oe and 0| could facilitate further binding of more repressor to the 
intervening DNA (which includes the promoters). This would "cover up" the intervening DNA, 
thereby preventing RNA polymerase binding in this region. Alternatively, repressor occupation of 
Oe and 0| may signal the condensation of another, say histone-like, protein in the promoters 
(reviewed by Adhya, 1988).
Although the overall genetic circuitry of the gal and other opérons may be known, many 
questions still remain to be answered. For instance, how does the switch from cAMP-inhibited to 
cAMP-activated promoter occur? How are the genes in the operon coordinated from a
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non-coordînated model? And how does repressor occupation at two distal operator sites modulate 
two intervening promoters? Answers to these questions will be invaluable in determining the 
mechanisms of transcriptional control at the various steps.
1.8 Control of Gene Expression in Bacteriophage
That phage lambda (>) is able to grow in two different modes has provided us with an invaluable
insight into the regulation of gene expression, in a X-infected bacterium, the phage chromosome
can enter the lytic cycle whereby various sets of phage genes are switched on ,or off, as directed by
a precisely regulated series of events. The Xchromosome is then extensively replicated, phage
proteins synthesised, new phage particles packaged within the bacterium, followed by bacterial lysis
releasing -100 phage some 45 minutes post-infection. Alternatively, the phage chromosome can
lysogenise its host cell. All but one of the phage genes, i.e. that coding for the Xrepressor, are
switched off. Integration of the phage chromosome into the host chromosome then occurs where
-to
it is passively replicated and distributec t^he progeny bacteria, if unperturbed, this process can carry 
on indefinitely, with phage production occurring only very rarely. The phage chromosome can 
utilise bacterial enzymes to "sense” an impending demise of its host and can then abandon its 
passive replication pathway (reviewed by Ptashne, 1986b).
in very broad terms the switch from the lysogenic to the lytic state works in the following way. In 
a lysogen, a single phage gene, encoding the A-repressor, is on. The protein acts both positively 
and negatively to regulate gene expression. Binding of Xrepressor to six sites, within two operator 
regions, on the phage DNA can turn off all other phage genes at the same time as switching on its 
own gene. There are -100 active molecules of repressor per lysogen. The excess repressor is free 
to bind to an additional Xchromosome which may be injected into that cell thus preventingXfrom 
growing lytically on aX-lysogen. Ultra violet irradiation of lysogens inactivates the repressor resulting 
in the synthesis of a second phage regulatory protein, Cro, which promotes, and is required for lytic 
growth. This protein binds to the same operator sites on the phage DNA as does repressor, but 
with opposite physiological effects. Lambda Cro and repressor, together with RNA polymerase, and 
their promoter and operator sites on the DNA, constitute the "genetic switch”, where, in a lysogen.
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the repressor gene is on and the Cro gene off, and where, during lytic growth, the Cro gene is on 
whereas the repressor gene is off (reviewed by Ptashne, 1986b).
Despite differences in size, domain organisation and tertiary structure, Xrepressor and Cro 
interact with DNA in essentially the same way. Each binds to operator DNA as a dimer and usesoC' 
helices to contact adjacent major grooves along one face of the DNA double helix (reviewed by 
Pabo and Sauer, 1984).
The cl and cro genes which encode Xrepressor and Cro are adjacent and divergently 
transcribed from the Xchromosome (Figure 6). The mRNA start sites of these two genes are 
separated by ~80 bp and within this region lie promoter and operator sequences which are directly 
involved in the binding of Cro and repressor (reviewed by Ptashne, 1986b). The intergenic region 
contains two promoters. One of these, Pr, directs rightward transcription of a set of early genes, 
including cro. The other promoter, Pr m , directs leftward transcription of cl in a lysogen (Ptashne et 
al., 1980). A tripartite operator, O r , overlaps these two promoters. Three adjacent sites, O r I  , O r 2 
and O r 3 comprise O r , the right operator of X. Each of the operator sites overlaps one or the other 
promoter, or, in the case of O r 2, both of the promoters (Figure 6) (reviewed by Ptashne, 1986b). 
Each of the three operator sites is a 17 bp, the sequences of which are similar, but non-identical, 
and each of which is approximately symmetric. These sites are recognised specifically by both 
repressor and Cro; each protein having different affinities for the individual sites (Ptashne et al.. 
1980).
1.8.1 The Action of Lambda Repressor
Lambda repressor acts as both a negative and a positive regulator of transcription. Repressor 
dimers normally bind cooperatively to adjacent operator sites O r I  and O r 2, the dimer at O r I  
helping a second to bind to O r 2, and block transcription of the early lytic genes when bound at 
these sites (reviewed by Hochschild and Ptashne, 1988). Stimulation of repressor transcription 
from Pr m  appears to involve contact between repressor bound at O r 2 and RNA polymerase bound 
at Pr m - The repressor protein contains 226 amino acids and can fold into two nearly equal sized
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BFigure 6.Xgenes and regulatory elements
A.A portion of the X genome. The arrows indicate the directions' and start sites of transcription of 
various genes. O lP l and O r Pr  are the left and right operator and promoter regions, respectively. 
P r m  is the cl promoter active in a lysogen.
B. An expanded diagram of the X o r  region. 0 r1  , O r2 and O r3  are the 17 bp repressor and Cro 
binding sites. The start sites of transcription from Pr  and P r m , which are located outside the 
operators, are indicated (Ptashne et al., 1980).
domains connected by a string of 40 amino acids. The amino terminal domain contacts the DNA and 
RNA polymerase (Pabo and Lewis, 1982), and the carboxyl domain which facilitates dimer formation 
and mediates interaction between dimers (Sauer et ai, 1979). Each of the three sites in O r  can 
bind one repressor dimer. The sole role of O r I  (a high affinity binding site for repressor) is to help 
ensure the occupancy of O r 2 (a weak repressor binding site), which means that at higher 
concentrations repressor can bind to O r 2 and activate transcription in the absence of repressor 
bound at O r I  (Meyer et ai, 1980).
Positive control of transcription by repressor is mediated by the action of repressor at O r 2 
helping RNA polymerase to bind and begin transcription at Pr m  (which governs transcription of cl in 
a lysogen). This increases the rate of transcription -tenfold. The repressor dimer bound to O r 2 
increases the affinity of P r m  for RNA polymerase since protein-protein contacts as well as RNA 
polymerase/DNA contacts are required to position the polymerase. A repressor dimer bound at 
O r 2 therefore represses Pr  by excluding the binding of RNA polymerase to that promoter (Meyer 
et ai, 1980). This in turn prevents transcription to the right but facilitates transcription to the left (a 
difference which is attributed to O r 2 being slightly closer to P r  than to P r m )- A repressor dimer 
bound at O r I  would block binding of RNA polymerase to P r  but would be too far away to affect 
polymerase at P r m  which functions only at a very low level since no repressor is bound at O r 2. 
Binding of a single repressor dimer at O r 3 would block binding of RNA polymerase to Pr m  and have 
no effect on transcription from Pr . In summary, when Xrepressor acts as a positive regulator of 
transcription, repressor dimers are nearly always bound at O r I  and O r 2 with O r 3 being generally 
free of repressor. This arrangement of repressor at O r  turns off transcription from Pr  but turns on 
Pr m - In this way repressor, but not Cro, is synthesised (reviewed by Ptashne, 1986b).
Interaction of repressor dimers with the three operator sites is dependent on two factors. The 
first is the affinity of repressor for each isolated site in Or -  this is known as the “intrinsic" affinity of a 
site and can be measured using Or DNA in which neighbouring sites are mutated such that they no
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longer bind repressor. The second factor affecting the order of binding is the interaction of 
repressor dimers at adjacent binding sites (Ptashne etaL, 1980). Just as repressor at O r 2  assists 
binding of RNA polymerase to promoter Pr m . so repressors can interact with each other to facilitate 
binding.
The cooperative binding of repressor to O r  was demonstrated in In vitro studies of the binding 
of repressor at various concentrations to wild type and mutant O r  templates (Ptashne etaL, 1980). 
The intrinsic affinities of O r 2 and O r 3 for repressor are approximately equal and are more than an 
order of magnitude lower than that of O r I  . However, over a broad concentration range (including 
that found in a lysogen) O r I  and O r 2 are filled and O r 3 tends to be vacant. This is due to a 
favourable interaction between repressor dimers bound at O r I  and O r 2 which ensures that these 
sites are filled coordinateiy. Yet another favourable interaction between dimers bound at O r 2 and 
O r 3 is apparent if no repressor is bound to O r I .  This cooperativity of repressor binding has been 
ascribed by Ptashne and coworkers (1980) to protein-protein interactions as opposed to 
conformational changes in the DNA transmitted through the double helix (isolated amino domain of 
repressor binds to all three sites in O r  non-cooperatively). It is believed that the flexibility in the 
region connecting the amino and carboxyl domains could orient the carboxyl portion of a repressor 
bound at O r 2 such that it could contact one neighbouring dimer but not another. This contrasts the 
situation found with Cro/operator interactions in which Cro binds non-cooperatively. As with the 
repressor amino domain, mutations of any site in O r  affects the affinity of that site alone for Cro 
(Johnson etaL, 1979).
In a lysogen, repressor bound at O r I  and O r 2 maintain the cro gene in the off position while 
stimulating transcription of Its own gene, cl. As cells grow and divide, repressor is constantly being 
synthesised. However, if the repressor concentration increases, perhaps due to ceil division being 
temporarily Inhibited, then repressor would bind also to O r 3, thus turning off the cl gene. Once ceil 
division had been resumed, and repressor concentration dropped to the proper level, the cl gene 
would then function to provide more repressor. In this way a constant level of repressor is
32
maintained in the cell despite changes in growth rate (reviewed by Ptashne, 1986b).
The concentration of repressor in a cell is high enough to ensure that O r I  and O r 2 are likely to 
be filled at any one time. This means that in the absence of an inducing agent the lysogenic state is 
stable and can thus be maintained more-or-less indefinitely. If the switch from the lysogenic to the 
lytic state is induced then the action of Cro comes into play.
1.8.2 The Action of Lambda Cro
On induction of iysogens with UV light or other inducing agents, the primary effect is to damage 
DNA which leads to quite a marked change in the behaviour of the bacterial protein RecA (Roberts 
and Devoret, 1983). Under normal conditions, RecA catalyses recombination of DNA, but when the 
DNA is damaged, RecA then becomes a highly specific protease that cleaves repressor monomers 
at a site in the region connecting the amino and carboxyl domains. It is this physical separation of 
the two domains that is responsible for repressor inactivation because the separated amino domains 
can no longer dimerise. The affinity of the monomeric domains for the operator is too low to result in 
efficient binding at the concentrations found in a lysogen. This means that as repressor dimers are 
released from the operator, there are too few dimers to replace them (reviewed by Ptashne, 1986b).
As repressor vacated O r I  and O r 2, the rate of repressor synthesis drops; RNA polymerase 
then binds to P r  and transcription of cro is initiated (Ptashne, 1986b). The sequence of events 
which “activate the switch" is now determined by Cro.
Cro dimer binds non-cooperatively to the same three 17 bp sites in O r  as repressor (Ptashne 
etaL, 1980; Johnson etaL, 1981). However, unlike repressor, Cro acts solely as a negative 
regulator of transcription. A salient feature of Cro's action Is the order of its affinity for the three sites 
in O r  which is opposite to that of repressor (Ptashne et aL, 1980). Cro first binds to O r 3 preventing 
RNA polymerase from binding to Pr m  which in turn prevents further synthesis of repressor. At this 
stage the "switch” from the lysogenic to the lytic state is activated and lytic growth ensues. As Pr  
continues to operate and more cro is transcribed, so to are the genes to the right of cro (whose
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products are required for the early stages of lytic growth). Production of Cro continues until a level is 
reached whereby 0 r 1 and O r 2 are also filled and RNA polymerase is prohibited from binding to Pr . 
in this way Cro functions firstly to turn off repressor synthesis and then, at a slightly later stage, to 
turn off expression of its own gene, as well as that of other early lytic genes (reviewed by Ptashne, 
1986b).
So it would appear that the ability of Xto grow in two alternate modes is dependent on the 
interplay of two regulatory proteins with specific sites on the phage DNA. Repressor and Cro bind to 
the same three sites in O r  and it is the order of site occupancy by repressor or Cro which activates 
the switch from the lysogenic to the lytic state. The effects on transcription of the proteins binding 
to O r  can be summarised as follows. Occupation of O r I  and O r 2 (or both) by either protein 
represses P r ; occupation of O r 3 by either protein represses synthesis from P r m - Finally, 
repressor bound to O r 2 stimulates Pr m -
1.8.3 Specific Recognition of Operator Sites by Repressor and Cro
Lambda repressor and Cro, in common with many other repressors and activators, use a 
common structural motif to recognise their binding sites in DNA (reviewed by Pabo and Sauer, 
1984). This consists of a pair ofo^-helices (the “helix-turn-helix” substucture), one of which , the 
recognition helix, protrudes from the surface of the protein and fits into the major groove of the 
DNA. Solvent-exposed residues lie along the external surface of this helix contacting DNA 
functional groups in the major groove (W.F. Anderson et aL, 1981; J.E. Anderson et aL, 1981; 
Wharton and Ptashne, 1985). Hochschild and coworkers (1986) carried out a detailed study to 
explain how repressor and Cro distinguish between O r I  and O r 3 in terms of specific amino 
acid/base pair interactions. Base pair changes were made in the operator sequences as well as 
amino acid substitutions in the proteins to analyse the basis of repressor binding more tightly to O r I  
than to O r 3, and vice versa for Cro. Solvent exposed amino acids were exchanged between the 
recognition helices of repressor and Cro. The sensitivities of these mutant proteins to the base pair 
changes that distinguish O r I  and O r 3 were then tested.
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Models of the proposed contacts made to specific positions in the operator are depicted in 
Figure 7. One half site of both O r 1 and O r 3 is the so called “consensus sequence" with the two 
operators differing at positions 3, 5 and 8 in the other half site (Figure 7A). Provided that flanking 
DNA sequences have no effect on binding, it would seem feasible that Cro and repressor must 
each distinguish between 0 r 1 and O r 3 on the basis of one or more of these three base pair 
differences. If we examine the model describing the interaction of the recognition ©C-helix of 
repressor and Cro with a consensus operator half site, we see that the first two residues in the 
recognition helices (Gin and Ser) contact base pairs at positions 2 and 4, respectively (Figure 7B). 
The base pairs at these two positions are invariant in all 12 lambda operator half sites. This would 
suggest that repressor and Cro make identical contacts to invariant positions in the operator but that 
other residues in the recognition helices (and amino- terminal arm in the case of repressor) are used 
to distinguish between O r I  and O r 3 (Hochschild and Ptashne, 1986). This was indeed shown to 
be the case by Hochschild and coworkers (1986) where they demonstrated that the preferences for 
the two operator sites are determined by amino acid residues 5 and 6 of the recognition helices of 
both repressor and Cro, and by the amino terminal arm in the case of repressor. In addition, the 
most important base pairs in the operator which enable repressor and Cro to discriminate between 
O r I  and O r 3 are position 3 (for Cro) and positions 5 and 8 (for repressor). If the recognition helices 
of repressor and Cro are similarly disposed and the amino acids in the helix function somewhat 
independentiy, then a particular amino acid in one of the two recognition helices should function 
analogously in the other recognition helix. Results from studies in which homologously positioned 
amino acids were exchanged found this to be the case (Hochschild and Ptashne, 1986). This 
suggests that the alignment between amino acid position in the operator is approximately the same 
for the two proteins. So it would appear that both repressor and Cro make an optimal set of contacts 
to the consensus half site and that the two proteins are differentialiy sensitive to a iterations from the 
consensus as seen in the non-consensus half sites of O r I  and O r 3.
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Figure 7. Operator sequences and proposed Interactions with recognition 
helices
A. Comparison of the sequences of 0 r 1  and O r 3  are identical in the consensus half site. In their 
non-consensus half sites, 0 r 1  and O r 3  differ at positions 3,5 and 8. The circled bp each match the 
bp found at the corresponding position in the consensus half site. At position 5, neither 0 r 1  nor 
O r 3  had the consensus bp in the non-consensus half site.
B. Recognition o^-helices of Cro and repressor and models of their proposed contacts. For 
repressor, the contacts are those proposed by Lewis et al. (1982) and for Cro, the contacts are 
those proposed by Ohlendorf ef a/. (1982) and Hochschild ef a/. (1986). Two contacts are shown 
involving amino acids outside the recognition helices. One involves the repressor's N-terminal arm 
and the other makes a proposed contact with repressor's AsnSS (Hochschild et al., 1986).
1.8.4 Phage DNA-Protein Interactions
in addition to phage X, repressor and Cro proteins are aiso encoded by the related phages 434 
and P22. The amino acid sequences of the proteins are homologous especially in a region in which 
repressor and Xcro have a similar “helix-turn-helix" secondary structure (Sauer et ai, 1982). 
Model-building studies indicated that this structure is important in specific binding to DNA and 
indeed this “helix-turn-heiix" motif has been shown to be a common feature of many DNA binding 
proteins (reviewed by Pabo and Sauer, 1984). Even though a known structural motif can be 
assigned to a given DNA binding protein, this still does not allow us to predict how the protein 
actually contacts its binding site, or which residues, if changed, would alter the specificity of the 
interaction. Detailed structural information about site-specific recognition for several DNA-protein 
complexes is needed to ascertain whether or not any general principles arise. Such detailed 
information is now emerging and indeed X-ray crystallographic data on the repressor/operator, 434 
repressor/operator and the 434 Cro/operator complexes is now available (Jordan and Pabo, 1988; 
Anderson etal., 1987; Wolberger et ai, 1988).
The crystal structure of the amino terminal domain of X repressor has been reported and a 
model for the repressor/operator interactions proposed (Pabo and Lewis, 1982; Lewis et ai, 1983). 
More recently the crystal structure of a complex containing the DNA binding domain of Xrepressor 
and a Xoperator site has been determined (Jordan and Pabo, 1988) which has revealed important 
side- chain/side-chain interactions previously unpredicted from modelling or genetic and 
biochemical studies.
The amino-terminal domain of X repressor was co-crystalised with a 20 bp fragment that contains 
the operator site Oi_1 (Jordan and Pabo, 1988). The overall structure of the complex reveals that 
the protein dimer binds by inserting onehe l ix  from each subunit into the major groove of the DNA. 
The complex is roughly symmetric with the twofold axis of the dimer coinciding approximately with 
the twofold axis of the operator site. A similar arrangement was also observed in co-crystals that 
contain the 434 repressor (Anderson et ai, 1987). As previously observed in the protein crystal 
structure (Pabo and Lewis, 1982), the repressor monomer contains fiveot’ helices the first four of 
which form a compact globular domain, with helices 1, 2 and 3 on the face that is closest to the
36
operator DNA (Jordan and Pabo, 1988). Helices 2 and 3 form the conserved “helix-turn-helix” 
substructure. Helix 5 extends out from the globular domain and contacts helix 5' of the other 
protein subunit forming the dimer interface. The amino terminal arm wraps around the DNA and 
makes sequence-specific contacts in the major groove. The operator DNA is primarily B-form DNA 
with the largest deviations from this form occurring at the ends of the operator site, which bend 
slightly towards the repressor.
The repressor contacts sites in the major groove and phosphate oxygens of the DNA 
backbone (Jordan and Pabo, 1988). Gln44, the first amino acid of helix 3, forms two H-bonds with 
the adenine of bp 2 (Figure 8A). The contact made by Gin44 \s stabilised by a H-bond from the 
side-chain of Gln33 (the first residue in helix 2); this residue also H-bonds to the oxygen of 
phosphate Pb - This gives an extended H-bonding network whereby two protein side-chains 
connect a phosphate with a base in the major groove. A similar type of extended interaction 
involving a glutamine at the start of helix 2 and at the start of helix 3 has been demonstrated in a high 
resolution study of 434 repressor co-crystals (Aggarwai etal., 1988). which may help explain why 
the conserved “helix-turn-heiix" substructure generally begins with a glutamine (Pabo and Sauer, 
1984). Ser45 (the second residue in helix 3) H-bonds to the N-7 of guanine 4 (a weaker interaction 
with the 0-6 of this guanine may also occur) (Jordan and Pabo, 1988). AsnSS, which Is in a loop 
three residues after the end of helix 3, H-bonds to the N-7 of guanine in bp 6. The co-crystai 
structure also demonstrates that hydrophobic interactions involving thymine methyl groups in bps 3 
and 5 of the consensus half site contribute to the specificity of the repressor/operator interaction.
The repressor makes H-bonds with oxygens on each of five phosphates in both operator half 
sites (Jordan and Pabo, 1988). Many of these backbone contacts are to residues flanking the helix 
2/helix 3 recognition unit and it is presumed that these contacts help to orient and position the 
residues that contact the edges of the base pairs (Figure 8B). It has been suggested that 
sequence-dependent variations in the structure of the DNA backbone may be important for 
site-specific recognition (Dickerson, 1983). However, in the X  repressor/operator complex no 
dramatic kinks or distortions in the DNA are observed (Jordan and Pabo, 1988) which would point 
towards those backbone contacts enhancing specificity by positioning the residues that contact the
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Figure 8. Details of the\repressor/operator interactions
A. Schematic representation of the amino acid side chains that interact with base pairs in the major 
groove. H-bonds are indicated by the dotted lines. In the upper half of the figure, the major groove 
is readily visible for base pairs 1-3; in the lower half, the minor groove is readily visible.
B. Diagram showing the amino acid side chains that interact with the sugar-phosphate backbone in 
the consensus half site. Contacted phosphates (Pa“ Pe) are indicated (Jordan and Pabo, 1988).
GLN 33
GLN44
B.
T Y R 2 2  
LY S  19
LY43
ASN58 ASN6
bases. Jordan and Pabo (1988) have demonstrated that several amino acids from different sections 
of repressor may cooperate to recognise a particular bp, and it appears that recognition, like protein 
folding, involves cooperative interactions.
The Cro and repressor proteins of phage 434 are much more similar in structure and sequence 
than the corresponding proteins of X which structurally agree only within the "helix-turn-helix” motif 
(Ohlendorf et al., 1983). Transcriptional regulation in phage 434 is dependent on the ability of 
repressor and Cro to bind with different orders of affinity to the same set of six, partially symmetric, 
14 bp operator sites. However, studies using systematic base substitutions in a “standard” operator 
sequence have shown that these two remarkably similar proteins are affected differently by a single 
substitution in othenwise identical operator sequences. To compare how 434 repressor and Cro 
bound to operator DNA, Wolberger and coworkers (1988) determined the crystal structure of 434 
Cro bound to the same 14 bp operator site previously used in determining the co-crystal structure of 
the DNA binding domain of 434 repressor (R1-69) and its binding site in the operator DNA. It was 
presumed that since Cro and repressor are so similar in sequence and three dimensional structure 
they would form very similar complexes when bound to the same DNA fragment. This was found not 
to be the case: the 14 bp operator adopted a different conformation depending on whether Cro or 
R1-69 was bound.
The model of the Cro/DNA complex is shown in Figure 9 (Wolberger et a!., 1988). Each 
monomer consists of 5ol< helixes. In each Cro monomer the recognition helix, 3, lies in the major 
groove. The N-termlnus of oi'2 lies against the sugar-phosphate backbone on one side of the major 
groove. Helix 4 lies with Its N-terminus near a phosphate and its C-terminus pointing away from the 
DNA. Helix 5 lies between the end of helix 4 and the N-terminus of helix 1. There appears to be no 
significant conformational change in the Cro monomers on binding to DNA.
If we superimpose models of Cro and R1-69 (Anderson et a!., 1987) we see a basic similarity 
(Figure 9A and B). However, there are also several important differences between the two 
structures in the conformations of both DNA and protein dimer (Wolberger et al., 1988). Firstly the 
relative disposition of the two subunits are different as is the overall conformation of the two 
operator half sites. Also, the relation between protein and DNA in each operator is different. If we
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BFigure 9. Models of the 434 Cro/operator and 434 repressor/operator 
Interactions
A. General view of 434 Cro/14-mer complex. Parts of adjacent 14-mers are shown, stacked as in 
the crystal. Amino acid residue numbers are indicated at the beginning and end of the SoQielices. In 
addition, certain residues important for the interaction with operator are indicated. Base pairs in one 
half site are numbered (1-7) along the backbone ribbon in a 5' to 3' direction (Wolberger etal., 
1988).
B. Schematic representation of the elements of the 434 repressor/operator complex. R1-69 * 
helices are represented as cylinders and non-identical polypeptide chains as tubes. Key residues 
in the lower R1-69 monomer are shown as are the numbers of the first and last amino acid residues 
in eachWielix. Numbers along the ribbon indicate DNA base pairs in the operator half site 
(Anderson et a!., 1987).
Figure 10. Contacts between 434 Cro and operator DNA backbone phosphates
Schematic representation of the phosphate residues contacted by 434 Cro. Phosphates 1 and T 
are not shown. The positions of the recognition helices,*=^2 and<3, are indicated. Phosphate 6' 
appears to have H-bonds from peptide -NH groups 40 and 41 ; phosphate 5', from -NH 43; 
phosphate 4', from -NH 27; phosphate 3', from Lys 27; and phosphate -T, from -NH 17 (Wolberger 
etal., 1988).
examine the Cro monomer with respect to R1-69 positions, each appears to be rotated about the 
axis of helix 3 in such a way as to approximately preserve the spacing between the two alphas 
helices and, at the same time, widening the gap across the dimer interface. The difference in 
relative disposition of protein monomers in the Cro and R1-69 complexes stem from different 
protein-protein contacts across the dimer interface.
In the Cro/DNA complex, only a slight bending of the DNA is observed (Wolberger etal., 1988) 
whereas DNA in the R1-69/14-mer complex is bent quite substantially (Anderson et al., 1987). This 
difference in bending has been confirmed by results from gel electrophoresis DNA binding assays 
which indicate that binding of 434 repressor, or of R1-69 to the 14 bp operator, bends the DNA 
whereas binding of Cro does not (Koudeika et al., 1988).
Each Cro monomer interacts in its half site with at least five phosphates (Figure 10) which 
correspond to those previously identified in éthylation interference studies (Wolberger etal., 1988). 
With the exception of one phosphate group (P3'), éthylation of the same phosphates interferes 
with repressor binding (Bushman etal., 1985). The contacts to P6', PS' and PI are similar to those 
described in the R1 -69 complex. Four of the five contacted phosphates can form H-bonds with the 
peptide -NH groups (Wolberger et al.. 1988). In two cases, the -NH groups lie at the N-terminus of 
ano(-helix. This is consistent with protein/DNA backbone interactions also observed in the 
R1-69/14-mer and 20-mer complexes (Anderson etal., 1987; Aggarwai etal., 1988).
The affinity of 434 Cro and repressor for operator DNA is influenced by bp in the centre of the 
binding site which are not contacted by either protein (Koudeika et al., 1987). This must therefore 
be due to effects of the central bp on DNA structure. This has Indeed been shown to be the case 
with 434 repressor/operator complexes in which the non-contacted central bp influence repressor 
binding affinity by affecting the ability of the operator DNA to twist along Its helical axis (Koudeika et 
al., 1988). Unlike 434 repressor, Cro does not significantly bend the DNA but nevertheless 
exhibits the same sensitivity to central bp changes, as does R1-69, suggesting that the central bp 
likewise influence Cro affinity by affecting the ability of the operator to twist (Wolberger etal., 1988). 
A network of bifurcated H-Bonds is seen in the R1-69/20-mer complex (Agganwal et al., 1988). It is 
possible that such a network is also found in a similar complex with Cro to the extent that the array of
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non-coplanar bp which participate in such a network could represent a response to helical twist at 
the central bp rather than to bending and minor groove compression (Wolberger etal., 1988).
Although it may be possible to design a set of rules governing the specific recognition for a 
given DNA binding protein with its cognate site, these rules need not necessarily be true, even for 
proteins such as the 434 repressor and Cro that recognise DNA by virtue of the same structural 
motif (Anderson etal., 1987; Wolberger etal., 1988).
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2.Control of Gene Expression In Eukaryotes
2.1 Transcriptionally Active Chromatin
To date, most detailed information available on how genes function has come from studies of 
prokaryotes whose genetic material is distributed throughout the cell. A major difference between 
prokaryotes and eukaryotes is the presence in the latter of a group of basic proteins, histones, 
which are strongly complexed with DNA in chromosomes (reviewed by Bradbury et ai, 1981). 
Chromatin represents the state of DNA in the living eukaryotic cell in which linear DNA molecules are 
compacted up to 10,000 fold in association with histones and other proteins (reviewed by Gross 
and Garrard, 1987). The basic unit of chromatin Is the nucieosome, a repeating subunit constructed 
by wrapping 166 to 168 bp of DNA into two left-handed superheilcai turns around an octameric 
histone core (H2A, H2B, H3, H4)2. One molecule of histone HI is bound to DNA entering and 
leaving the nucieosome particle thus stabilising this region. A variable length of linker DNA, up to 70 
bp, is found between neighbouring particles (reviewed by Yaniv, 1986). Most chromatin within the 
eukaryotic nucleus is then packed into a higher order structure, a 30 nm solenoid, that results from 
the ordered folding of poly nucieosome strings (Feisenfeld and McGhee, 1986).
Ceil free extracts capable of specific gene transcription In vitro have been established but they 
generally employ non-physiologicai templates (Gross and Garrard, 1987). Indeed, nucieosome 
formation in vitro has been shown to block initiation of transcription (Gottesfeld and Bloomer, 1982) 
yet most genes that are being expressed in vivo (as well as quiescent genes) are organised into 
nucleosomes (Weintraub, 1985). How then is the transcriptional machinery able to transcribe 
through a nucleosomal template?
When nuclei are digested with DNase I, an interesting difference between transcriptionally 
active and inactive genes emerges. Active genes show increased sensitivity to nuclease treatment 
when compared to their inactive counterparts (Weintraub and Groudine, 1976). They are aiso 
preferentially solubilised by brief micrococcalnuclease treatment (Bellard etal., 1977). These 
differences mat be attributable to chromatin- containing active genes being packed less tightly in 
relation to the more compact chromatin-containing inactive genes, in addition, modification of the 
primary nucieosome structure of active genes may also result in a modified higher order structure.
Transcriptional control in eukaryotes is dependent on the recognition of specific cis- acting
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DNA sequences with a variety of trans- acting regulatory proteins. X n view of this, an important 
question then is whether proteins which recognise sequences in B-form DNA in solution can 
recognise the same sequence features when the DNA is incorporated into nucleosomes. Such 
recognition is likely to depend not only on the conformation of nucleosomal DNA , i.e. on 
parameters such as helical twist, bp opening angles, groove width etc.. but aiso with its 
configuration, i.e. the long-range bending of the DNA and its proximity to the histone proteins 
(reviewed by Morse and Simpson, 1988).
A fundamental clue towards understanding the mechanisms that initiate the formation of 
transcriptionally active chromatin, was provided by the discovery of nuclease hypersensitive sites in 
viral and cellular chromatin (reviewed by Gross and Garrard, 1987). Sites hypersensitive to DNase i 
often reside within cis- acting DNA sequences that are crucial for gene expression, such as 
upstream promoter regions. These sites often appear before the onset of transcription and are 
deveiopmentaily programmed (Weintraub, 1985). The occurrence of DNase i hypersensitive sites 
has been frequently observed, in many different types of genes, i.e. constitutiveiy expressed, 
inducible, deveiopmentaily regulated and viral genes. For example, in the genes coding for the 
Drosophila 70 Kda heat shock protein, rearranged genes coding for the kappa chains of 
immunoglobulins, mouse alpha and 8- giobin, c-myc, histone genes of Drosophila or sea urchins 
and SV40 and polyoma viruses. Nuclease hypersensitive sites have also been mapped around 
promoter and UASs of several yeast genes (reviewed by Yaniv, 1986).
The SV40 genome is transcribed into two primary transcripts originating from opposite strands. 
The 5' ends of the transcripts are located near the origin of DNA replication. SV40 mini 
chromosomes contain a nuclease sensitive region which lies between the origin of replication and 
the major start site of late mRNA (Varshavsky, et al., 1979; Sargosti et al., 1980). Treatment of 
nuclei, prepared from infected cells or of isolated mini chromosomes, with DNase i or a variety of 
restriction endonucleases, resulted in double stranded cleavage of the viral DNA in this region of 
the genome. In addition, electron microscopy studies of extracted SV40 mini chromosomes 
revealed a "gap", or nucleosome-free segment of DNA, in the circular nucleo-protein complexes 
(reviewed by Yaniv, 1986). This 400 bp segment was mapped by restriction analysis to the region 
between the origin of DNA replication and the 5' end of the late mRNA (Jakobovits et al., 1980).
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The presence of this nucieosome free region was not, however, as a result of the dissociation of 
one or two histone octamers since the total number of nucleosomes counted in gapped or 
ungapped molecules was the same (Saragosti et ai, 1980). It is believed that a segment of DNA can 
be excluded from nucleosomes thus becoming more sensitive to nuclease digestion than 
nucleosomal DNA. This region then acts like an “open window" in the chromosome structure but 
that the sensitivity of this window is modulated by the interaction of certain non-histone proteins, in 
turn creating as series of protected and hypersensitive DNA sequences, indeed, a variety of trans- 
acting cellular factors have been identified which bind to the gapped region of SV40 containg the 
viral enhancer element and early promoter (Zenke et ai, 1986; for review see N.C. Jones et ai, 
1988).
Many DNase i hypersensitive sites are observed in sequences upstream of the transcription 
initiation site of a gene in tissues that express such a gene, suggesting that these sites are 
intimately associated with gene activity arising as a consequence of the transcription process. 
Alternatively, these sites could play a crucial role in permitting this transcription. The acquisition of at 
least some of the hypersensitive sites appears to be a prerequisite for transcription activation 
(reviewed by Yaniv, 1986).
Brown and coworkers (1988) have recently described a hypersensitive site in chromatin formed 
over sequences 5' to the human hsp70B gene transcription unit. Determinants sufficient to form 
the hypersensitive site were contained in a 280 bp sequence which corresponded approximately to 
the region that is hypersensitive. Deletion of sequences from either end of this region resulted in 
reduced hypersensitivity which suggested that multiple genetic elements contributed to the 
formation of this chromatin structure. This structure is present prior to heat treatment (Wu, 1980; 
Costiow and Lis, 1984; Brown et ai, 1988) and does not change in intensity or position after heat 
shock, even though hsp70 gene expression is entirely dependent on heat induction. Heat shock 
gene expression shows a sequence-dependence that is best explained by a requirement for 
several heat shock regulatory elements (Schiller et ai, 1988). However, binding of heat shock 
transcription factor (HSTF) or heat shock activator protein, appear not to be responsible for the 
hypersensitive chromatin structure (reviewed by Brown et ai, 1988). in addition to heat shock 
element consensus sequences, there are a number of potential binding sites for the transcription
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factor Sp1 (Briggs et al., 1986) within the hypersensitive region of hsp7QB (Brown et al., 1988). 
The DNA segment 5' to the hsp70B gene aiso contains several close matches to a sequence 
resembling the core of the human metaiiothionein II metal response element (Karin et al., 1984). 
Such an element Is aiso present upstream from the human hsp70A transcription unit (Wu et al., 
1985). So it may be that chromatin structure is dependent on the interactions between proteins 
bound to DNA segments that are distant from one another and the spacing between these binding 
sites. Their phasing on the DNA double helix with respect to one another, may also be crucial. 
Since determinants for the hypersensitive site described by Brown etal. (1988) cannot be resolved 
to a segment of DNA shorter that about 280 bp, it suggests that multiple protein-binding sites are 
involved. It has been speculated (Ptashne 1986a) that hypersensitive sites may be regions of 
chromatin distorted due to interactions between proteins bound at sites separated by long 
stretches of DNA.
An extensive study of the tissue-specific hypersensitive site within the 200 bp promoter region 
immediately upstream of the chicken adult 8-giobin gene has been carried out (Emerson et al., 
1985) and results have shown this element to be nucieosome free but containing several regions of 
protection-associated specific trans- acting factors. What is of particular interest is that the 
hypersensitive site can be reconstituted in vitro on cloned DNA templates provided that red blood 
ceil protein factors are present prior to, or during the assembly of nucleosomes. The site cannot be 
induced by these trans- acting factors in vitro once a nucieosome has formed within the promoter 
region, in a similar manner, the ability of transcription factor TFIliA to generate a transcriptionally 
active 5S RNA gene template is dependent on the addition of non-histone chromosomal proteins 
prior to, or during nucieosome formation, but not after (Gottesfeld and Bloomer, 1982; Kmiec and 
Worcel, 1985).
It has recently been observed that nucleosomes are frequently positioned at preferred, or even 
fixed locations, along specific DNA sequences. The determinants governing this "phasing” appear 
to depend, in part, on the bendability of the DNA molecule itself (Travers, 1987b). 
Sequence-dependent variation in the mechanical properties of the DNA seem to define the 
rotational orientation of the major and minor grooves with respect to the histone octamer, i.e., which 
helical face of the DNA is in contact with the octamer. However, it is believed that additional
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sequences are required to bring about a precise transiationai setting for the nucieosome, i.e., the 
nucleotide sequences entering and leaving the nucieosome or the nucieosome phasing frame 
(reviewed by Gross and Garrard, 1987). So far phasing frames appear to be constant irrespective of 
whether or not a gene is destined for expression in a given tissue. For example, the mouse 
B-giobin gene has nucleosomes phased along the sequence in an identical manner in erythroid and 
non-erythroid cells (Benezra et ai, 1986). In erythroleukamia ceils, four nucleosomes appear to be 
removed, or modified, from the promoter region of the gene before, and after, induction of giobin 
gene expression. The adjacent phasing frames are not disturbed -  a phenomenon aiso observed 
in fibroblasts (reviewed by Gross and Garrard, 1987).
It is easy to visualise how “open” regions within promoters could act as entry sites for RNA 
polymerase molecules. Enhancer elements also possess DNase I hypersensitive sites but these 
transcriptional control elements can be located several kilobases away from promoters, it is possible 
that enhancers and promoters come into intimate contact via interaction between trans- acting 
factors bound at their hypersensitive sites. This could then lead to a looping out of the intervening 
DNA (Ptashne, 1986a). Such a multiprotein complex as the base of this loop would afford a strong 
attraction site for RNA polymerase to initiate transcription . A specific class of DNA sequences, 
matrix associated regions (MARs) have been identified, which sometimes lie close to enhancer 
elements, and which contain consensus sequences for the interaction with topoisomerase il, 
known to be localised at or near the base of chromosomal loops in mitotic chromosomes (reviewed 
by Gross and Garrard, 1987). it is possible that the base of a chromosomal loop could regulate the 
level of DNA supercoiiing in the entire loop (or mini-loop) through the action of topoisomerase li and 
trans- acting factors with MARs and enhancers.
Of current interest is whether chromosomal loops that contain transcriptionally active chromatin 
are under torsional stress, i.e., do they contain unrestrained DNA supercoils? E  coli chromosomal 
DNA is organised into loops, or domains. The DNA is negatively supercoiied. The torsional strain is 
introduced into the bacterial DNA by an ATP-dependent action of DNA gyrase. Topoisomerase I 
has the reverse action, it relaxes negatively supercoiied DNA. So the final extent of supercoiiing of 
bacterial DNA is achieved as a result of the balance between the action of these two enzymes, in 
bacterial DNA, changes in torsional strain correlate with changes in gene expression (reviewed by
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Yaniv, 1986). Recent evidence for torsional stress in eukaryotic chromatin has been provided in 
that amphibian oocyte 5S RNA genes are assembled, both in vivo and in vitro, into chromatin that 
contains topoisomerase l-reiaxable, supercoiied DNA (Kmiec and Worcel, 1985). These stressed 
molecules are believed to be transcriptionally active in that they are preferentially sensitive to 
nucleases, they are insoluble, they have a disrupted nucleosomal structure and their product is 
stimulated by the 5S-specific transcription factor TFIliA (Kmiec and Worcel, 1985). However, yeast 
2|xm minichromosomes, which are moderately transcribed, are not under torsional stress in vivo and 
do not appear to act as substrates for the putative gyrase-iike activity of topoisomerase II (reviewed 
by Gross and Garrard, 1987). it appears then that torsional stress may play a role in transcriptional 
activation of some eukaryotic genes, but not of others.
Trans- acting factors may only be required to establish transcriptionally active chromatin and not 
for its maintenance or propagation. Indeed many of the biochemical properties of transcriptionally 
active chromatin are maintained and/or transmitted to progeny long after transcription has ceased. 
For example, the promoter region of a previously transcribed Immunoglobulin light chain can 
spontaneously delete with a concomitant reduction in transcription to 0.7 % of the normal level, but, 
without any loss of the transcriptionally active chromatin phenotype (reviewed by Gross and Garrard, 
1987). In addition, preferential nuclease sensitivity and DNase I hypersensitive sites persist within 
the chicken B-globin domain and vitellogenin gene long after the removal of an inducing stimulus or 
transcription has come to an end. This would suggest that the transient binding of trans- acting 
factors to enhancers and/or other cis- acting regulatory elements directs chromatin to generate and 
memorise a stable heritable complex. The mechanisms that determine “memory ” are probably due 
to multiple phenomena such as alternative DNA conformations, dynamic equilibria between 
protein-DNA and protein-protein interactions, timing of DNA replication, accessibility to 
post-transiational machinery and selective undermethylation of DNA (reviewed by Gross and 
Garrard, 1987)
It is clear that future research has to centre on characterising the proteins that bind to particular 
sites in active chromatin and on understanding their function at the domain level. It is necessary to 
pinpoint the mechanisms controlling synthesis of these proteins and on their binding to target DNA 
sequences in certain ceil types and not in others.
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2.2 Control of Gene Expression in Yeast
2.2 Yeast Promoter Elements
Analysis of RNA polymerase il transcribed genes in the yeast Saccharomyces cerevisiae 
{S.cerevlsiae ) has identified three essential promoter elements (Figure 1), the TATA box, the 
upstream activation site, and the initiation site, ail of which have been shown to be necessary for the 
control, accuracy and frequency of transcriptional initiation (Oiesen et al, 1987 and references 
therein), in addition, some yeast promoters contain operator (OP) elements that are involved in 
transcriptional repression (reviewed by Brent, 1985).
The initiator element (i) is located near the mRNA start site and is the principal determinant 
governing where transcription begins. In contrast to the situation found in the promoters of higher 
eukaryotes, in which initiation sites are generally determined by their distance from the TATA 
element, accurate initiation in yeast is still observed even when the distance between the TATA 
element and the initiator element is varied (Chen and Struhi, 1985). The close proximity of the 
initiation site to the initiator element may represent specific DNA sequences preferred by RNA 
polymerase II itself, or by a closely associated factor.
TATA elements (consensus sequence TATAAA) are present in nearly all yeast promoters and 
are a necessary component of the promoter. However, in isolation they are not sufficient for 
transcriptional initiation of most yeast genes (Struhi, 1987). The distance between the TATA 
element and the transcriptional start site ranges between 40 and 120 bp. This differs from the 
situation in higher eukaryotes where TATA sequences are frequently located 25 to 30 bp upstream 
of the initiation site. Because they are present in a variety of promoters, TATA elements are 
presumed to play a somewhat general role in the transcription process, perhaps mediated by the 
binding of a general transcription factor. However, two functionally distinct classes of TATA 
elements, involved in constitutive or inducible transcription of genes, have been described in S. 
cerevisiae (Struhi, 1986). his 3 and pef 56 are adjacent genes that are expressed at similar levels 
under normal growth conditions, and are transcribed in opposite directions from initiation sites that 
are separated by 200 bp. Although each gene has its own TATA element, a 17 bp poly (dA-dT) 
sequence, located between the genes, serves as the upstream promoter element for both (Struhi,
1985). This constitutive element thus acts bidirectionaiiy to activate transcription of two unrelated
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Figure 1.1. Yeast promoter elements
The regions of a yeast promoter including the transcription start site or initiator element (I), the 
TATA box, operator (OP) and upstream activating sequence (DAS) are shown. The 
approximate distances between the various promoter elements and the transcription initiation 
site are indicated.
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During conditions of amino acid starvation, his 3 but not pet 56 transcription is induced over the 
basal level, even though the critical regulatory site Is upstream of both respective TATA regions. In 
addition, only one of the two normal his 3 initiation sites is subject to this induction. It has been 
suggested that the his 3-pet 56 intergenic region contains constitutive and inducible promoter 
elements with different properties (Struhl, 1986). In particular, two classes of TATA elements, 
constitutive (Tc) and regulatory  T r ) that are involved in constitutive and inducible his 3 
transcription. These elements are distinguishable on the basis of several criteria; by their ability to 
respond to upstream regulatory elements, by their effects on the selection of particular initiation 
sites, and by their physical structure In nuclear chromatin (presumably due to the unusual structure 
of poly (dA-dT)) (Struhl, 1986). Recent genetic evidence (Chen and Struhl, 1988) from studies 
using saturation mutagenesis in vitro and functional analysis in vivo, demonstrated a strict DNA 
sequence requirement for transcriptional induction from T r , strongly suggesting that the T r  
element is a target site for a sequence-specific DNA binding protein. Since most yeast promoters 
contain the sequence TATAAA or TATATA near the mRNA start sites -  it is extremely likely that the 
protein which binds to T r  will be Involved in transcription initiation. However, not all yeast promoters 
contain sequences compatible with T r  function, despite the fact that they may contain A/T-rich 
sequences (Chen and Struhl, 1988). If we assume that these promoters require “downstream 
elements” for transcription, it follows that such elements will not be recognised by the putative T r  
binding protein but, instead, are targets for other DNA binding proteins. It is possible then that 
yeast cells contain multiple proteins with distinct sequence specificities that function in a similar way 
to that of the T r  binding protein and that yeast promoters can be divided Into different classes on 
the basis of their downstream promoter elements. This is suggestive of the situation involving the 
different bacterial sigma factors that Interact with the core RNA polymerase to generate distinct 
holoenzymes recognising different -10  and -35 promoter sequences (Losick and Pero, 1981). By 
this analogy, the protein which binds to T r  may be similar to the 70 Kda sigma factor In that both 
proteins are general transcription factors Important in the expression of the majority of the 
organism's genes. In view of this, one could speculate that proteins which recognise Tc, or other
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sequences, would parallel the minor sigma factors (Chen and Struhl, 1988). However, the yeast T r  
binding protein differs from the bacterial sigma factor in that it binds directy to DNA and not to RNA 
polymerase.
The phosphoglycerate kinase (PGK) gene of S. cerevisiae encodes one of the most abundant 
mRNA and protein species in the cell (Holland and Holland, 1978). Deletion analysis of the 5' 
non-coding region of the PGK gene revealed that a UAS located some 450 bp upstream of the 
mRNA start site was required for full transcriptional activity, but expression of this gene did not 
appear to require any TATA sequences. Deletion of one or both of the potential TATA sequences 
did not affect either the levels of PGK mRNA, or the site of transcription initiation (Ogden, et a!.,
1986). This finding that PGK gene expression does not appear to be dependent on TATA 
sequences is rather novel amongst yeast genes but Is similar to the situation observed in the 
expression of several higher eukaryotic genes, such as those coding for papovavirus late functions 
and adenovirus-2 DNA binding protein, which both lack TATA boxes (reviewed by Benoist and 
Chambon, 1981). Similarly, there is no TATA box requirement for expression of the sea urchin 
histone H2A gene when injected into Xenopus oocytes, although its absence leads to the use of 
several new cap sites (Hentschel et a i, 1980). Ogden and coworkers suggest that, in the case of 
PGK gene expression, the mRNA initiation site may be all that is required to position the 
transcriptional start site.
Ruden et ai, (1988) have demonstrated GAL4-activated transcription at nearly identical levels 
when the GAL4 responsive element was located at nine different positions, 33 to 67 bp upstream of 
the 5TATAAA3' sequence in the GAL1 promoter (which contains the GAL1 TATA box). This 
activation was not dependent on GAL4 binding to the same side of the DNA double helix with 
respect to the TATAAA sequence. This apparent lack of requirement for a strict alignment between 
an activator (GAL4) and its target (for example the TATA-binding protein or RNA polymerase II), 
assuming that they contact each other through the formation of DNA loops, might be explained if, 
when bound to DNA, the interacting regions of one or both the proteins protrude laterally from the 
opposite (or nearly opposite) sides of the DNA helix, but this would make detection of any helical 
periodicity very difficult (Ruden et ai, 1988). Alternatively, the interaction between the activator 
and its target site may be strong enough to supply the energy required to twist and bend the DNA;
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DNA supercoiling might decrease the energy required for this loop formation (Kramer et al., 1988).
The third class of RNA polymerase II transcribed promoter elements are the upstream activating 
sequences (UASs) which normally determine the particular regulatory properties of a given yeast 
promoter (reviewed by Guarente, 1984). These upstream elements resemble mammalian enhancer 
sequences in that they can function at long distances (up to 600 bp) in an orientation-independent 
manner with respect to the responding promoter. But, unlike most other enhancer elements, they 
do not appear to function downstream from the responding promoter (Guarente and Hoar, 1984; 
Struhl, 1984). Regulatory proteins have been isolated, such as the yeast trans- activators GAL4 and 
GCN4, which bind in a sequence-specific manner to the upstream elements (Giniger eta!., 1985; 
Hope and Struhl, 1986). In addition, UASs for several constitutively expressed yeast genes have 
been shown to consist of poly (dA-dT) homopolymer sequences which may act by altering 
chromatin structure rather than binding specific factors (Struhl, 1985).
Chen and coworkers (1987) carried out a series of experiments designed to distinguish 
between chromatin accessibility and protein-protein contact models for the mechanism of 
transcription activation by eukaryotic upstream elements. Two types of recombinant plasmids were 
introduced into yeast cells; those which expressed T7 RNA polymerase and a second set of target 
molecules In which the yeast UASq or the poly(dA-dT) element from the dedi gene were fused 
upstream of the T7 promoter which in turn was fused directly to the his3 mRNA coding sequences, 
effectively replacing the yeast (TATA-dependent) transcription machinery with T7 RNA polymerase. 
The chromatin accessibility model predicts that activation should be independent of the particular 
transcription machinery. This means that upstream elements that operate by this mechanism should 
also stimulate T7 RNA polymerase transcription. In contrast, elements that work by proteln-protein 
contact should be unable to stimulate transcription by T7 RNA polymerase since it is unlikely that 
yeast activator proteins could make the required specific contacts with this prokaryotic enzyme. By 
comparing the levels of his3 RNA initiated from target or control molecules, they were able to 
determine whether transcription by T7 RNA polymerase is enhanced by yeast upstream elements. 
Under conditions where the UASq would normally be either activating or non-activating, T7 RNA 
polymerase- stimulated transcription, above the level observed in the absence of any upstream 
element, was not detected. They could also show that the yeast ded1 poIy(dA-dT) upstream
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element enhances transcription by T7 RNA polymerase in yeast cells but not in vitro on purified 
DNA indicating that the observed enhancement reflects properties of the transcriptional activation 
process in vivo, as opposed to some unusual property of the RNA polymerase. So it would appear 
that activation by the ded1 poly(dA-dT) element may involve effects on the chromosome template, 
thereby facilitating entry of the transcription machinery, whereas activation by the UASq may 
involve specific contacts between GAL4 and the transcriptional machinery.
Repression of transcription in yeast has been shown to be dependent on the binding of 
regulatory proteins to the DNA at sites other than the UAS (Brent, 1985). The best studied case of 
transcriptional repression in yeast depends on the product of the MAT012 gene {otz). S. cerevisiae 
can exist as one of three distinct cell types; as a non-mating diploid, or as a haploid of either the a or 
the oL-mating type (Brand et ai., 1987). Theot2 protein Is a cell-type specific repressor which turns off 
transcription of its target genes -  the a-specific genes -  by binding to an operator located upstream 
of each a-specific gene. The mating type of each cell is determined by the allele at the MAT locus 
which encodes the ocor a gene products. At almost every cell division, haploid cells are able to
“switch” their mating type by replacing the allele at the MAT locus with an allele of the opposite
\
mating type copied from either the HMR (a) or HML (<*) loci. Because alpha2 Is present in cells but 
not in a cells, the a-speclfic genes are turned off in oLcells but are expressed in a cells (reviewed by 
Herskowitz and Oshlma, 1981). The repressor proteln(s), in the presence or absence of cofactors, 
might interfere sterically with the binding of positive regulatory proteins to the UAS, or the TATA 
element, or even hinder the movement of an RNA polymerase molecule from its binding site in the 
promoter to the mRNA start site.
2.3 Yeast Activator Proteins
Genetic evidence has shown that the expression of several well characterised yeast genes 
occurs by positive activation of transcription (reviewed by Guarente, 1984). Attempts to identify 
yeast activator proteins have generally begun by the isolation of trans- acting mutations that are 
defective in the induction of specific genes. However, biochemical evidence is necessary to prove 
that a particular mutation directly affects transcription, for example, by altering a specific 
DNA-protein interaction. Such specific binding to upstream promoter elements has been
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demonstrated for the yeast GAL4, HAP1 and GCN4 proteins (reviewed by Struhl, 1987). in 
addition, mutational analysis of yeast activator proteins indicates that DNA binding and 
transcriptional activation are independent functions carried out by distinct regions of the protein 
(Brent and Ptashne, 1986; Hope and Struhl, 1986; Keegan et ai, 1986).
2.3.1 The GAL4 Trans- A c tiva to r
When yeast Is grown on medium containing galactose, transcription of the galactose metabolic 
genes, GAL1, GAL7 and GAL10, is induced by more than 5000-fold (Hopper e ta l, 1978; St. John 
and Davis, 1981). In the case of GAL1 and GAL10, induction of these divergently transcribed 
genes is dependent on a short DNA sequence located between them, the GAL upstream activation 
sequence (UASq), as well as the product of the constitutively expressed GAL4 gene.
GAL4 recognises and binds to four related, 17 bp dyad symmetric sequences within UASq, 
both in vivo and in vitro (Giniger and Ptashne, 1988). Moreover, a double stranded, synthetic 
oligonucleotide, the 17-mer, which is a near consensus of the GAL4 binding sites and has a higher 
affinity for GAL4 in vitro than any of the binding sites from UASq, was suficient to confer nearly wild 
type levels of regulated, GAL4-mediated inducibility in yeast (Giniger et ai., 1985). A single copy of 
the synthetic 17-mer was placed 130-300 bp upstream of transcription start sites of separate 
constructs which fused the GAL1 or CYC1 genes to the coding sequence of the E. coH lacZ gene. 
In yeast cells grown on galactose-containing media, these plasmids produced 50-70% of the 
B-galactosldase activity observed in analagous constructs that carried a complete UASq. Moreover, 
the 17-mer conferred no activity when plasmids containing this sequence were transformed into a 
yeast GAL4 ~ strain. The yeast GAL4 protein can also activate transcription in mammalian cells. 
KakidanI and Ptashne (1988) demonstrated that GAL4 could activate the mouse mammary tumour 
virus (MMTV) promoter in mammalian cells when the glucocorticoid-response elements (GREs) were 
replaced by UASg- However, insertion of a GAL4 binding site in the MMTV promoter containing the 
GREs abolished the promoter's ability to respond to glucocorticoid receptor (GR) in the presence of 
dexamethasone. This may be a consequence of displacing the GREs from their normal position by 
insertion of the UASq. thus impairing the response to GR. Another possibility is that a protein
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present in the transfected cells binds to the GAL4 regulatory sequences and blocks the effect of an 
upstream activator. Considering the findings of Giniger and Ptashne (1988), it is feasible that GR 
and GAL4 could bind cooperatively and this may reflect a direct interaction between these proteins 
or an indirect interaction mediated by contact with a common, third factor of the transcriptional 
machinery.
Giniger and Ptashne (1988) demonstrated that two of the naturally occurring GAL4 binding 
sites for UASg, sites 3 and 4, work synergistically to activate transcription (neither site alone had any 
appreciable UAS activity but together formed a UAS nearly 20% as active as the wild type UASq)- 
This synergism was attributed to the cooperative binding of GAL4 -  in vivo footprinting experiments 
showed that neither site 3 nor site 4 was occupied to any great extent by GAL4 when the sites were 
isolated, but, when paired, both sites were significantly (though not fully) occupied. Studies carried 
out using the synthetic 17-mer suggested that there is no mechanistic requirement for multiple sites 
for each bound GAL4 to activate transcription efficiently, rather the activity of a GAL UAS Is roughly 
proportional to the number of GAL4 molecules bound.
The cooperative binding of GAL4 to UASq is very similar to the situation observed in phage 
lambda repressor binding to its operator sites O r I  , O r 2 and O r 3) on the phage DNA. The intrinsic 
affinities of O r 2 and O r 3 for lambda repressor are approximately equal but are more that 10-fold 
lower than that of O r I  (reviewed by Ptashne et ai., 1980). However, over a broad concentration of 
repressor, O r I  and O r 2 are filled and O r 3 is usually vacant. It would appear that repressor-bound 
O r I  facilitates repressor binding at O r 2 much more readily than repressor binding at O r 2 facilitates 
binding at O r I  . In addition, an alternative favourable interaction between repressor dimers bound at 
O r 2 and O r 3 Is evident only if no repressor is bound at O r I .  The observed cooperativity was 
ascribed to proteln-protein Interactions and not to DNA conformational changes transmitted through 
the doublehelix.
The DNA binding and transcriptional activation domains of GAL4 are clearly separable functional 
domains. The 74 N-terminal amino acids of GAL4 are sufficient for DNA binding but fail to activate 
transcription (Keegan et ai., 1986; Hope and Struhl, 1986). The transcriptional activation function of 
GAL4 has been ascribed to two relatively short regions (region I. residues 148-196, and region II,
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residues 768-^81) both of which have an acidic character {Ma and Ptashne, 1987a).
Webster and coworkers (1988) have reported that the yeast UASq exhibited properties 
indistinguishable from those of higher eukaryotic enhancer elements in HeLa cells producing 
GAL4. In addition, a UASg 17-mer and the SV40 enhancer could synergistically stimulate 
transcription from the B-globin promoter in HeLa cells synthesising GAL4 (a phenomenon also 
observed in studies of the MMTV promoter by Kakldani and Ptashne, 1988). A chimeric protein 
containing the human oestrogen receptor DNA binding domain and GAL4 activating region II could 
stimulate oestrogen response element-controlled transcription with approximately the same 
efficiency as the wild type oestrogen receptor. Takahashi etal., (1986) have suggested that protein 
factors bound to enhancer elements stimulate transcription by interacting with factors bound to 
other promoter elements -  such a mechanism, involving DNA-bound GAL4 has also been 
suggested in yeast (Ptashne, 1986). This in turn implies that the same type of contacts exist in 
yeast and HeLa cells between GAL4 and other proteins. Accordingly, it would be of interest to 
establish whether there is any stereoalignment required for GAL4 to stimulate transcription from 
higher eukaryotic promoter elements. Further studies with higher eukaryotic transcription factors 
are necessary to investigate the possible presence and function of acidic regions similar to those 
present in yeast activators.
Mutational analysis of the activating regions of GAL4 indicate that the acidic nature of these 
regions is important for activity (Gill and Ptashne, 1987). Giniger and Ptashne (1987) constructed a 
synthetic protein bearing a novel 15 amino acid peptide linked to a DNA binding fragment of GAL4. 
The synthetic peptide was acidic and should therefore form an amphipathic©i-helix, having one 
hydrophilic face bearing the acidic residues, and one hydrophobic face. When expressed in yeast, 
this artificial protein could efficiently activate transcription of the GAL1 gene, but a similar protein 
with the novel 15 amino acids in a scrambled order, which was unable to form an amphipathic 
structure, was unable to activate transcription of GAL1. This lends support to the Idea that 
amphipathicity of putative K-helices in GAL4 is necessary for its transcriptional activity. Furthermore, 
the regions of bacteriophage lambda and 434 repressors involved in transcriptional activation are 
known from X-ray crystallography to be negatively charged, amphipathic -helices, and it has been 
proposed that these function by contacting RNA polymerase (Pabo and Lewis, 1982; Hochschild et
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al., 1983; Anderson etal., 1985; Bushman and Ptashne, 1986).
In the absence of galactose, the stimulatory action of GAL4 is abrogated by the specific 
negative regulatory protein G ALSO. Thus, yeast strains which lack GAL80, but not GAL4, transcribe 
the GAL genes constitutively (reviewed by Ma and Ptashne, 1987b). GAL4 binds specifically to 
DNA sequences in UASq by its N-terminus. A surface of GAL4, not involved in binding to DNA, 
appears to activate transcription via interaction with another component of the transcriptional 
machinery. In the absence of galactose, GAL80 binds to GAL4 and blocks gene activation . The 
region recognised by GAL80 is the 30 amino acids at the C-terminus of GAL4, an essential element 
of activating region II (Ma and Ptashne, 1987a). Johnston etal., (1987) suggest the following model 
for negative regulation by GAL80. Under non-inducing conditions, GAL4 is bound to UAS regions 
of GAL1 and other galactose regulated genes. Transcriptional activation is blocked by GAL80 
binding to the C-terminai region of GAL4, thus preventing this region from interacting with a 
transcription factor(s). Galactose (or a derivative) activates transcription by binding to GAL80 and 
inducing a conformational change in the protein, thereby releasing GAL80 from GAL4 which is now 
capable of interacting with other transcription factors. Under non-inducing repressing conditions 
(i.e. glucose medium), other regulatory circuits are probably involved (Oshima, 1982).
In addition to activating transcription in yeast, GAL4 can also function as a transcriptional 
repressor in E. coll (Paulmier etal., 1987). The chromosomal /ac operator was replaced by a yeast 
GAL4 binding site and this was found to repress B-galactosidase synthesis by at least 30-fold in 
GAL4-containing bacteria. Paulmier and coworkers (1987) have suggested that binding of a GAL4 
protein dimer to the target DNA overlapping the transcriptional initiation site will Inhibit transcription 
by a similar mechanism to that of the lac repressor. These findings provide us with yet another 
means for the study of eukaryotic DNA binding proteins using the tools of the classical bacterial 
geneticists. The DNA target sites of various eukaryotic transcription regulatory proteins could be 
substituted for the lac operator, expression cDNA libraries in plasmid or bacteriophage introduced, 
followed by screening for the few lac- descendants that can be expected. It is feasible that even 
short cDNA sequences or yeast DNA fragments carrying only the DNA binding domain of a protein 
will allow repression and hence easier identification of genes encoding transcription factors.
Gill and Ptashne (1988) reported that various GAL4 derivatives, when expressed at high levels
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in yeast, could Inhibit transcription of certain genes lacking GAL4 binding sites. This inhibitory effect 
was localised to the activating region of GAL4 and that derivatives bearing stronger activating 
regions had a greater inhibitory effect. Two closely related transcripts were analysed and only the 
one which was inducible by GAL4 when the UASq was present could be Inhibited by high levels of 
GAL4. They suggest that this inhibition, termed "squelching", reflects a titration of a transcription 
factor by the activating region of GAL4. This inhibition could be relieved by simultaneous 
expression at high levels of the negative regulator GAL80. The stimulatory effect of GAL80 may be 
a consequence of GAL80 masking the activating region of GAL4, thereby relieving the 
"squelching". It is possible that interaction between an activating region on a protein and a 
transcription factor, for example the TATA-binding protein, although facilitated by DNA binding, can 
also occur free in solution. At high concentrations of activator, this reaction would appropriate the 
factor thereby Inhibiting transcription. (Gill and Ptashne, 1988).
2.3.2 The HAP Activator Proteins
The products of the MAPI, HAP2 and HAP3 regulatory loci in yeast activate transcription of two 
cytochrome c genes, CYC1 and CYC7 (Pfeifer eta!., 1987a and 1987b). There are two upstream 
activation sites adjacent to the CYC1 gene; UAS1 which is activated by HAP1, in a reaction 
dependent on haem, by HAP1, and UAS2 which is activated by the combined action of HAP2 and 
HAP3 (Guarente etal., 1984; Pinkham and Guarente, 1985).
Within UAS1 there are two distinct subsites, A and B, both of which are required for activity. 
Region B forms part of a recognition site that binds to a yeast factor, RC2, In vitro (Arcangioli and 
Lescure, 1985). When cells are grown under haem-defflcient conditions, extracts do not 
demonstrate RC2 binding activity ~ neither is activity restored by addition of haem to the extracts.
Pfeifer and coworkers (1987a) investigated the activity of the HAP1 gene product In vitro and 
found that the protein bound in region B of UAS1 to the same DNA sequences as RC2, but that 
binding of these factors was mutually exclusive. Moreover, haem was shown to stimulate the 
binding of MAPI to UAS1 but not RC2, even though haem was required for the In vivo synthesis of 
RC2. This would suggest that haem is directly involved In the activation of UAS1. Haem may 
function as a ligand that binds to HAP1 or, alternatively, the effect of haem could be indirect.
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occurring via a second protein that modifies HAP1 in some way.
The role of RC2 in activation is not known. However, the regulation of the activity of RC2 and 
HAP1 suggests that RC2 Is not a repressor that is inactivated by the inducer haem. It Is possible that 
RC2 is a negative regulator that modulates UAS1 activity by competing with HAP1 for binding. 
Another possibility is that RC2 could be a positive regulatory factor involved in the activation of the 
adjacent UAS2. An additional factor, RAF (Region A Factor), distinct from HAP1, has been 
identified, and it has been suggested that it Is the complex of RAF and HAP1 that is required for 
transcriptional activation.
The CYC7 gene which encodes the minor form of cytochrome c In yeast is regulated 
coordinately with CYC1 (Pfeifer etal., 1987b). In addition, loss of function mutations in the HAP1 
gene abolish the activity of the CYC7 UAS as well as UAS1. HAP1 binds to a site in the CYC7 UAS 
that bears no obvious sequence similarity to the HAP1 binding site in UAS1 of the CYC1 gene. 
Furthermore, the binding site of HAP1 to the CYC7 site, like its binding to UAS1, is stimulated by 
haem (Pfeifer et a!., 1987a and b).
In general, genes coordinated by the same regulator are marked by a consensus sequence in 
their S'-flanking DNA. The case of CYC1 and CYC7 is an obvious exception to this rule with the best 
alignment of the binding site sequences yielding only a match of seven nucleotides that are 
scattered across the 23 bp bound (Pfeifer et a!., 1987b). How then does HAP1 recognise two 
different DNA sequences?
HAP1 could contain physically distinct DNA binding regions, one of which recognises UAS1 
and the other CYC7 UAS. However, dramatically increasing the dosage of HAP1 results only in a 
two-fold increase in CYC7 expression (K. Pfeifer, unpublished data), suggesting that the supply of 
HAP1 does not limit CYC7 expression to any great extent. Another possibility is that a single DNA 
binding domain of HAP1 could recognise both UAS1 and CYC7 UAS. This idea is consistent with 
the findings of Pfeifer etal. (1987b), namely that truncated HAP1 proteins do not separate the 
binding domains for the two sites. Secondly, the specific contacts made between HAP1 and the 
two DNA sites are similar, and finally, UAS1 and CYC7 sequences compete with each other, with 
comparable affinity, for binding to HAP1. How this single DNA binding domain recognises these 
two divergent sequences remains to be elucidated but the answer may in fact lie in the DNA itself in
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that the DNA sequences of the UAS1 and CYC7 sites could create some common structure that 
contributes to recognition by MAPI (Pfeifer etal., 1987b; Rhodes and Klug. 1986).
Activation of UAS2 of the CYC1 gene is highly regulated by catabolite repression and is 
repressed about 30-fold by a shift of cells from lactose to glucose containing medium. The activity 
of UAS2 depends on the products of both the HAP2 and HAP3 genes (Guarente et ah, 1984). 
Mutations in either HAP2 or HAP3 result in the inability to activate UAS2 and a global defect in the 
expression of genes involved in respiratory metabolism.
Analysis of the UASs of the HEM1 gene (Keng and Guarente, 1987), C0X4 (Schneider and 
Guarente, unpublished data) and UAS2 reveals that all these HAP2-HAP3 dependent UASs 
contain the sequence TN(A/G)TTGGT. Wild type UAS2 contains the sequence TGGTTGGT but a G 
to A transition in UAS2 (termed UAS2UP1) alters this to TGATTGGT, thus Increasing the homology 
to the HEM1 and C0X4 UASs and resulting in a 10-fold increase in UAS2 activity In vivo (Guarente 
etal., 1984). Linker scanning analysis of UAS2 has confirmed the critical nature of the consensus 
element for activity of the site (Forsburg and Guarente, 1988). In addition, this element is 
homologous to the CCAAT box of higher eukaryotes. Moreover, major groove contacts made by 
HAP2-HAP3 in UAS2UP1, as determined by méthylation interference experiments, and the 
CCAAT box binding factor are identical (Olesen etal., 1987).
Olesen and coworkers (1987) have shown that both HAP2 and HAP3 in yeast extracts bind to 
UAS2UP1 and give rise to a single DNA-protein complex in native polyacrylamide gels. The 
binding of either HAP2 or HAP3 is abolished if either of these two proteins is synthesised In a strain 
mutant in the complementary HAP gene, implying that the binding of HAP2 and HAP3 is 
interdependent. It may be that the two proteins bind in very close proximity to one another and 
stabilise each other's binding cooperatively, or they exist as a heterodimer.
A series of experiments were carried out by Hahn and Guarente (1988) in an attempt to 
distinguish between the aforementioned possibilities. HAP2 and HAP3 were tagged by gene 
fusion to E. coll LexA and lac Z  genes, respectively, and the products purified through four 
chromatographic steps. The co-purification of LexA-HAP2, HAP3-B-gaIactosidase, and UAS2 
binding activity demonstrated that HAP2 and HAP3 associate in the absence of DNA to form a 
multisubunit activation complex -  a complex which must be capable of at least three functions. First,
58
the complex must bind specifically to UAS2 and related sequences In the yeast genome. It must 
activate transcription once bound at UAS2, and finally it must be able to respond to signals 
generated under inducing conditions in media containing a non-fermentable carbon source. To 
date, it would appear that these functions are not distributed evenly between the two proteins. 
Although both HAP2 and HAP3 are required for binding to UAS2UP1, either HAP2 and HAP3 both 
make contacts with the DNA, or one protein makes all the contacts and is held in the proper 
conformation by the other. In addition, activation of transcription by the bound complex appears to 
require both proteins (Olesen and Guarente, unpublished data).
Recently Chodosh and coworkers (1988) demonstrated that the subunits of the human 
CCAAT-binding protein, CBP1, and yeast HAP2/HAP3 heterodimer are functionally 
interchangeable in that the yeast/human hybrid complexes which are formed retain the ability to 
specifically recognise eukaryotic CCAAT-containing transcription elements. A CCAAT motif has 
also been found in the UASs of several yeast genes regulated by HAP2 and HAP3 (Keng and 
Guarente, 1987), suggesting that the HAP2/HAP3 complex is a global activator of respiratory 
genes, functioning specifically by recognising CCAAT elements located in the UASs of this family.
2.3.3 The Yeast GCN4 Activator Protein
The product of the yeast GCN4 gene is required for the coordinate induction of amino acid 
biosynthetic genes (reviewed by Jones and Fink, 1982). GCN4 protein, synthesised in vitro from 
the cloned gene, has been shown to bind specifically to the promoter regions of his 3 and three 
other coordinately regulated genes, but not to similar regions regulated by general control (Hope 
and Struhl, 1985). Deletion analysis of the his 3 promoter region, coupled with DNAse I 
footprinting, revealed that GCN4 binds specifically to a 12 bp region that is critical for the induction of 
transcription In vivo. It appears that the sequence requirements for protein recognition and for 
transcriptional activation are indistinguishable. Mutations which abolish his 3 induction also fall to 
bind GCN4. Similarly, derivatives which confer his 3 inducibility are able to bind GCN4, strongly 
suggesting that GCN4 binding to the his 3 regulatory site directly mediates induction In vivo (Hill et 
al., 1986).
Hope and Struhl (1986) generated a series of deletions of the GCN4 gene and examined the
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properties of the resulting peptides in three different ways. First the mutant proteins, after 
transcription and translation in vitro, were tested for their ability to bind specifically to his 3 DNA. 
Second, the truncated derivatives were introduced Into yeast cells and assayed for their ability to 
induce his 3 expression under conditions of amino acid starvation. Finally, by analogy with 
experiments of Brent and Ptashne (1985), deleted derivatives of LexA-GCN4 hybrid proteins were 
examined for their ability to induce transcription of a promoter containing the lexA operator as an 
upstream element in vivo. Results of these studies demonstrated that the 221 N-terminal amino 
acids of GCN4 can be deleted with no apparent effect on specific DNA binding in vitro. This 
Indicates that the remaining 60 C-terminal amino acids can fold independently of the rest of the 
protein into a discrete, fully functional DNA binding domain (Hope and Struhl, 1986).
When Chou and Fasman (1978) rules for predicting protein secondary structure were applied 
to GCN4, three alpha-helices and a stretch of 8-turn were predicted within the DNA binding domain. 
However, these sequences fail to show any of the homology typically observed in the 
"helix-turn-helix” motif of prokaryotic repressors and activators (reviewed by Pabo and Sauer, 1984). 
Further, the “zinc finger” motif, exemplified by the eukaryotic transcription factor TFIIIA (Miller etal., 
1985), does not apply to GCN4 since there are no cysteine residues In the protein. Clearly then. 
X-ray crystallographic analysis or 2-dimensional nuclear magnetic resonance studies will be required 
to determine the molecular basis for this particular DNA-protein interaction.
Hope and Struhl (1988) demonstrated that a 19 amino acid segment of GCN4 (amino acids 107 
to 125) was critically involved in transcriptional activation suggesting that either this 19 amino acid 
region was sufficient for activation, or that GCN4 contains redundant activities. The apparent small 
size of the activating region would suggest that activation, per se, does not involve a catalytic 
function such as a topoisomerase, methylase or nuclease. It is more likely that activation involves 
proteln-protein contacts with no strict sequence requirements.
Hope and coworkers (1988) investigated the structure and function of the GCN4 activation 
region using high resolution deletion analysis and proteolytic mapping. The primary observation 
from their studies was that the 19 amino acid segment was insufficient for transcriptional activation -  
many LexA-GCN4 derivatives removing part or all of this segment showed full or partial 
transcriptional activation. Analysis of internal deletions revealed that this 19 residue segment was
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neither sufficient nor essential for transcriptional activation activity. Activation appeared to correlate 
fairly well with the amount of the acidic region of GCN4 (amino acid residues 88-147) remaining, but 
not so well with the particular regions that are retained. Perhaps the most striking feature resulting 
from their studies is that progressive deletion of the activation region causes a series of small, 
step-wise reductions in activity as opposed to defining a position which results in an abrupt loss of 
activity. This would indicate that transcriptional activating regions do not have a defined tertiary 
structure analogous to that found in active sites or domains in a protein. Results from proteolysis 
experiments (Hope et ai, 1988) lend support to this idea in that a protease resistant C-terminal 
domain was readily released by treatment with proteases which preferentially cleave unstructured 
protein regions. However, under the same conditions, the N-terminal portion of GCN4 was 
completely cleaved, indicating that GGN4 contains an independently structured DNA binding 
(C-terminal) domain with the remainder of the protein being relatively unstructured. In contrast to 
this, cleavage by chymotrypsin generates two equally stable intermediates suggesting an 
apparently contradictory view In which the N-terminal region Is structured. However, deletion 
analysis showed that large N-terminal segments of GCN4 were resistant to protease digestion just as 
if they were part of a structured domain but that these segments could be removed without 
destroying the integrity of that domain. This unusual chymotrypsin cleavage pattern correlates well 
with the presence of a functional transcriptional activation region. One might interpret this result by 
speculating that the activation region has a local structure that inhibits chymotrypsin cleavage of an 
otherwise unstructured N-terminal region of GCN4.
Saturation mutagenesis of a target sequence within the his 3 promoter defined a 9 bp region 
as being the major determinant for GCN4 binding -  with optimal binding to DNA containing the 
palindromic sequence ATGA(C/G)TCAT (Hill et ai, 1986). In the course of studies involving 
truncated GCN4 molecules, it was observed that the electrophoretic mobility of specific 
DNA-protein complexes was inversely related to the molecular weight of the GCN4 derivative (Hope 
and Struhl, 1986). Hope and Struhl (1987) devised a novel means of examining the subunit 
structure of GCN4. It was based on the principal that if GCN4 were to bind DNA as a dimer, then a 
protein-DNA complex involving a heterodimer of GCN4 monomers having different molecular 
weights should migrate electrophoretically between the two complexes involving the homodimers.
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When both monomeric units are equally radiolabelled and all three possible dimeric species are 
capable of binding DNA, then the band corresponding to the heterodimer complex should be twice 
as intense as each of the bands representing the homodimer complexes. Using this strategy they 
observed three bands whose relative intensities were in a 1:2:1 ratio -  completely consistent with 
GCN4 binding as a dimer to the single site in the his 3 target DNA, and not as a monomer or as a 
multimer with a larger number of subunits. Deletion analysis revealed that GCN4 could dimerlse 
through the C-terminal 60 amino acids, suggesting that dimérisation requires an intact DNA binding 
domain. In addition, although dimer formation appears to be critical for DNA binding, stable dimers 
can form even in the absence of target DNA.
Although GCN4 binds as a dimer to a 9 bp palindrome, its binding appears to involve 
non-identical contacts between GCN4 monomers and overlapping half-sites in the target DNA. It is 
feasible that when GCN4 is bound to a regulatory element. It would be symmetrically disposed with 
respect to the DNA template and hence capable of activating transcription bidirectionally, even 
though the protein-DNA contacts cannot be identical for the half-sites of a single promoter. Thus 
bidirectional activation of eukaryotic transcription may reflect the DNA binding properties of activator 
proteins rather than the actual mechanism of transcriptional activation.
On the basis of several criteria, Hope and coworicers (1988) propose that the activation region 
of GCN4 is a dimer of intertwined alpha-helices, one helix from each GCN4 monomer. Firstly the 
unusual chymotryptic pattern reveals a structure in GCN4 which is dependent on the acidic 
activation region. Second, the stability of the dimeric DNA binding domain ,even In the absence of 
target DNA (Hope and Struhl. 1987), should allow the formation of and/or stabilise the proposed 
interactions between helices of different monomer subunits. Finally, since the LexA DNA binding 
domain binds very poorly to its operator because of weak dimérisation (Little and Hill, 1985; Hurstel 
et ai., 1988), it would seem likely that transcriptional stimulation via the LexA domain also requires 
that the activation region should permit dimérisation. This model would also explain why 
amphipathic helices should form functional transcriptional activation regions since this would readily 
permit a structure involving interacting hydrophobic residues which are protected from solvent and 
acidic residues.
A new oncoprotein, Jun, which causes sarcomas in chickens, has recently been identified
62
(Maki etal., 1987). Jun shows significant homology to the DNA binding domain of GCN4 (Vogt etal.,
1987). even though the DNA binding domains share only 45% identity in amino acid sequence. 
This homology suggests that Jun might bind to DNA in a sequence-specific manner and perhaps 
recognise the same DNA sequences as GCN4. Additionally, the consensus sequence for binding 
of the mammalian transcription factor AP-1, which interacts with phorbol-ester inducible promoter 
elements (Angel et al., 1987; Lee et al., 1987), is very similar to the GCN4 recognition site. To 
determine if the Jun oncoprotein would bind to the same DNA sequences as GCN4, molecules 
encoding LexA-GCN4-Jun (LGJ) hybrid proteins, which contained the LexA DNA binding domain, 
the GCN4 transcriptional activation region and the putative Jun DNA binding domain, were 
constructed and the DNA binding properties of the hybrids analysed in yeast (Struhl, 1987b). The 
main finding of these studies was that the C-terminus of the Jun oncoprotein could replace the 
GCN4 DNA binding domain in vivo. In addition, the LGJ hybrid could induce the expression of his 3 
and other amino acid biosynthetic genes, whereas Jun-dependent transcriptional activation 
appeared to require the LexA DNA binding domain. The most likely explanation for this observation 
is that the LexA domain facilitates dimérisation of the Jun domain -  given the palindromic nature of 
the optimal his 3 target site, Jun, like GCN4, probably forms dimers in order to bind DNA.
To determine whether or not the Jun protein Itself was capable of transcriptional activation in 
yeast. Lex A-Jun hybrids were constructed in which the entire JUN coding region was fused directly 
to the LexA DNA binding domain (Struhl, 1988). This construct was introduced into yeast strains 
lacking the GCN4 gene but harbouring the E.coli LexA operator fused upstream of a yeast TATA 
element and a lacZ structural gene. Transcriptional activation through the LexA DNA binding 
domain could then be quantified by B-galactosidase activity, and activation via the Jun oncoprotein 
could be assessed by complementation of the GCN4 deletion. LexA-Jun was found to activate 
transcription, thus indicating that the JUN oncoprotein contains a sequence (or sequences) which 
can function as a transcriptional activator in yeast. Lex A-Jun could functionally replace GCN4 even 
though this hybrid protein lacked any GCN4 coding sequences. This also suggests that Jun and 
GCN4 contain transcriptional activation regions that are equally functional when fused to a 
heterologous DNA binding domain. It may be that JUN activation in yeast reflects both an 
evolutionary and mechanistic similarity between yeast and vertebrate transcription factors.
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The similarity between the DNA recognition sites for GCN4, Jun and AP-1 suggests that the 
Jun oncoprotein may be derived from the normal AP-1 transcription factor. If this is indeed the case, 
it is possible that signals such as phorbol-esters, are received at the cell membrane and transmitted 
to intracellular messengers such as protein kinase C. Activated protein kinase C could modify AP-1, 
thereby resulting in altered gene expression. It may be that the Jun oncoprotein differs from AP-1 
in such a way as to escape the normal regulatory pathway (Struhl, 1987b).
The AP-1 recognition element (ARE) consists of the following consensus sequence: 
(C/G)TGACT(C/A)A (Angel etal., 1987; Lee etal., 1987). The ARE has the same central pentameric 
sequence as the GCN4 recognition element (GORE): TGACT (Hill etal., 1986). During analysis of 
DNA binding proteins from yeast nuclear extracts, Harshman and coworkers (1988) identified a 
factor that binds to the SV40 ARE. This factor was present in wild type and GCN4 deletion mutant 
strains, demonstrating that this protein was not GCN4. The ARE found in the SV40 enhancer was 
also able to activate transcription from an heterologous promoter in S. cerevisiae strains lacking 
GCN4. This activation was attributed to a previously unknown yeast transcription factor. Moreover, 
this factor and AP-1 have nearly identical DNase I, methidiumpropyl-EDTA-iron(ll) and DMS 
"footprints”, suggesting that it is the yeast homologue of the mammalian AP-1 and has therefore 
been designated yAP-1 (Harshman etal., 1988; R.H. Jones etal., 1988). An interesting feature of 
the DNA binding properties of yAP-1 Is that it binds very poorly to the GCRE, despite the fact that 
the GCRE is almost Identical to the ARE. GCN4, on the other hand, can bind to both the GCRE and 
the ARE with near equal affinities. This would suggest that yAP-1 can discriminate between the 
GCRE and the ARE in vivo, whereas GCN4 cannot. Determination of the amino acid sequence of 
the gene encoding yAP-1 and comparison of the DNA binding domain with those of others in this 
class of transcriptional activators, that is GCN4, Jun and AP-1, might shed some light as to which 
amino acids are responsible for the ability of yAP-1 to discriminate between the GCRE and the ARE.
The human proto-oncogene c-jun has recently been isolated (Bohmann et ai., 1987) and the 
DNA sequence of c-jun has revealed significant homology to the GCN4 DNA binding domain. 
Indeed, c-jun expressed in E.coli produces a protein that will bind to the ARE, strongly suggesting 
that c-jun Is the AP-1 gene. In contrast to AP-1, the structural homology between GCN4 and Jun is 
limited with virtually no Identity in the N-termlnal 250 amino acids and only small regions of homology
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in the C-terminal 60 amino acid DNA binding domain (Bohnman et al., 1987). Furthermore, the 
highly acidic amino acid sequence of the transcriptional activation domain of GCN4 is not conserved 
in JUN. This would suggest that GCN4 and Jun are Involved in transcriptional regulation via different 
control pathways in the cell.
2.4 Repression of Transcription in Yeast
Saccharomyces cerevisiae can exist as one of three distinct cell types: as a non-mating diploid 
(aM). or as a haploid of either the oCor the a mating type (Brand et al., 1987). A cell-type specific 
repressor of S. cerevisiae, oL2, turns off transcription of the a genes by binding to an operator 
located upstream of each a-specifIc gene. Alpha2 is present in «(.cells but not a cells which means 
that the a-specific genes are turned off in «<cells but are expressed in a cells.
Several observations suggested to Keleher and coworkers (1988) that oC2 is not the only 
protein involved in repression by the oi2 operator. The operator is a 32 bp region of highly 
conserved sequence (Johnson and Herskowitz, 1985) which contains much more information than 
would be expected to form the recognition site for a single protein. In addition, the operator 
appears to contain two different axes of partial 2-fold symmetry which may function as recognition 
sequences for two different proteins. Another Interesting feature is that purified«42 binds to two 13 
bp sites at the ends of the operator leaving the centre of the operator accessible to DNase I 
cleavage (Sauer etal., 1988). The centres of these protected regions are separated by 25 bp, thus 
positioning them on opposite faces of the DNA double helix. Finally, mutant <12 proteins with small 
deletions in the N-terminal domain, but which retain the ability to bind to the operator in vitro, fail to 
bring about repression in vivo (Hall and Johnson, 1987). These findings suggested that one of the 
functions of the N-terminal domain of «(.2 might be to contact a second regulatory protein, bound to 
the centre of the operator, which is also required for repression. A non cell- type- specific yeast 
protein, GRM (general regulator of mating type), which recognises the central region of the 
operator, has been Identified (Keleher etal., 1988). GRM binds cooperatively with c2.2 to the 
operator in a manner presumably brought about by proteln-protein interaction between GRM and 
the N-terminal domain of «(2. (The isolated C-terminal domain of <*2 binds the «(2 operator but shows 
no cooperativity with GRM). The arrangement of GRM and d.2 on the operator is somewhat unusual
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In that GRM binds to the centre of the operator and Is flanked on either side by an eC2 monomer -  a 
feature which Is attributable to the flexible and elongated structure of oC2 (Sauer etal., 1988).
In addition to a role inoL2 repression, GRM may also function as a transcriptional activator in «(.cells 
(Keleher etal., 1988). A yeast protein, PRTF, has been identified by Bender and Sprague (1987). 
This protein binds, together with the o(.cell-type-speciflc activator protein o^1, to the oL2 operator to 
turn on the ol- specific genes. The binding sites for GRM and PRTF share 10 out of 12 bp identity 
and like GRM, PRTF is found in all three yeast cell types. In addition, a mutant which has decreased 
GRM binding activity andoi2 mediated repression, also shows decreased expression of an«(.-specific 
gene (S. Passmore, unpublished data), a phenotype which would be expected of a PRTF mutant. 
So it would seem likely that GRM and PRTF are identical, suggesting that in oLcells the same protein 
serves as a co-repressor with «(2 and a co-activator with'>^-1.
The GRM may also function as a transcriptional activator in a cells. Kronstad et al., (1987) have 
shown that the ot2 operator located upstream of an a-specific gene was required for expression of 
that gene in a cells. Similarly, Keleher et al., (1988) have shown that the oC2 operator located 
upstream of the STE6 gene supplies weak UAS activity and that this activity resides within the 
central region of the operator. Bender and Sprague (1987) have also arrived at this conclusion 
based on studies of PRTF In a cells. Accordingly it would appear that a single non-cell-type- specific 
protein, GRM/PRTF, has different functions (that Is, activation or repression) depending on the 
cell-type-specific protein with which it acts in concert.
The two yeast mating type loci HML and HMR, although they contain complete copies of the 
mating type genes together with the appropriate regulatory sequences, are transcriptionally inactive 
or "silent" (Brand et al., 1987). This repression of the two silent mating type loci is brought about by 
the action of at least four trans- acting gene products, SIR1, 2, 3, and 4, as well as c/s- acting sites 
located a kilo base or more from the mating type gene promoters (reviewed by Kiar et al., 1984). 
One of the regulatory sites at the HMR locus, a "silencer" sequence, exhibits eukaryotic 
enhancer-like distance- and orientation-independence, but it represses rather than stimulates 
transcription (Brand et al., 1985). Brand et al., (1987) have defined three short DNA sequences 
within the silencer that are required for its ability to repress transcription: A, E and B. Mutations in 
the individual elements do not seriously affect transcriptional control but mutating two out of three of
66
these elements completely inactivates the silencer suggesting that the silencer is composed of 
sequences that are able to substitute functionally for one another. In addition to their role in 
repressing transcription, these sequences are also responsible for the autonomous replication 
sequence (ARS) activity or the centromere-like segregation functions of the silencer. This implies 
that DNA replication and segregation, or the proteins Involved in these processes, may play pivotal 
roles in silencing transcription.
The E and B sequences of the silencer contain the binding sites for two proteins which may be 
involved in silencer function; RAP1 and SBF-B (Shore and Nasmyth, 1987; Brand etal., 1987), but 
neither of these proteins is the product of an SIR gene (Shore et al., 1987). Element E exhibits 
sequence homology to the UASs of several ribosomal protein genes. Moreover, both the E and B 
sites can activate transcription from the CYC1 gene (Brand et al., 1987). However, the ability of 
silencer sequences to activate transcription may be unrelated to their role in transcriptional 
repression in that activation and repression may be brought about by different proteins which act via 
the same DNA sequences. On the other hand, factors which bind to the silencer could have roles in 
several different cellular processes, or be modified in some way by other factors so as to carry out 
the various functions.
Shore and Nasmyth (1987) have studied the function of RAP1 by affinity purifying the protein 
and cloning its gene. They were able to demonstrate quite clearly that RAP1 bound to sequences 
involved in silencer function at HMR. They were also able to show that RAP1 bound to the UASs of 
MAT and ribosomal protein genes in vitro. Could RAP1 be involved In vivo in both activation and 
repression? The RAP1 gene has a null phenotype which indicates that the protein is required for 
cell growth. This finding Is therefore consistent with RAP1 having an essential role in activation of 
ribosomal protein genes, ruling out the possibility that Its only involvement is in silencer function. In 
addition, similarities were revealed between the eukaryotic GTF/NF-1 group of cellular proteins. 
Implicated in both DNA replication and transcription, and RAP1 (Santoro etal., 1988). (A 30 amino 
acid domain present in the N-terminus of CTF shows 30% identity and 60% sequence similarity with 
the C-terminal portion of RAP1). If RAP1 has a role in transcriptional activation then its 
silencer-associated binding sites should, under certain conditions, have UAS activity. This has 
been demonstrated for both the HMR and HML binding sites (Brand et al., 1987; D. Shore,
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unpublished data) which are both able to activate partially a UAS-deleted promoter. That RAP1 is 
involved in silencer function is suggested by the observation that the effect of deletion of its normal 
binding site at the HMR silencer can be overcome by the addition of UAS-associated binding sites 
from ribosomal protein genes (Shore and Nasmyth, 1987). To confirm that RAP1 does have a role 
in both activator and silencer functions will require the Isolation and characterisation of conditional 
RAP1 mutants. That SIR proteins bind directly to silencers Is a possibility which at the present time 
cannot be ruled out. However, it is possible that RAP1 acts, not as a transcriptional activator at the 
silencer, but as a component of a protein-DNA complex unique to silencers which in turn targets 
them to be acted upon by the SIR proteins (Shore and Nasmyth, 1987). Examination of the 
possible interactions between RAP1, other silencer binding factors and the SIR proteins should 
prove to be most interesting.
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2.5 Control of gene expression in higher eukaryotes
Eukaryotic transcriptional control elements are generally grouped into two distinct classes of 
CIS- acting regulatory sequences, promoters and enhancers, which can overlap both physically and 
functionally (Serfling etal., 1985). These sequences govern eukaryotic gene expression. Efficient 
transcription is generally dependent on the correct spatial arrangement of the promoter elements 
with respect to the mRNA start site (Cochran and Welsmann, 1984; McKnIght and Kignsbury, 1982; 
Everett et al., 1983). However, considerably more flexibility is shown by enhancer sequences in 
that they are able to activate transcription independently of position or orientation from the 
responding promoter -  an effect first observed in DNA sequences present in the small animal DNA 
tumour virus, SV40 (Banerji etal., 1981; Moreau etal., 1981).
The double stranded DNA viruses that infect animal cells rely heavily on the host cell's 
transcriptional machinery for expression of their genes, as well as encoding regulatory proteins 
which have the potential to modify transcriptional specificity. Much is known about the genetics and 
molecular biology of animal viruses and as such a detailed description of their interaction with the 
cellular transcriptional apparatus will provide us with an invaluable insight into how gene expression 
is controlled in animal cells. In addition to the genetic approaches which led to the Identification of 
viral regulatory genes, two strategies have been adopted in studying the control of viral gene 
expression. In the first of these, DNA sequences which act in cis to regulate expression In vivo 
have been identified and analysed using In vitro mutagenesis. In the second, soluble cellular 
extracts capable of accurate transcription In vitro have been established and fractionated. 
Combination of these approaches has begun to shed some light on the molecular interactions 
between host cell transcription factors and viral regulatory information which account for viral 
selectivity (reviewed by McKnight and Tjian. 1986).
Gene expression in higher eukaryotes is controlled at many steps, including the accessibility of 
genes to transcription factors in exposed active chromatin as opposed to condensed inactive 
chromatin; the rate of transcription initiation on open chromatin; and various post-transcriptional 
steps (reviewed by Wasylyk, 1988). There are three types of eukaryotic RNA polymerases. I, II and 
III, which are known to transcribe ribosomal RNA genes, protein coding and small U RNA genes, and 
5S and transfer RNA genes, respectively (Sentenac, 1985). The protein coding genes are the
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most heterogeneous class and are especially important in that they code for the regulatory proteins 
e.g., those that control development. RNA polymerase II has been the most extensively studied of 
the three polymerases and signals controlling the transcription of this class of genes have been 
defined. To this end, this review will focus on transcriptional regulation of the RNA polymerase II 
transcribed genes.
In general, promoter sequences in RNA polymerase II transcribed genes can be subdivided 
into those which select the site of initiation and those which modulate the specific rate of initiation 
e.g., upstream elements and enhancers. The mRNA start site selection region extends from about 
-45 to +30 and contains two highly conserved DNA sequence motifs, the TATAAA sequence at 
around -30 and the CA at +1 (see Figure 12). General transcription factors bind to this region and 
direct RNA polymerase II to the specific start site (reviewed by Wasylyk, 1988). The same general 
factors are probably involved in specific initiation from most protein coding genes. Promoter 
mapping studies of several eukaryotic genes have disclosed the importance of a GGGCGG 
hexanucieotide (GC box) and a CCAAT sequence (CAAT box) which are often found 40-100 bp 
upstream of the initiation site. These upstream elements appear to be critical in directing efficient 
transcription from certain mammalian promoters, e.g., the SV40 early promoter, mammalian (3-globin 
promoters and the herpes simplex virus (HSV) thymidine kinase (TK) promoter (reviewed by
I
Kadonaga etal., 1986). j
In most protein coding genes the short DNA sequences of -10 to 20 bp (transcription !
elements), which lie upstream of the mRNA start site, serve as the recognition sites for a variety of j
trans -acting factors. Promoters can be constructed from a large number of different transcription |
j
elements and transcription factors. The factors can vary in activity in response to a variety of stimuli, j
e.g., hormones, heat, phorbol esters, etc., or from cell type to cell type (reviewed by Wasylyk, |
1988). This combinatorial organisation of eukaryotic promoters could therefore lead to quite !
convoluted regulatory patterns Involving only a small number of transcription factors. How a given |
combination of these factors leads to a particular pattern of gene regulation is only now beginning to |
be understood. |
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Figure 12. Model of a eukaryotic RNA polymerase II transcribed gene 
promoter
BTF1 (TFIID) binds specificaily to DNA in the mRNA start site selection region, possibly in 
association with STA (TFIIA). This proteln-promoter complex is recognised by RNA polymerase 
II perhaps in combination with BTF2 (TFIIE) or BTF3 (TFIIB). Various other transcription factors 
(TFs) bind to specific DNA sequences or transcription elements (TEs), which can be located up 
to 10,000 bp upstream or downstream from the initiation site (+1 ). It is common to find at least 
one TE immediately upstream from the start site selection region (from -45 to -110). Efficient 
distal activation by enhancer elements appears to require the association of several (TFs) 
(Wasylyk, 1988).
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2.5.1 The Eukaryotic Promoter and Transcription initiation
Two types of eukaryotic promoter can be distinguished: those in which the TATA and mRNA 
start site both make significant contributions to promoter strength; and those in which either region 
will have a predominant effect. The former situation is illustrated by the adenovirus major late 
promoter (MLP) in which point mutations in either the TA motif, or the mRNA start site, decrease 
transcription, whereas mutation of both these sequences has a synergistic effect resulting in the 
elimination of transcription (Concino et ai, 1984). In the SV40 early promoter, which has no TATA 
homology sequence, the start site regions are the primary determinants of transcription initiation. 
This has been demonstrated by the effects of small deletions or insertions upstream from the start 
sites which did not alter the locations of the 5'-ends of the RNA upon infection with the mutant viral 
strains in vivo (Somasekhar and Mertz, 1985). In addition, it is now evident that many promoters, 
particularly those of house-keeping genes, lack TATA boxes and are instead composed of GC-rich 
elements that are often located within methylation-free islands (Bird, 1986). Transcription from 
these promoters often initiates at multiple sites. It has been demonstrated that TATA-less 
promoters, such as the adenovirus E2a and SV40 late promoters, form complexes with the same 
purified transcription factors as other TATA box-containing promoters. However, the affinity of 
these factors is somewhat lower for the non-consensus promoters (reviewed by Wasylyk, 1988).
Purification of transcription factors from crude cell extracts has shown that at least four factors, 
as well as RNA polymerase II, are required for specific transcription initiation (Figure 12). 
Unfortunately these factors have been assigned different names. However, STF, BTF1, BTF2 and 
BTF3 (Moncoliin et ai, 1986) are equivalent to TFIIA, TFIID, TFIIE and TFIIB, (Reinberg and Roeder, 
1987; Reinberg et ai, 1987) respectively. Using highly purified preparations, it has been shown 
that two of these factors TFIIA and TFIID, act first to form a stable pre-initiation complex on the -45 to 
+30 region of the promoter which in turn commits the template to transcription. TFIIA does not bind 
directly to DNA but appears to act by stabilising the interaction between TFIID and the promoter, via 
protein-protein interactions (Fire et ai, 1984; Elgy et ai, 1984). At a later step in initiation, involving 
RNA polymerase II, TFIIE and TFIIB associate with the pre-initiation complex to help form a complex 
which mediates rapid initiation of RNA synthesis (IVIoncollin et ai, 1986; Reinberg and Roeder,
1987). TFIIE and TFIIB do not bind specifically to DNA. Several observations suggest that they
71
interact with other factors, including RNA polymerase II again via protein-protein interactions 
(reviewed by Wasylyk, 1988).
An increasing of evidence suggest that regulation of transcription initiation may be exerted 
directly on the general transcription factors. For example, the adenovirus Ela gene products, 
produced early in viral infection, can trans- activate transcription from a variety of promoters. The TA 
motif has been shown to be the target for Ela trans- activation in some cases (Berk, 1986). This 
motif also appears to be the target for trans- activation of the HSV TK gene by viral immediate early 
gene products (Coen et ai, 1986). The slow formation of the pre-initiation complex may also be a 
target for regulation of initiation. In the adenovirus MLP a specific factor binds to DNA sequences 
upstream of the TATA box and binding of this factor increases the rate of pre-initiation complex 
formation (Sawadogo and Roeder, 1985). In vivo experiments on the Drosophila hsp70 gene have 
suggested that later steps in the initiation reaction may also be transcriptional control points. In the 
non-induced, non-transcribed state, the hsp70 gene has protein bound to the -40 to +60 region of 
the promoter. RNA polymerase II is also associated with this promoter. Heat shock rapidly 
stimulates transcription through association of heat shock transcription factor (HSTF) with the 
upstream region. A simple interpretation of these results suggests that an inactive, pre-initiation 
complex Is present on the promoter, and HSTF binding activates this complex (Wu, 1984; Parker 
and Topal, 1984).
Studies on the mechanism of basal transcription have mainly been carried out in vitro. 
However, the start site selection region generally requires additional elements for efficient 
transcription in vivo. These elements are probably the major determinants of the efficiency of 
transcription and may serve to activate a segment of DNA, thereby facilitating interaction of general 
transcription factors (reviewed by Wasylyk, 1988). The factors are most likely to be responsible for 
subsequent Interactions which determine both the precise site(s) of initiation and the final efficiency 
of transcription.
Upstream promoter regions and enhancer elements can be distinguished functionally by the 
inability of the upstream elements to stimulate transcription when distanced from the start site 
selection region. Enhancers, on the other hand, are able to stimulate transcription at some distance 
from the responding promoter, raising the possibility that different transcription factors Interact with
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upstream, or enhancer, elements to activate transcription via different mechanisms. However, many 
transcription factors are capable of both short- and long-range activation suggesting that such a 
distinction may not actually exist (reviewed by Wasylyk, 1988).
Many factors which interact with elements in upstream regions are able to stimulate transcription 
from distantly located promoters. For example, in the SV40 early gene promoter (see “Results” 
Figure 1.1) there are binding sites, located in the 21 bp repeats, for the transcription factor Spl. 
However, this upstream element is considerably less efficient at stimulating transcription when 
moved away from the transcription start site (Moreau etal., 1981). The 21 bp repeats are also part of 
the divergently transcribed late promoter and it has been shown that Spl stimulates transcription 
from the late start sites located some 200 bp away (reviewed by Wasylyk, 1988). In addition, it has 
been reported that the Spl binding sites in this upstream element can behave like a transcriptional 
enhancer if the concentration of Spl Is increased tenfold (unpublished, R. Tjian, 13th Harden 
Conference, 1988). Spl binding sites have been located up to 250 bp upstream from the start site 
of different eukaryotic promoters , including the HSV TK gene, HSV IE3 gene, HIV LTR promoter, 
mouse dihydrofolate reductase gene and the human metallothionein IIa gene (reviewed by 
Kadonaga etal., 1986).
The immunoglobulin (Ig) octamer motif (ATGCAAAT) is present in both upstream elements 
(e.g., IgH and Igk promoters) and enhancers (e.g., SV40, igH and Xenopus U2 gene; for review see 
Falkner etaf., 1986). Indeed B-cell-specifIc transcription of ig genes is dependent on the presence 
of an intact octamer motif (Gerster et a!., 1987; Wirth et a!., 1987). These sequence elements are 
recognised by the B-cell specific octamer binding transcription factor OTF-2 (Landolfl et a!., 1986; 
Staudt etal., 1986). This element is also an important functional component of many ubiquitously 
expressed genes where it is recognised by one or more ubiquitous octamer binding proteins, e.g., 
NFIII (Pruijn etal., 1986), NF-AI (Singh etal., 1986), OTF-i (Fletcher etal., 1987) and OBP100 
(Sturm etal., 1987). An octamer motif is present in each 72 bp repeat of the SV40 enhancer and in 
its natural promoter context has been shown to be active only in lymphoid cells, but not in other 
non-lymphoid cells tested so far (Davidson etal., 1986; Nomiyama etal., 1987). This observation 
has been strengthened by the results of Schirm etal., (1987), in which a multimerised domain A of 
the Sv40 enhancer (see "Results", Figure 1.2), which contains the octamer motif, was active only in
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lymphoid cells. A single copy of this element did not appear to efficiently activate transcription of a 
linked gene at a distance. However, on multimerisation of this motif, transcription was enhanced 
(Gerster et al.. 1987). Generation of enhancer activity by duplication is now widely recognised (Herr 
and Gluzman, 1985; Weber eta!., 1984; Schirm et a i, 1987) suggesting that a large number of 
transcription elements have the potential to activate transcription at a distance.
2.5.2 Eukaryotic Promoter Organisation: The SV40 Eariy promoter
Many of the double stranded DNA viruses that infect animal cells express their genetic 
information in temporal cascades that are regulated by defined genetic loci. SV40 provides us with 
such an example (for a review see Tooze, 1982). The SV40 genome is a double stranded, 
covalently closed, circular molecule of 5243 bp. The genome can be functionally divided Into two 
divergently transcribed regions: the early region which is transcribed throughout the virus lytic cycle 
and in transformed cells; and the late region which is transcribed only in permissive ceil types after 
the onset of viral DNA replication (Figure 13). The primary transcripts from both regions are 
differentially spliced generating two eariy mRNAs which code for the eariy proteins, large T antigen 
(T antigen) and small t antigen (t antigen), and at least two mRNAs which code for the late capsid 
proteins VP1, VP2 and VP3 (reviewed by Hamer and Khoury, 1983). The transcriptional control 
elements of the virus lie within the 400 bp region between the early and late coding sequences 
(see expanded portion of Figure 13). Studies have centred on the role of this region in the initiation 
of eariy transcription which occurs primarily at the site marked “Early E" (nucleotides 5232-5236) in 
the early stage of lytic infection and in transformed ceils. At late times during lytic infection, the major 
cap site shifts approximately 40 bp upstream to position “Early L” (nucleotides 28-34) (reviewed by 
Hamer and Khoury, 1983).
The SV40 early promoter has been the subject of intense investigation; deletions insertions, 
base substitutions and sequence rearrangements have been introduced into the SV40 
chromosome and their effects analysed by a variety of assays, including virus propagation, 
morphological transformation, T antigen synthesis, as well as mRNA synthesis In vivo and In vitro 
(reviewed by McKnight and Tjian, 1986).
The 300 bp stretch lying between the early and late transcription units contains a number of
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Figure 13. Transcription map and controi region of SV40
The location of the origin of DNA replication (or) and the general structures of the predominant 
transcripts are indicated. The expanded top part shows the viral control sequences lying between 
the early and late AUG initiation codons. This region contains a number of early transcriptional 
regulatory elements, including an AT-rich sequence (the TATA box), three 21 bp repeats and two 
72 bp repeat sequences (Hamer and Khoury, 1983).
regulatory DNA sequences, and a number of sequence-specific protein-DNA interactions are 
known to take place within this transcriptional control region. The origin of DNA replication is located 
within a 70 bp segment containing three binding sites for T antigen (Myers and Tjian, 1980), as well 
as the mRNA initiation sites from the early promoter (Khoury et ai, 1973). Perturbation of the DNA 
replication origin affects transcriptional control. Elimination of T antigen binding sites prevents 
initiation of eariy transcription. In addition. Inactivation of the origin severely limits the number of 
templates available for late mRNA synthesis, resulting in a reduction of late gene expression 
(reviewed by McKnight and Tjian, 1986).
Directly adjacent to the replication origin is a stretch of DNA associated with defining the 
locations of the early mRNA start sites. Within the mRNA start site selection region there are several 
major and some minor start sites for transcription from the eariy promoter which are used both eariy 
and late in viral infection. About 30 bp upstream from the major EES there is a TATA-like motif within 
an A-T stretch of DNA. However, deletions in this region, and point mutations in the TATA motif, 
have only about a five fold effect on transcription efficiency suggesting that this region contributes 
minimally to overall promoter efficiency (Benoist and Chambon, 1981 ; Mathis and Chambon, 1981; 
Wasylyk et at., 1983). it may be that the A-T rich sequences in the early promoter can act as 
alternative TATA motif recognition sequences for general transcription factors resulting in initiation 
from the minor start sites (reviewed by Wasylyk, 1988).
Three direct repeats of a GC-rich 21 bp sequence lie in the upstream region of the eariy 
promoter. Within each repeat element are 2 copies of the hexanucieotide sequence 5'-GGGCGG-3' 
(GO motif). Deletion of all three 21 bp repeats severely inhibits promoter function, as well as virus 
viability (Myers etal., 1981; Fromm and Berg, 1982; Everett etal., 1983). However, it is interesting 
to note that viral mutants which lack up to four copies of the GO motif can still be propagated. This 
effect is probably due to the redundant nature of the 21 bp repeats (McKnight and Tjian, 1986). 
The GO motifs in the 21 bp sequences bind the transcription factor Spl (Barrera-Saldana et al., 
1985; Kadonaga etal., 1986; McKnight and Tjian, 1986), which was Isolated from HeLa cells and 
shown to activate transcription from the SV40 eariy promoter (Dynan and Tjian, 1983). Of the GO 
boxes that bind S p l, boxes III and V have the strongest affinity for Spl, II and VI have intermediate 
affinity, I is a weak binding site, with box IV being essentially inaccessible to Spl when GO box V is
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occupied. Mutational analysis has indicated that interaction of Sp1 with three of the binding sites, 
GC boxes I, II and III, is largely responsible for mediating early transcription, whereas binding to 
boxes IV, V and VI predominantly affects late transcription (Gidoni et ai, 1985). Spl stimulates 
both early and late transcription whose start sites lie at different distances, and in opposite 
orientations, to one another. Moreover, Spl binding sites are found interspersed with other 
transcription elements, suggesting that it can interact with other transcription factors in addition to 
those found in the SV40 early promoter (reviewed by Wasylyk, 1988). However, Takahashi and 
coworkers (1986) have demonstrated that stereospecific alignment with the start site selection and 
enhancer regions is required for maximal transcription efficiency. They altered the spacing between 
the three SV40 early promoter elements by inserting either odd or even multiples of one half turn of 
the DNA helix and could show that marked differences in transcriptional activation in vivo, of these 
two types of insertions on initiation from the early promoter. This suggests that Spl probably 
mediates this effect via protein-protein interactions.
Finding six closely spaced, but apparently independent Spl binding sites has suggested how 
the bidirectionality of these promoter elements may function (Gidoni et a!., 1985). For example, the 
binding site closest to the transcription start site has the greatest influence on activation of RNA 
synthesis for a given direction of transcription, suggesting that the functional directionality of the 21 
bp repeats could actually be due to multiple directional elements. Alternatively, each individual Spl 
binding sequence would have the ability to activate transcription in a position and orientation 
independent manner with the direction of transcription being determined by the position of the Spl 
binding site in the context of the other promoter elements. Bidirectional stimulation of transcription 
by Spl could occur by virtue of Spl having two symmetrically disposed interaction sites. The 
interaction could take place by having two functional domains linked by a flexible arm, one which 
binds DNA, and another which interacts with other transcription factors as seen in repressor proteins 
of E. coll phage lambda (reviewed by Ptashne, 1986b). Kadonaga and coworkers (1987) isolated a 
cDNA that encodes human Spl and by expression of truncated fragments of Spl in E. coll were 
able to localise the DNA binding activity to the C-terminal 168 amino acid residues. The DNA 
binding domain was found to harbour three contiguous “Zn finger” motifs (Miller etal., 1985; Brown 
et al., 1985) which are believed to be metalloprotein structures that interact with DNA. Indeed,
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purified Sp1 required Zn(ll) for sequence-specific binding to DNA suggesting that Sp1 interacts with 
DNA by binding of the “Zn fingers" (Kadonaga et ai, 1987).
Two additional tandem repeats are positioned towards the “late” side of the SV40 
transcriptional control region (see “Results", Figure 1.1). Extensive mutagenesis, or removal of 
both these 72 bp repeats, impairs virus viability and reduces early transcription. However, deletion 
of only a single copy of the repeat does not, to a large extent, affect virus growth or eariy promoter 
function (reviewed by McKnight and Tjian, 1986). The 72 bp repeats are also able to potentiate 
early transcription regardless of their orientation. They can activate transcription when placed 
thousands of bp upstream from a promoter element, or downstream from a transcription unit. It 
should be stressed, however, that this enhancing activity is diminished at distant locations and that 
even a 5 bp displacement of the 72 bp sequence decreases promoter efficiency six- to ninefold 
(Takahashi et ai, 1986).
In addition to housing elements critical for early promoter function, the 72 bp repeats also 
contain determinants of the late promoter which appears to be the major contibuter to expression 
from the late promoter. A series of deletion mutants identified two domains within the enhancer 
element which contain sequences important for efficient late transcription. Both domains I and II 
function after DNA replication, and sequence motifs within these domains, shown to be Important 
for late promoter activity, also corresponded to sequence motifs important for enhancer activity. 
May and coworkers (1987) carried out their deletion analysis in the absence of T antigen. They 
suggest that the change observed in the regulation of late genes, coincidental with initiation of DNA 
replication, may be due to T antigen binding to its three natural sites which could directly, or 
indirectly, modify some interactions between the different trans- acting factors bound to promoter 
elements. This in turn could lead to down regulation of the early promoter and to an up regulation of 
late gene expression.
2.5.3 Enhancer Elements
Enhancers are cis- acting DNA sequences which constitute an important part of the 
transcriptional control apparatus of eukaryotic cells. The main feature of an enhancer which 
distinguishes it from other cis- acting transcriptional control elements, e.g., promoter sequence
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elements, is its ability to activate transcription of a linked gene in a position- and 
orientation-independent manner (Guarente, 1988). Enhancers have been Identified in many 
different viruses that in experimental constructions fulfilled the following criteria:
1. strong transcriptional activation of a linked gene from its correct initiation (cap) site:
2. activation of transcription independently of the orientation of the enhancer element:
3. the ability to function over large distances (>1000 bp) from a position upstream or downstream 
relative to the initiation site: and
4. in cases examined, to preferentially stimulate transcription from the most proximal of two tandem 
promoters (reviewed by Schaffner, 1986 and Muller etal., 1988).
The first cellular enhancer was discovered in the Ig heavy chain gene (deVilliers etal., 1983; 
Gillies et al., 1983; Neuberger, 1983). This was of great interest in the studies of eukaryotic gene 
reguiation in that it showed that remote gene control by the enhancer effect was not simply a viral 
peculiarity; stimulation of transcription by the Ig enhancer was ceil type-specific (the first genetic 
element described to have such a property); and, this enhancer element was found to be located 
within the Ig gene, downstream of the cap site (reviewed by Schaffner, 1986 and Muller et al.,
1988).
in general, DNA sequences with enhancer activity, are located -100 to -300 bp upstream of the 
transcription unit. They can however, be found in other positions, such as within introns (e.g., the Ig 
heavy chain gene enhancer) or between two genes. It is evident that upstream promoter 
components and enhancers overlap physically and functionally, implying that an enhancer is not so 
much a physical entity with clearly defined boundaries, but rather that there exists an “enhancer 
effect" (reviewed by Schaffner, 1986). This effect can be exerted by combinations of a variety of 
DNA sequence motifs.
The minimum enhancer activity of SV40 can be attributed to one copy of the 72 bp repeat plus 
an additional 30 bp of DNA located on the late side of the repeated element (Zenke etal., 1986). it 
is possible to dissect this region into two large domains, A and B (see "Results”. Figure 1.2), which 
in isolation have minimal enhancer activity, but which in combination act synergistically to generate 
the substantial enhancement of transcription typical of the complete enhancer (Zenke et al., 1986). 
Deletion/duplication events within each large domain have identified small DNA sequence motifs
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that are important for enhancer function (Swimmer and Shenk, 1984; Weber et ai, 1984; Herr and 
Gluzman, 1985; Herr and Clarke, 1986; Fromental et al., 1988). In general, single copies of these 
motifs tend not to show enhancer activity but when multimerised, or combined with other motifs can 
function as bona fide enhancers (Ondek ef al., 1987; Schirm et ai, 1987). Each of these DNA 
sequence motifs appears to represent the binding site for at least one trans -acting factor (Wildeman 
et al., 1986) and it is thought that formation of a nucleoprotein complex containing multiple trans 
-acting factors arrayed on the the enhancer is required for efficient stimulation of transcription.
it is now clear that individual motifs have the potential to bind multiple trans -acting factors and 
this is exemplified in the region of the enhancer "core" sequence (5'-GTGGA/TA/TA/TG-3') 
identified by comparison of DNA sequences from a number of different enhancers (Laimins et al., 
1982; Weiher et al., 1983), where a variety of proteins bind to overlapping DNA recognition sites. 
Three proteins, one of which was cell type specific, were shown to bind to sites In the GT-i or "core” 
region of the SV40 enhancer (Xiao et al., 1987) (see “Results”. Figure 1.2). Although present in 
crude extracts these proteins could be distinguished from one another by their ability to bind to a 
variety of mutated templates and by their unique méthylation interference patterns (Xiao et ai, 
1987). Purification of factors which bind to this region has led to the identification of EBP20, a
20,000 molecular weight species present in rat liver (Johnson et al., 1987) and AP-3, a protein 
derived from HeLa cell nuclei (Mitchell et ai, 1987). To date the relationships, if any, between these 
proteins has not been established.
Although the SV40 enhancer has been shown to be active in a variety of cell types, it also 
demonstrates distinct cell type specificities. Schirm et ai, (1987) demonstrated that the SV40 
enhancer can be dissected into multiple segments, each with a different cell type specificity. They 
suggest that a particular cell type specificity is typical for the individual segments, and that 
enhancers of differing specificity could be assembled by combining the individual sequence motifs 
in different ways. Activation of transcription by individual DNA sequence motifs is cell type specific 
in vivo (Ondek et ai, 1987; Nomiyama et ai, 1987; Fromental et ai, 1988) and this is paralleled by 
cell type specificity in the binding of cellular factors to these motifs in vivo (Davidson et ai, 1986; 
Xiao et ai, 1987a).
Nomiyama and co-workers (1987) have proposed that the activity of an enhancer, in a given cell
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type, results from the nature of its constituent motifs as well as the presence or absence of the 
appropriate specific trans- acting factors in that cell type. Thus in complex enhancers, such as that 
present in SV40, a situation exists whereby gene expression may be controlled by the binding of 
different combinations of interacting factors . Fromental and coworkers (1988) have investigated 
the cell-type specificity of individual SV40 enhancer motifs, the effects of spacing between motifs 
and the synergism between combinations of motifs. Their results showed the existence of three 
distinct classes of sequence motifs which interact with different classes of cell-type specific 
enhancer binding factors, but which in isolation do not demonstrate enhancer activity. This 
demonstrates three distinct levels of functional organisation the first of which is the DNA sequence 
motif itself, which represents the binding site for a particular class (A, B, C or D) of trans- acting factor. 
The second level of organisation comprises of the minimum enhancer element which when 
oligomerised, or combined with other enhancer elements, acts synergistically to generate enhancer 
activity. The third level exists when a single minimal enhancer element is oligomerised or combined 
with two or more similar elements -  a situation which is apparent in the SV40 enhancer (Fromental et 
al., 1987) and the Ig heavy chain gene enhancer (Leonardo etal., 1987; Perez-MutuI etal., 1988). 
In one category (functional level 1, class A), a HeLa cell factor, TEF-1 (Davidson et al., 1988), binds 
specificaily to two apparently unrelated sequence motifs (GT-I 1C and Sph) (see “Results, Figure 1.2) 
in the SV40 enhancer. This factor binds cooperatively to DNA templates containing tandem repeats 
of its cognate motifs which correlates with the ability of the tandem repeats to generate enhancer 
activity in vivo.
Transcriptional activation in response to extracellular stimuli is now a well established 
phenomenon. The cellular transcription factor AP-1 interacts with DNA sequences common to both 
SV40 and the human metallothionein IIa (hMTIlA) gene enhancers (Lee et al., 1987a), both of 
which are inducible in cells treated with the tumour promoter 12-0-tetradecanoyl-phorboi-14 
acetate (TPA). It is thought that AP-1 is involved in mediating both the basai level of transcription 
and specific response to induction by TP A from these enhancer elements (Lee et al., 1987b). In 
the case of the transcription factor NF-kB, which binds to a site in the Ig kappa iight chain gene 
enhancer (Sen and Baltimore, 1986a) and whose activity is normally restricted to B-cells, stimulation 
of the factor occurs in other cell types after treatment with agents such as bacterial
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lipopolysaccharides and phorbol esters (Sen and Baltimore, 1986b). In mammalian cells, 
transcription of several genes can be rapidly and transiently activated following serum stimulation. A 
short DNA sequence element, the serum response element (SRE), has been identified which 
binds the serum response factor (SRF) and mediates transcriptional activation of c-fos and 
cytoskeletai actin genes (Treisman, 1985; Gilman et al., 1986). The precise role of the SRE in c-fos 
transcription has not been defined but it is probable that activation of c-fos gene expression 
involves an increase in the DNA binding properties of SRF and modification of its ability to activate 
transcription. In addition, exposure of cells to elevated temperatures leads to transcriptional 
activation of the heat shock genes, again mediated by a short DNA sequence, the heat shock 
element (HSE), which is the binding site for the heat shock transcription factor (HSTF) (Shuey and 
Parker, 1986; Sorger etal., 1987; Welderrecht etal., 1987). HSTF has been shown to be regulated 
differently in yeast and HeLa cells. In HeLa cells, binding activity is detectable only after heat shock 
whereas in yeast cells, the HSTF appears to bind constitutively to DNA and is thought to activate 
transcription after heat-induced phosphorylation (Sorger etal., 1987).
Transcriptional activity may also be modulated by the ability of bound proteins to exclude 
binding of other antagonistically acting factors. An example of this type Is provided by the inducible 
enhancer element of the human 8-interferon gene. It is thought that prior to induction a repressor 
protein bound to the interferon gene regulatory element (IRE) excludes the binding of a 
transcriptional activator (Goodbourn et al., 1985). Mutational analysis has indicated that the IRE 
contains a constitutive transcription element, PRDll, that is prevented from functioning in uninduced 
mouse C l27 cells by an adjacent or overlapping negative regulatory element. The PRDll region is 
related to the SV40 enhancer “core” sequence and contributes significantly to the high basal level 
of gene expression when the negative regulatory element is deleted. The inability to observe 
“down” effects on transcription in uninduced cells when this region is mutagenised suggests that 
access of transcription factors to this element may be blocked by negative regulatory factors 
(Goodbourn and Maniatis, 1988).
In addition to their role in stimulation of transcription, enhancers have also been demonstrated 
to have a cis- acting involvement in Polyoma (Py) virus DNA replication (deVilliers etal., 1984, and 
references therein). Only DNA molecules which have both the Py virus origin of DNA replication
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and adjacent (but non-overlapping) sequences within the enhancer region can replicate in mouse 
COP-5 cells (Py transformed mouse fibroblasts), even though these cells constitutively express the 
viral T antigen (shown to be essential for virus DNA replication) (reviewed by deVilliers et ai, 1894). 
DeVilliers and coworkers (1984) constructed viral hybrid genomes in which the Py enhancer was 
replaced by other such DNA fragments in an attempt to identify heterologous sequences which 
might substitute for the replicatory activation component. What their results demonstrated was that 
Py virus DNA replication could be activated by enhancer sequences of both viral (Py and SV40) and 
cellular origin (Ig heavy chain gene). Deletion analysis of the Py enhancer region has identified a 23 
bp DNA segment which exhibits minimal replicatory ability. However, tandem duplication of this 
fragment restores full activation of DNA replication while further oligomerisation generates an 
efficient transcriptional enhancer (Veldman et ai, 1985). If enhancers function by localising DNA at 
the nuclear matrix, or by altering the DNA conformation, it is possible that such molecular 
mechanisms could also be involved in DNA replication or transcriptional activation, in addition, 
transcription could be directly involved in DNA replication (reviewed by deVilliers et ai, 1984).
Studies on SV40 DNA replication have revealed that transcription elements do function as 
components of eukaryotic origins of DNA replication. Deletion of the 72 bp repeated elements 
does not affect DNA replication provided that at least three copies of the GC-boxes in the 21 bp 
repeats are present. Elimination of ail six GC-boxes reduces DNA replication two- to threefold iv 
vivo. If the enhancer elements are also eliminated then a 10- to 100-fold reduction in DNA 
replication is observed (reviewed by DePamphilis, 1988). It has been suggested that the 
transcription elements facilitate binding of replication proteins to the core origin region but that this 
is not achieved by promoting transcription through the core origin. It may be that the role of 
transcription elements in DNA replication is to facilitate the interaction of replication proteins which 
bind to transcription elements. For, example, transcription factor AP-2, which binds to enhancer 
sequences of SV40 and stimulates RNA synthesis in vitro, also binds to T antigen (Mitchell et ai, 
1987). AP-2 binds to sequences in the early promoter recognised by Spl and T antigen, and 
juxtaposed binding sites for AP-2 and SP1 In the 21 bp repeats may facilitate productive interaction 
between transcription factors (Mitchell et ai, 1987). Autoregulation of SV40 early transcription in 
vitro depends, to a large extent, on binding of T antigen to sites in the eariy promoter region. The
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findings of Mitchell etal., (1987) suggest that an additional component of this autoregulation could 
involve direct repression by T antigen of AP-2. Alternatively, proteins that recognise transcription 
elements may stabilise binding of DNA replication initiation proteins to the origin by promoting local 
unwinding of the DNA (DePamphilis, 1988)
In summary, it is likely that enhancer-mediated transcriptional control requires the formation a 
large nucleoprotein complex whereby a limited set of proteins interact with their recognition sites on 
the genome, and with the transcriptional machinery, to initiate RNA synthesis at the promoter, which 
may be some distance from the enhancer element. Understanding the mechanism of enhancer 
action will require the reconstruction of this process In vitro. Purification of individual transcription 
factors and detailed information on their interaction with DNA will clearly be required to attain this 
goal.
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MATERIALS AND METHODS
1. Cells and tissue culture medium
HeLa S3 spinner cells (WS line) were grown in suspension in Earle's minimal essential medium 
{Gibco Europe Ltd., Paisley, Scotland) containing 50 units/ml of penicillin (Glaxo Labs. Ltd., 
Greenford, England). 50 pg/mi of streptomycin (Evans Medical Ltd.. Greenford, England), 2.2 g/l 
sodium bicarbonate and 5% new born calf serum (Sera-lab Ltd., Sussex, England). HeLa S1 
monolayer cells were grown in Glasgow modified minimal essential medium (Gibco)containing 
penicillin, streptomycin sodium bicarbonate as described above for HeLa S3 cells, plus 10% foetal 
calf serum (Sera-lab Ltd.).
2. Bacterial strains
All plasmids were grown in E. coli K12 strain DH1 (F“ , me A l, endAI, gyrA9Q, f/7/-1, hsd 
R17 (r'k, m+k), sup E44, Xr: Maniatis etal., 1982).
Bacteriophage M13mp8 was propagated in E. coli K12 strain JM101 (/acpm del, sup EJhi, F' 
tra D36, pro AB, laclq, ZM15del ; Messing, 1979).
3. Bacterial culture medium
Bacteria were propagated in Luria Broth (LB); 10 g/l bacto-tryptone (Difco Labs., Detroit, USA) 
and 5 g/i yeast extract (Difco) in 10 mM NaCI pH 7.5, sterilised by autociaving. Agar plate cultures 
contained LB supplemented with 1.5% Agar (Difco ) and MgSO^ to a finai concentration of 10 mM. 
Culture media were supplemented with 100 pg/ml ampicillin (Sigma) where appropriate.
4. Buffer solutions
The following buffers were routinely used in this study:
TE : 10 mM Tris.HCI, 1 mM EDTA, pH 8.0
TEN : 10 mM Tris.HCI, 1 mM EDTA, 100 mM NaCI, pH 8.0
TEN300  NaNg : 10 mM Tris.HCI, 1 mM EDTA, 300 mM NaCI. 0.02% NaNs, pH 8.0
TBE : 100 mM Tris. Bo rate, 1 mM EDTA, pH 8.3
TGS : 25 mM Tris.HCI, 200 mM glycine, 0.1% SDS, pH 8.3
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Hypotonie buffer : 25 mM HEPES.NaOH, 5 mM KCi, 0.5 mM MgCl2 , 0.5 mM DTT (Sigma), 0.5 mM 
PMSF (Sigma), pH 7.5
isotonie buffer : 25 mM HEPES.NaOH, 5 mM KCI, 0.5 mM MgClg, 0.5 mM DTT, 0.2M sucrose, 1 mM 
PMSF, pH 7.5
Buffer A : 25 mM HEPES.NaOH, 1 mM EDTA, 1 mM DTT, 20% glycerol, 0.1% NP40,1 mM PMSF, 
pH7.5
Binding buffer : 25 mM HEPES.NaOH, 1 mM EDTA, 1 mM DTT. 10% glycerol, 0.05% NP40,100 
mM NaCI, 100 pg/ml BSA, pH 7.5
5. Reagents
Reagents were purchased from May & Baker Ltd., Dagenham, Essex, England and BDH 
Chemicals Ltd., Broom Road, Poole, Dorset, England (Analar grade), except where otherwise 
specified.
6. Restriction endonucleases, DNA and RNA modifying enzymes
Enzymes were obtained from Northumbria Biologicals Ltd., Cramlington, Northumberland, 
England; Boehringer Mannheim Ltd.. Lewes, East Sussex, England; or New England Biolabs, 
Bishop's Stortford,Herts., England, and used as specified by the manufacturer.
7. Preparation of plasmid DNA
(I) Preparation of competent cells
Competent E. coli cells were prepared essentially as described by Hanahan (1983). Colonies 
were picked off a fresh streak of celis and resuspended in 6.5 ml SOB (2% bacto-tryptone, 0.5%
yeast extract, 10 mM NaCI, 2.5 mM KCI, 10 mM MgCl2 , 10 mM MgS0 4 ). The culture was maintained 
%
at 37®C In an orbital incubator (275 r.p.m.) until the cell density was ~4~7x107/ml (OD550  = 
0.45-0.55), about 2-2.5 hours. Ceils were placed on ice for 2 minutes, collected by centrifugation 
at 2,500 r.p.m., 4°C, for 10 minutes and resuspended in 2 ml FSB (10 mM KOAc, 100 mM KCI, 45 
mM MnCl2 .4 H2 0 . 10 mM CaCl2 .2 H2Û, 3 mM HAC0 CI3 ), placed on ice for 10 minutes then pelleted 
at 2,500 r.p.m., 4'^ C, for 10 minutes. The pellet was resuspended in 0.5 ml FSB. Freshly prepared
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DMSO was added to 0.5%, mixed, and the suspension allowed to stand on ice for 5 minutes. This 
DMSO treatment was repeated and incubation on Ice continued for a further 5 minutes. Competent 
cells were dispensed into 200 pi aliquots, quick frozen in a solid C02/ethanol bath, and stored at 
-70°C until required.
(II) Transformation of bacteria
Competent ceiis were transformed by the method of Hanahan (1983), a), or the “one 
minute" transformation method of Goiub (1988), b).
a) Plasmid DNA (1-10 ng) was added to 200pl competent E. coli cells and incubated on ice 
for 30 minutes prior to heat-shock at 42°C for 90 seconds. After 1-2 minutes on ice, SOB (800pl), 
containing 20 mM glucose was added and the mixture incubated at 37®C for one hour. Aliquots of 
50-1 OOpI of the culture were removed, plated onto LB Agar plates supplemented with 100 pg/ml 
ampicillin and incubated at 37®C overnight to establish colonies.
b) Competent cells (3 pi) were mixed on ice with 1pl plasmid DNA (1-100 ng DNA in TE 
buffer, pH 8.0). The mixture was then transferred immediately to 44®C and, after one minute, lOOpI 
of LB was added and the entire mixture directly plated onto selective media as described in a).
(iii) Small scale preparation of plasmid DNA
For the initiai characterisation of recombinant plasmids, small scale preparations of plasmid 
DNA were carried out essentially as described by Birnboim and Doly (1979). The colony of 
transformed bacterial cells to be tested was placed in 1.5 ml LB containing 100 pg/ml ampicillin and 
incubated at 37®C, 275 r.p.m., for 3 hours. Cells were collected by centrifugation in an MSE 
microfuge (12,000 x g for 10 seconds) then resuspended in 100 pi of 8% sucrose, 0.5% 
tritonX-100, 50 mM EDTA, 50 mM Tris.HCI, pH 8.0, by vortexing. Lysozyme (Sigma) was added 
(16pl of a 10 mg/ml solution), the sample vortexed then heated at 100°C for 2 minutes. Cell debris 
was sedimented in an MSE microfuge (12,000 x g) for 15 minutes. The gelatinous pellet was 
removed using a sterile toothpick and 100 pi isopropanol added to the supernatant. After 
incubation at room temperature for 10 minutes, precipitated DNA was collected by centrifugation for 
5 minutes, the dried pellet taken up in 50 pi 3 mM EGTA then heated at 100°C for one minute. 
Appropriate restriction enzyme digests in the presence of RNAse A (50 pg/ml) were carried out on 
10 pi of plasmid DNA/EGTA solution and reaction products analysed by electrophoresis in 6-8%
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polyacrylamide gels. After electrophoresis, gels were stained in running buffer containing 1 pg/ml 
EtBr and DNA visualised under longwave UV.
(iv) Large scale preparation of plasmid DNA
Bacteria transformed by the plasmid of interest were grown to stationary phase in 500 ml 
cultures of LB containing 100 pg/mi ampicillin. Cells were harvested by centrifugation at 8,000 
r.p.m. in a Beckman JA.14 rotor for 10 minutes. The pellet was resuspended in 9 ml of a buffer 
containing 50 mM glucose, 25 mM Tris.HCI, 10 mM EDTA, pH 8.0 and 1 ml of a freshly prepared 
solution of 20 mg/mi lysozyme in 0.2 M Tris.HCI, pH 8.0. After 5 minutes on ice, 20 ml of a freshly 
prepared 0.2 M NaOH- 1.0% SDS solution was added and the lysed cells swirled on ice for 5 
minutes followed by the addition of 10 ml of ice cold 5 M KOAc, pH 4.8. Cell debris was mixed 
gently on ice for a further 15 minutes and the mixture clarified by centrifugation at 10,000 r.p.m. for 
10 minutes. Nucleic acid was precipitated by the addition of 16.5 mi isopropanol. The precipitate 
was recovered by centrifugation at 10,000 r.p.m. for 15 minutes, the pellet washed with 70% 
ethanol and resuspended in 2 ml of TE buffer, pH 8.0. Caesium chloride and EtBr (Sigma), to final 
concentrations of 1.55 g/mi and 600 pg/ml respectively, were added to the DNA/TE solution, mixed 
well, allowed to stand at room temperature for 5 minutes and clarified by spinning in an MSE 
microfuge (12,000 X g) for 3 minutes. The supernatant was then loaded into 11X32 mm Beckman 
polyallomer beli-top Quick-Seal tubes, heat-seaied and plasmid DNA centrifuged to equilibrium at
100,000 r.p.m. for 4.5 hours at 20°C in a Beckman TLA100.2 rotor. Plasmid bands were visualised 
under longwave UV and removed by side puncture using a hypodermic needle. Caesium chloride 
was removed by passage over a 10 ml Sepharose CL-4B (Pharmacia Ltd., Milton Keynes, 
Buckinghamshire, England) column and the EtBr removed by passage over a 0.5 ml Dowex AG 
50-WX8 (Bio-Rad, Richmond, California, USA) column in TEN buffer. DNA was then ethanol 
precipitated, treated with 50 pg/ml RNase A, extracted once with phenol and once with chloroform, 
ethanol precipitated and resuspended in H2 O. DNA concentrations were determined by scanning 
the absorbance from 220 to 320 nm in a Perkin-Elmer Lambda 5 UV/VIS spectrophotometer. One 
optical density unit (A26O ) was taken to be equivalent to 40 pg of double stranded DNA. In 
addition, concentrations were checked by separating DNA samples on agarose gels containing 0.5 
pg/ml EtBr and comparing the intensity of the fluorescence, under longwave UV, with that of known
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standards-
8. Recombinant plasmids
Plasmid pUC1X72 contains the SV40 regulatory region inserted between the Eco RI and Bam 
HI sites of pUC13 (Figure 1M). The regulatory region was contained within an Eco RUBam HI 
fragment of pMKD 231 which contains the SV40 eariy promoter region, including both copies of the 
72 bp repeat element (Everett et a ! 1983). Deletion of the DNA between the two Sph 1 sites of 
pMKD 231 generated a recombinant which contained only one copy of the 72 bp element. 
Digestion of this recombinant with Eco RI and Bam HI released a fragment containing the SV40 
enhancer region, which was then transferred to pUC13, thus generating pUC1X72. Plasmid pMKD 
231 was a kind gift from R.D. Everett, MRC Institute of Virology, Glasgow, Scotland.
The pA series of plasmids (Zenke etal., 1986) contains clustered point mutations in the SV40 
enhancer in which three neighbouring nucleotides were mutated simultaneously in vitro by 
generating non-complementary transversions (A è C, G ^ T). The mutated enhancer sequences 
were cloned into the expression vector pAO, yielding the recombinants pA11-pA16 (Figure 2M). 
These pA.. plasmids were generously provided by P. Chambon, CNRS, Strasbourg, France.
Plasmid pIFlO (Figure 3M) contains the human 8-interferon (8-IFN) gene plus upstream 
regulatory sequences extending to the -77 8-IFN nucleotide (Goodbourn et a!., 1985). The 
interferon gene regulatory element (IRE) is located between sequences -77 and -36. A series of 
pIFlO mutants were constructed containing single point mutations in the IRE. The nucleotide 
changes incorporated in these mutants are listed in Figure 3M.B. The pIFIO.. series of plasmids 
was a kind gift from S. Goodbourn, ICRF, Lincoln's Inn Fields, London.
Plasmid pSPIRE was generated by replacing the small region between the Bam HI and BglW 
sites of pSP64 with the Bam hW/Bgl Ii IRE fragment (Goodbourn etal., 1985) and was a kind gift from
S. Goodbourn.
The recombinant plasmid pSVI contains one copy of the SV1 double stranded synthetic 
oligonucleotide inserted into the Bam Hi site of the pUC19 multicloning site. Digestion with Eco RI 
and Pst\, or HindlW and Kpn I, generated DNA restriction fragments of 66 bp and 58 bp respectively, 
both of which contained the double stranded SV1 oligonucleotide, as determined by Maxam and
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Figure IM . Structure of plasmid pUC1x72
Plasmid pUCI X72 contains one copy of the SV40 72 bp repeat element plus upstream 
sequences extending to the Hpa II site (346). (In this construct, the Hpall site has been 
replaced with an EcoRI site). The EcoRi/BamHI fragment, containing the SV40 enhancer 
element, was inserted between the EcoRI and Bam HI sites of the pUC19 plasmid 
multicloning site (MCS) within the lacZ gene.Relevant restriction enzyme cleavage 
sites are indicated and the positions of the ampicillin resistance and lacZ genes are 
represented by the black boxes. The BOB numbering system for SV40 nucleotides 
was employed (Tooze, 1982).
rFigure 2M. Structure of pAO recombinants
A. Structure of the basic recombinant pAO which contains the SV40 early promoter region, from 
Hpa II (Eco RI in this contruct) to Hind ill, cloned upstream of the coding sequences of the rabbit 
B-globln gene, in a pBR322-based vector (Zenke etal., 1986). Relevant SV40 DNA restriction 
sites, the 72 bp sequence and the 21 bp region, the TATA box, the early (EES) and late (LES) 
early transcription initiation sites, are indicated. All pA-type recombinants contain an engineered 
Bam HI site at the junction between the 72bp sequence and the 21 bp region. The BBB 
numbering system for SV40 nucleotides was employed (Tooze, 1982).
B. Sequence of the triple point mutations present in the pAO derivatives pAI 1-pA16, aligned 
with the wild-type SV40 DNA sequence.
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Figure 3M. Structure of the pIFIO recombinants
A. Sînjcture of the basic recombinant plF10 which contains cDNA sequences encoding the 
human B-interferon (B-iFN) gene pius its upstream reguiatory sequences extending to the -77 
B-iFN nucleotide and encompassing the B-iFN gene regulatory element (IRE), which spans 
nucleotides -77to -36 (Goodbourn etal., 1985). E. coli. Bovine Papilloma virus (BPV) and M l3 
origins of DNA replication, as well as relevant DNA restriction sites, are indicated.
B. Table of pIFlO mutants which contain single point mutations in the IRE. The nucleotide 
changes incorporated in these mutants are indicated.
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Figure 4M. Structure of the CAT expression vectors
Plasmid pKTMLP contains DNA sequences from the E. coli transposabJe element Tn9, which 
contains the coding sequences for the chloramphenicol acetyl transferase (CAT) gene. The CAT 
gene insert (depicted by the black box) consists of a 29 bp S' untranslated segment, the CAT 
coding sequence and 86 bp 3' to the translation stop codon (Gorman et ai, 1982), Adjacent to 
the CAT gene are sequences derived from the Adenovirus type 2 major late promoter spanning 
nucleotides -50 to +33 (MLP), relative to the transcription start site at +1. Plasmid pKTBMLP also 
contains the Bam Hl/Pvu II fragment from SV40 which contains two copies of the 72 bp element 
plus upstream flanking sequences (depicted by the striped box), cloned into the Sma I site of 
pKTMLP. Plasmids pCATSV1/1, 2 and 3 contain one, two or three copies, respectively, of the 
SV1 double stranded synthetic oligonucleotide inserted into the Sma I site of pKTMLP.
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Gilbert (1980) chemical sequencing of the DNA fragments.
Plasmid pHIVEn contains DNA sequences from the HIV enhancer from position -79 to -108, 
inserted into the Bam HI site of the pUCI 3 polylinker. Digestion with Eco RI and Pst I, or HindWl and 
Sac I, released DNA restriction fragments of 73 bp and 76 bp respectively, both of which contained 
the enhancer sequences. Plasmids pHIV-L and pHIV-R contain one copy of either the HIV-L or 
HIV-R double stranded oligonucleotide inserted into the Bam HI site of the pUC13 polylinker. 
Digestion with Eco RI and Psf I, or H}nd\\\ and Sac I, released DNA restriction fragments of 59 bp and 
62 bp respectively, which contained the double stranded HIV-L (In the case of pHIV-L) or HIV-R (in 
the case of pHIV-R) oligonucleotides. The DNA sequences of the enhancer-containing restriction 
fragments were determined by Maxam and Gilbert (1980) chemical sequencing.
CAT expression vectors are derivatives of plasmid pKTMLP (Figure 4M) which contains the 
Adenovirus type 2 major late promoter (MLP) and the bacterial CAT gene inserted into the pUCIB 
polylinker. Plasmid pKTBMLP contains two tandem copies of the 72 bp repeat element of the 
SV40 enhancer inserted into the Sma I site of pKTMLP. Plasmids pKTMLP and pKTBMLP were a 
generous gift from C. Goding, Marie Curie Research Institute, Oxted, Surrey. Constructs containing 
SV1 double stranded oligonucleotides were prepared by first inserting Bgl II linkers into the Sma I 
site of pKTMLP. Double stranded SV1 oligonucleotides were then inserted into this engineered 
Bgl II site generating plasmids pCATSV1/1, pCATSV1/2 and pCATSV1/3 which contain one, two or 
three tandem copies of the SV1 oligonucleotide.
9. Radiolabelling of DNA
(i) Radiochemicals
[oL-32p]dATP (3,000 Ci/mmol), K-32p]dCTP (3,000 Ci/mmol), [^-32p]ATP (5,000 Ci/mmol) and 
[I4c] chloramphenicol (54 mCl/mmol) were all obtained from Amersham International Limited, 
Bucks., U.K.
(ii) Radioiabeiiing of DNA fragments
DNA fragments were 3'-end labelled using an end repair method (Drouin, 1980). The 
Klenow fragment of E. coli DNA polymerase I (Klenow et al, 1971) was used to fill in from a 
recessed 3'-end using the corresponding 5'-extension as a template for DNA synthesis. A DNA
89
fragment to be labelled (10-1000 ng) was incubated with 20 inCi [oL-32p]dATP, 20 p.Ci [<<-32p]cicTP, 
unlabelled dTTP and dGTP to final concentrations of 100 p.M, 0.5 fxg gelatin and 10 units of the 
Klenow fragment in a 10 jil reaction containing 50 mM Tris.HCI, 5 mM MgCl2 , 1 mM DTT, pH 8.0. 
After 15 minutes at room temperature unlabelled dATP and dCTP were added to final 
concentrations of 100 pM and incubation at room temperature was allowed to proceed for a further 
20 minutes. The reaction was either terminated by the addition of one fifth volume of 50% glycerol, 
100 mM EDTA, bromophenol blue and xylene cyanol FF, or, labelled DNA was extracted once with 
phenol, once with chloroform, ethanol precipitated and taken up in HgO prior to secondary cleavage 
with the appropriate restriction endonuclease. (The Klenow fragment of E. coli DNA polymerase I 
was obtained using a recombinant plasmid that directs overproduction of the polymerase fragment 
as described by Joyce and Grindley (1983) and was a kind gift of Celia Toogood).
DNA fragments with 5'-protruding termini were radiolabelled in a reaction catalyzed by T4 
polynucleotide kinase (Maxam and Gilbert, 1977). The DNA was dephosphorylated at 5'-termini by 
treatment with alkaline phosphatase. One pg of DNA was incubated with 0.01 unit of bacterial 
alkaline phosphatase in 100 mM Tris.HCI, pH 8.5 for 30 minutes at 60°C. EDTA was added to 10 
mM and the DNA purified by organic extraction followed by ethanol precipitation. The dry DNA 
pellet was redissolved in HgO and incubated at 37°C for 30 minutes in the presence of T4 
polynucleotide kinase (2 units/pg of DNA), 50 mM Tris.HCI, 10 mM MgCb , 5 mM DTT, pH 8.0 and 
40 pCi 1^-32p]ATP in a total reaction volume of 10 pi. Addition of EDTA to 50 mM terminated the 
reaction and the volume was adjusted to 100 pi by the addition of TEN buffer. Labelled DNA was 
purified as described previously and taken up in H2 O prior to secondary cleavage with the 
appropriate restriction endonuclease.
Double stranded synthetic oligonucleotides were 3'-end labelled as described for restriction 
fragments. In the case of all 3'- or 5'-end labelled fragments, unincorporated dNTPs were separated 
from labelled DNA in 8% polyacrylamide gels and the DNA electroeluted (Hay and DePamphilis, 
1982).
When preparing end-labelled DNA fragments generated from the various recombinant 
plasmids, the following restriction digests and labelling procedures were carried out:-
a). Plasmid pUCI X72 was digested with Bam HI, 3'- or 5'-end labelled at XheBam HI site and the
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labelled DNA cleaved with either Pvu II or Eco Rl, generating fragments of 97 bp and 173 bp 
respectively.
b). End labelled restriction fragments containing mutant SV40 enhancer sequences were 
generated from the pA.. series of constructs by digesting with both Bam HI and Pvu II followed 
by 3'-end labelling at the Bam HI site. Fragments of 97 bp were generated in each case.
c). In generating labelled fragments from the pIFlO series of plasmids, double digests using BgfW 
and A/co I were carried out and the fragments 3'-end labelled at the Bg/II site. Fragments of 65 
bp were generated in each case.
d). Plasmid pSPIRE was digested with Hind lil, 3'- or 5'-end labelled at the Hind III site and 
secondary cleavage of the labelled DNA with Bgl II carried out.
e). Radiolabelled fragments were generated from pSVI by double restriction digests using 
eitherEco Rl and Pst I, or Hind\\\ and Kpn I, followed by 3'-end labelling at either the Eco Rl or 
HindlW sites.
f). Plasmids containing sequences from the HIV enhancer ( pHIVEn, pHIV-L and pHIV-R) were 
digested with either Eco Rl and Pst I, or HindWl and Sac I, followed by 3'-end labelling at either 
the Eco Rl or HindWl sites.
10. Preparation of double stranded synthetic oligonucleotides
(i) Synthesis of single stranded oligonucleotides
Single stranded, synthetic oligonucleotides were synthesised on an Applied Biosystems 
Model 381A DNA-Synthesiser using 3-cyanoethyI phosphoramidites. This model of DNA 
synthesiser uses a solid phase synthesis chemistry in which the growing DNA chain remains 
covalently attached to an insoluble matrix, Controlled Pore Glass (GPG). CPG is easily derivatised 
with adenosine, guanosine, thymidine or cytosine phosphoramidites. An organic linker is attached 
to the surface of the CPG and the support is then derivatised by covalent attachment of the 
3'-hydroxyl of a nucleoside to the linker via an ester bond. Following derivatisation, all free amino 
groups are capped.
To begin synthesis, a column is placed on the DNA synthesiser containing one of four support- 
bound nucleosides. This nucleoside is the 3'-terminus of the sequence and DNA synthesis
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proceeds in a 3' to 5' direction.
The first step in the phosphoramidite chemistry of oligonucleotide synthesis is to remove the 
acid-labile, dimethoxytrityl (DMTO) group by treatment with TCA. This yields a reactive 5'-hydroxyl 
which can react with a phosphoramidite during the following coupling, or addition step. 
3-cyanoethyl phosphoramidites are chemically modified nucleosides which contain a 
diisopropylamine group on a 3 'trivaient phosphorous moiety. A 3-cyanoethyl protecting group is 
present on the 3' phosphorous group of the nucleoside with a dimethoxytrityl (DMTO) protecting 
group on the 5'-hydroxyl. The structure of guanosine 3-cyanoethyl phosphoramidite is shown in 
Figure 5M.
In the coupling step, tetrazole and the phosphoramidite are mixed as they enter the reaction 
chamber generating a highly reactive species which rapidly reacts with the free 5'-hydroxyl group of 
the support- bound nucleotide. Tetrazole protonates the nitrogen of the diisopropyl group on the 
3'-phosphorous which converts the amine into a very good leaving group upon nucleophilic attack 
by the S'-hydroxyl group. Thus an internucleotide linkage (S' to 3') is formed through a trivalent 
phosphorous group.
During the coupling step, a small percentage of support bound oligonucleotides may fail to 
undergo addition. These truncated, or failure sequences are chemically modified to prevent their 
participation in subsequent coupling steps. Acetic anhydride and dimethylaminopyridine are mixed 
and form a powerful acetylating agent which terminates, or "caps" any un reacted chains from the 
coupling step.
immediately after “capping", the labile trivalent phosphorous linkage formed in the coupling 
step, is oxidised to the stable pentavalent phosphorous linkage of biologically active DNA using 
iodine as a mild oxidant. Following oxidation, one cycle of nucleotide addition and DNA synthesis is 
continued by removing the DMTO group at the 5'-terminus of the oligomer and repeating another 
cycle of base addition. This is done until DNA of the desired length and sequence has been 
synthesised.
After synthesis is complete, the chains are cleaved from the CPG support and the 3-cyanoethyl 
protecting groups on the phosphates removed by four 15 minute washes with concentrated 
ammonium hydroxide. The base protecting groups are then removed by heating at 55°C in
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Figure 5M. Structure of guanosine B-cyanoethyl phosphoramidite
The positions of the 3-cyanoethyl protecting group on the 3'-phosphorus moiety, 
the DMTO protecting group on the 5'-hydroxyl, the isobutyryl protecting group on 
the exocyclic amine and the diisopropylamine on the 3'-trivalent phosphorus 
moiety are indicated.
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Figure 6M. Addition of the Aminolink 1 reagent to a synthetic 
single stranded oligonucleotide
The Aminolink 1 reagent is coupled to the 5'-end of the oligonucleotide 
generating a primary amine group which can then be linked to a 
variety of substrates..
ammonium hydroxide for 15 hours.
Following cleavage and deprotection, the ammonia is removed by evaporation under vacuum, 
DNA ethanol precipitated and the dry DNA pellet resuspended in H2O. DNA concentrations were 
determined by scanning the absorbance from 220 to 320 nm in a Perkin-Elmer Lambda 5 UV/VIS
spectrophotometer. One optical density unit (A260) was taken to be equivalent to 40 pg of DNA. 
Oligonucleotides were then further purified by gel electrophoresis. Electrophoresis of the 
oligonucleotides was carried out in 20% acrylamide (19% acrylamide : 1% N,N'-methylene- 
bisacrylamide) gels containing 7 M urea, cast between glass plates separated by 1.5 mm spacers. 
After electrophoresis, gels were removed from the glass plates and placed on clear plastic film on 
top of a fluorescent thin layer chromatography plate. The UV absorbing oligonucleotide masks 
fluorescein emission in the pi ate, and appears as a shadow, when viewed under shortwave UV. 
Oligonucleotides corresponding to the appropriate size were excised from the gels and the DNA 
recovered from the acrylamide by electroelution (Hay and DePamphilis, 1982).
(ii) Synthesis of single stranded Aminolink-oligonucieotides
Single stranded oligonucleotides were synthesized with primary amine groups coupled to their 
5'-ends. In the last step of the synthesis, Aminolink 1 reagent is coupled to the DNA in a reaction 
which generates an aminoethyl-phosphate linker containing a trifluoroacetyl amine-protecting 
group. Figure 6M depicts the addition of the Aminolink reagent to a single stranded 
oligonucleotide. Prior to deprotection, the Aminolink 1 phosphite triester is oxidised to the 
phosphate triester as described above. The trifluoroacetyl protecting group is removed during 
deprotection resulting in the functional amine.
All steps in the synthesis of oligonucleotides were carried out as described in the Applied 
Biosystems Model 381A DNA-Synthesiser User’s Handbook. Chemicals for the synthetic reactions 
were obtained from Applied Biosystems Limited. Warrington, Cheshire, England.
(iii) Hybridisation of complementary single stranded oligonucleotides
Complementary, single stranded synthetic oligonucleotides were annealed by heating to 
100°Cin0.1M NaCI, lOmM Tris.HCI, ImM EDTA, pH 8.0, followed by slow cooling to 16®C. Table 1 
shows the nucleotide sequences of the various oligonucleotides used in this study.
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Table 1.
Nucleotide sequences of the double stranded synthetic oligonucleotides used in this study.
Oligonucleotide Nucleotide sequence
SVl 5 ' GATCTAGGGTGTGGAAAGTCCCG 3 ’
3' ATCCCACACCTTTCAGGGCCTAG 5 ’
SVl.Ml 5 ’ GATCTAGGGTGTCCAAAGTCCCG 3'
3 ’ ATCCCACAGGTTTCAGGGCCTAG 5'
SVl. M2 5 ’ GATCTAGGGTGTGGAATGTCCCG 3 ’
3 ’ ATCCCACACCTTACAGGGCCTAG 5'
SVl.M3 5 ’ GATCTAGGGTGTGGAAAGTGGCCG 3'
3 ’ ATCCCACACCTTTCACCGGCCTAG 5'
SV2 5 ’ GATCTAAAGAACCAGCTGTGGAATGTGTG 3'
3' ATTTCTTGGTCGACACCTTACACACCTAG 5 ’
SV3 5' GATCCTGACTAATTGAGATGCATGCTTTGCATACTTCA 3'
3' GACTGATTAACTCTACGTACGAAACGTATGAAGTCTAG 5 ’
SVUP 5' GATCTGAGGCGGAAAGAACCAGCTG 3 ’
3 ’ ACTCCGCCTTTCTTGGTCGACCTAG 5 ’
IRE 5' GATCAAAGTGGGAAATTCCTCTG 3*
3 ’ TTTCACCCTTTAAGGAGACCTAG 5'
HIV 5 ’ GATCAAGGGACTTTCCGCTGGGGACTTTCCAGG 3 ’
3 ’ TTCCCTGAAAGGCGACCCCTGAAAGGTCCCTAG 5'
HIV-L 5' GATCTAGGGACTTTCCGCG 3 ’
3' ATCCCTGAAAGGCGCCTAG 5 ’
HIV-R 5' GATCTGGGGACTTTCCAGG 3 ’
3 ’ ACCCCTGAAAGGTCCCTAG 5'
NF-kB 5* GATCTGGGGACTTTCCGAG 3'
3* ACCCCTGAAAGGCTCCTAG 5
H2TF1 5' GATCTGGGGATTCCCCAG 3 ’
3 ’ ACCCCTAAGGGGTCCTAG 5 ’
H2KD 5 ’ GATGGGGAATCCCCAGCCCTGGGCTTCCCCACCCCTGACCTCA 3 ’
3' ACCCCTTAGGGGTCGGGACCCGAAGGGGTGGGGACTGGAGTGA 5'
EnA 5 ’ GATCCAAGCGCCGGATGTGGTAAAAGTGACA 5 ’
3 ’ GTTCGCGGCCTACACCATTTTCACTGTCTAG 5 ’
EnB 5 ’ GATCCAGAGGAAGTGAAATA 3'
3 ’ GTC1CCTTCACTTTATCTAG 5'
SYM 5 ’ GATCATGGGGAATTTCCCCAG 3'
3' TACCCCTTAAAGGGGTCCTAG 5 ’
11. In vivo transient expression assays
HeLa S1 monolayer cells were grown to ~30-40% confluency (approximately 8 X 10  ^cells/50 
mm plate) In Glasgow modified minimal essential medium containing 10% foetal calf serum. Calcium 
phosphate-DNA coprecipitates were prepared essentially as described by Graham and van der Eb 
(1973). Fine precipitates were achieved by incubating the DNA (4 |ig) with 113 pi TE and 125 pi 2 X 
MBS (560 mM NaCI, 100 mM HEPES, 3 mM (Na)2HP0 4 ) then allowing the mixture to stand at room 
temperature for 2 hours. Calcium chloride (to a final concentration of 100 mM) was added to the 
DNA solution and air gently bubbled through the reaction mixture. Precipitates were allowed to 
stand at room temperature without agitation before being added dropwise to the tissue culture cells. 
The cells were then incubated at 37°C for 48 hours. Prior to harvesting, cells were washed twice 
with STE buffer (150 mM NaCI, 10 mM Tris.HCI, 1 mM EDTA, pH 7.8) and scraped into 1 ml of STE. 
Cells were collected by centrifugation, resuspended in 50 pi of 250 mM Tris.HCI, pH7.5 and 
subjected to three rapid cycles of freezing and thawing at -70°C and 37®C respectively. Cell debris 
was sedimented by centrifugation at high speed for 10 minutes in an MSE microfuge. 50 pi of cell 
supernatant was added to 100 pi of assay mixture containing 70 pi 1 M Tris.HCL, pH7.8, 2 pi 40 mM 
acetyl coenzyme A (Sigma), 1.6 pi [14C] chloramphenicol (54 mci/mmol) (CAM) and the reaction 
mixture incubated at 37°C for 60 minutes (Gorman et al., 1982). The reaction was stopped by the 
addition of 1 ml of cold ethyl acetate, which was also used to extract the CAM. Samples were dried 
under vacuum, taken up in 20 pi ethyl acetate, spotted onto silica-gel thin-layer plates and 
developed with chloroform-methanol (95:5, ascending). Plates were air dried and exposed to X-ray 
film at -70®C.
12. Gei electrophoresis DNA binding assay
Assays contained 0.1-1.0 ng labelled probe (-10,000 cpm), 0.5-1 pg of unlabelled DNA 
(equimolar amounts of poly [d(A-T)]:poly [d(C-G)]) (Pharmacia), 20 mM HEPES.NaOH pH 7.5,1 mM 
DTT, 1 mM EDTA, 10% glycerol, 100 mM NaCI, 0.05% NP40 and 1-2 pi of protein fraction In a final 
reaction volume of 20 pi. Binding reactions were allowed to proceed to equilibrium for 20 minutes at 
20°C after which time 5 pi of 50% glycerol, 25 mM HEPES.NaOH pH 7.5, 0.1% bromophenol blue 
was added and the entire reaction loaded onto 6% (80:1 acrylamide: N,N'-methylene-bisacrylamide)
94
polyacrylamide gels containing 0.5 X TBE buffer. Electrophoresis was carried out at 200V for one 
hour. Gels were fixed in 10% acetic acid, dried and exposed to Fuji RX X-ray film (Fuji Photo Film 
(U.K.) Ltd., Finchley, London, England) at -70®C with an intensifying screen (Du Pont (U.K.) Ltd., 
Stevenage, Herts., England). As a rapid and quantitative means of determining the yield of 
enhancer-binding activity at each step during the fractionation, bands corresponding to bound DNA 
were excised from the gels and their radioactivity determined by Cerenkov radiation counting. One 
unit of activity represents the retention of 15 fmol specific DNA bound in the DNA/protein 
complexes in the standard gel electrophoresis DNA-binding assay.
13. Ion-exchange and affinity chromatography 
(I) Preparation of DEAE-Sepharose
Pre-swollen DEAE-Sepharose CL-6B was supplied by Pharmacia Fine Chemicals. The 
Sepharose was equilibrated in buffer A containing 0.3 M or 50 mM NaCI prior to use.
(ii) Preparation of DNA affinity matrices
Sequence-specific DNA affinity matrices were prepared essentially as described by 
Kadonaga and Tjian (1986). Single stranded synthetic oligonucleotides (250 pg of each containing 
the sequences
5'-GATCTAGGGTGTGGAAAGTCCCG-3' and 3’-ATCCCACACCTTTCAGGGCCTAG-5’) were 
phosphorylated in a reaction containing T4 polynucleotide kinase (2 units/pg of DNA), 50 mM 
Tris.HCI, 10 mM MgCIa , 5 mM DTT, pH 8.0, and 5 pCi [ -32r]atP (5,000Ci/mMol). Reactions were 
incubated at 37°C for 5 minutes after which time ATP was added to a final concentration of 2 mM and 
incubation continued at 37'^C for 2-3 hours. Complementary single stranded oligonucleotides were 
annealed and polymerisation of double stranded oligonucleotides carried out in the presence of 
600 units of T4 DNA ligase, 15 mM DTT and 2 mM ATP, overnight at room temperature. After 
extraction with phenol and chloroform, and ethanol precipitation, the ligated duplex 
oligonucleotides were taken up in H2 O and coupled to CNBr-activated Sepharose 4B (Pharmacia).
The CNBr-activated Sepharose (2 g) was swollen in 10 ml 1mM HCI followed by extensive 
washing (400 ml) with the same solution on a sintered glass filter (the activated Sepharose was 
never allowed to suction filter into a dry cake). The Sepharose was then washed with 400 ml H2O,
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400 ml 10 mM NaP0 4  buffer pH 8.0, and ligated oligonucleotides added immediately to the 
activated Sepharose slurry to facilitate efficient coupling. The DNA was allowed to couple overnight 
at room temperature with gentle rotation. In general, the concentration of covalently bound DNA in 
the affinity resin was 30-40 pg of DNA per ml of resin, as determined by retention of radioactively 
labelled DNA on the CNBr-Sepharose. Unreacted sites on the CNBr-derivatised Sepharose were 
blocked by washing with 100 ml of 1 M ethanolamine HCI pH 8.0 and the ethanolamine-containing 
slurry allowed to rotate gently at room temperature for 4 hours, after which time the resin was 
washed with 100 ml each of 0.1 M NaCI, 10 mM NaP0 4  buffer pH 8.0, 1 M NaCI and TENgooNaNg. 
The affinity resin was stored as a slurry in TENgogNaNg at 4^C until required. For the recognition site 
affinity chromatography steps, the resin was equilibrated in buffer A containing 0.25 M NaCI plus 3 
mM n-octylglucopyranoside (Sigma).
As a means of generating an affinity resin with a high coupling efficiency of specific DNA 
sequences, single copy, duplex oligonucleotides containing primary amine groups at their 5'-ends, 
were covalently coupled to CNBr-activated Sepharose essentially as described above.
(Ill) Pouring of columns
DEAE-Sepharose was packed in chromatography columns supplied by Amicon Limited, 
Gloucester, U.K. The Sepharose was poured as a slurry and packed using a peristaltic pump 
(Pharmacia) at a flow rate equivalent to two column volumes per hour.
The 1st round recognition site affinity matrices were packed in 5 ml plastic syringes containing 
two glass fibre discs (Whatman Limited, Maidstone, England) as a bed support. The 2nd and 3rd 
round affinity matrices were packed In 5 ml disposable chromatography columns containing 70 (im 
filters (lab m. Bury, Lancs., England). Affinity matrices were allowed to settle to form 5 ml, 1 ml and 
0.5 ml packed volumes under the influence of gravity.
All column chromatography manipulations were carried out at 4°C.
14. Purification of EBPl from HeLa nuclear extract
Uninfected HeLa cells (-2 X 1010) were harvested from 40 litre spinner cultures by 
centrifugation at 3,000 r.p.m. for 10 minutes in an MSE Coolspin. The wet weight of the cell pellet 
was -40 g. From this point onwards, all manipulations in the purification of EBPl were carried out at
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4®C. Cells were fractionated into nuclei and cytosol by swelling on ice in 80 ml of hypotonic buffer, 
lysed by 10 strokes with a tight fitting pestle In a Bounce homogenizer, and nuclei sedimented by 
centrifugation at 3,000 r.p.m. for 10 minutes (Challberg and Kelly, 1979). (The supernatant 
containing the cytoplasmic fraction did not contain any appreciable amounts of EBPl and was 
stored at -70®C for other purposes).
Nuclei were washed three times with isotonic buffer, resuspended in the same buffer
containing 0.35 M NaCI and stirred on ice for 30 minutes. Particulate material was removed by
centrifugation at 100,000 X g for 60 minutes. The supernatant was adjusted to 0.3 M NaCI and
applied to a 60 ml DEAE-Sepharose CL-6 B (Pharmacia) column equilibrated with buffer A
containing 0.3 M NaCI. The column was washed with 20 ml of the same buffer and the flow through
dialysed against buffer A containing 50 mM NaCI for 5 hours. Insoluble material was removed by
centrifugation at 100,000 X g for 30 min. The clarified extract was applied to a second
DEAE-Sepharose column (25 ml) equilibrated with Buffer A containing 50 mM NaCI. After washing
with two column volumes of equilibration buffer the column was developed with a linear gradient of
50 to 400 mM NaCI. Fractions containing EBPl activity (as determined by gel electrophoresis DNA
binding assays) were pooled,mixed with carrier DNA (poly [d(A-T)]: poly [d(C-G)]) and subjected to
three rounds of recognition site affinity chromatography on 5 ml, 1 ml and 0.5 ml DNA affinity
columns prepared with double stranded SVl oligonucleotides which contain the sequence
5 ’-GATCTAGGGTGTGGAAAGTCCCG-3 ’
3 ’-ATCCCACACCTTTCAGGGCCTAG-5'
essentially as described by Kadonaga and Tjian (1986) except that 400, 50, and 5 pg of carrier was
added to the first, second, and third round affinity loads, respectively and 3 mM n-octyl
glucopyranoside was included in all affinity chromatography buffers (Treisman,1987). The NaCI
concentration of the affinity loads was adjusted to 0.25 M by dilution in buffer A. Single step elution
in buffer A containing 1 M NaCI was carried out at each round of affinity purification. Active eluates
were aliquoted into small amounts and stored at -70°C. Extracts were stable for up to 6 months at
this temperature.
Protein extracts from various stages of the purification, which contained equivalent amounts of 
EBPl binding activity, as determined in the standard gel electrophoresis DNA binding assay, were 
precipitated in 10% TCA, washed with 80% acetone, resuspended in SDS/ 8-mercaptoethanol and
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analysed by SDS-polyacrylamide gel electrophoresis followed by silver staining (Heine etal., 1974; 
Oakley etal., 1980).
15. Get electrophoresis
(i) Agarose gel electrophoresis
Slab gels (100 mm X 70 mm) containing 1% agarose (w/v), 1XTBE buffer and 0.5 pg/ml EtBr, 
were run at 100V at room temperature in 1XTBE containing 0.5 pg/ml EtBr. One fifth volume of 
DNA dye mix (50% glycerol, lOOmM EDTA, bromophenol blue and xylene cyanol FF) was added to 
samples prior to electrophoresis. DNA was visualised under longwave UV.
(ii) Native polyacrylamide gel electrophoresis
Gels were made up to the required acrylamide concentration (generally between 6 and 10%) 
from a 30% acrylamide (29% acrylamide ; 1% N,N'-methylene-bisacryiamide) stock and contained 
0.5 or 1XTBE buffer. Polymerisation was initiated by the addition of 1/250 volume of 25% APS and 
1/2500 volume of TEMED (Eastman Kodak Co., Rochester, New York, USA) stock. 
Electrophoresis was carried out at up to 250V.
(ill) SDS polyacrylamide gel electrophoresis and silver staining
10 to 15% resolving gels were prepared from an -29% acrylamide stock (28% acrylamide : 
0.735% diallyltartardiamide) and contained 0.375 M Tris.HCI pH 8 .6  and 0.1% SDS. Polymerisation 
was carried out as described for native polyacrylamide gels. Gels were cast between glass plates 
separated by 0.35 mm thick spacers and sealed with Teflon tape. Resolving gels were poured to 
leave room for a 1 cm deep stacking gel and overlaid with 0.5 ml HgO to facilitate polymerisation and 
to ensure an even surface. Stacking gels contained 5% acrylamide stock in 0.105 M Tris.HCI pH 7.0 
and 0.1% SDS.
Samples were denatured prior to electrophoresis by heating to 100®C for 2 minutes in a 
solution containing 12.5% (v/v) glycerol, 2.5% (w/v) SDS, 62.5 mM Tris.HCI pH 7.0, 0.875 M 
B-mercaptoethanol and 0.015% (w/v) bromophenol blue. Electrophoresis was carried out in 1XTGS 
buffer, at 50V through the stacking gel and 100V through the resolving gel, at room temperature, 
until the dye front was 0.5 cm from the bottom of the gel.
Gels were fixed and stained using the Bio-Rad Silver Staining Kit (total protein stain) by
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following the manufacturers Instructions.
16. UV cross Unking
Double stranded SV1 oligonucleotide was Inserted into the Bam HI site of bacteriophage 
M13mp8. Clear plaques (which contained inserts that inactivated the 3-galactosidase
gene) were selected and bacteriophage grown in 1.5 ml cultures of E. coli JM101, in 2XTYE buffer 
( 16 g/l Bacto- tryptone, 10 g/l yeast extract, 5 g/l NaCI, 8  mM NaOH) at 37°C, 275 r.m.p., overnight 
(E. coli cultures were prepared from a 1/100 dilution of strain JM101 which had been grown to 
saturation). Cells were collected by centrifugation for 5 minutes in an MSE microfuge and 
bacteriophage precipitated from the supernatant by the addition of 0.5 M NaCI and 2.5% 
polyethylene glycol. Bacteriophage were sedimented by centrifugation for 5 minutes in a microfuge 
and organic extraction of the DNA carried out after treatment with 0.5% SDS, 2 mM EDTA and 
proteinase K (50 pg/ml). DNA was ethanol precipitated, dried and resuspended in H2 O. The 
sequence of the cloned inserts was confirmed by dideoxy-sequencing (Sanger et al, 1977). DNA 
synthesis, primed by the 17-mer sequencing primer, on single stranded M13 recombinant DNA was 
catalysed by the large (Klenow) fragment of E. Coll DNA polymerase I in the presence of dCTP,
dATP, [o<.-32p]dGTP (3,000 Ci/mMot) and 5-bromo- 2'deoxyuridine triphosphate (Pharmacia). DNA 
synthesis was allowed to proceed for 15 minutes at room temperature after which time the DNA was 
digested with Eco Rl and Pst 1, and the small fragment containing the EBPl binding site purified on 
6% polyacrylamide gels and electroeluted (Hay and DePamphilis, 1982).
Binding reactions were prepared in the same way as for the gel electrophoresis DNA binding 
assays but in a total reaction volume of 50 pi. Once equilibrium had been reached samples were 
transferred to 100 pi glass capillary tubes and both ends of the tubes heat sealed. Samples were 
then irradiated on a TM-36 Transiiluminator (Ultra Violet Products Ltd., Cambridge, England) - peak 
wavelength, 302nm; peak intensity, 7,0mW/cm2 - the samples were packed on ice to maintain a 
constant temperature throughout irradiation. Reaction mixtures were then transferred to eppendorf 
tubes and digested with 0.17units/pl DNase I (Amersham) and/or 0.07U/pl micrococcal nuclease 
(Pharmacia) for 30 minutes at 37®C after addition of MgCl2 and CaCl2  to a final concentration of 3 
mM . Reaction products were heated to lOO'^ C for 2 minutes, in 12.5% (v/v) glycerol, 2.5% (w/v)
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SDS, 62.5 mM Tris.HCI, pH 7.0, 0.875 M 8-mercaptoethanol and 0.015% (w/v) bromophenol blue, 
and fractionated by electrophoresis in 10% SDS-polyacrylamide gels and the dried gels exposed to 
X-ray film, in the presence of an intensifying screen, at -70°C.
17. DNase I protection
Reactions contained 0.1-1.0 ng labelled probe (-10,000 cpm), various amounts of uniabelled 
carrier DNA, poly [d(A-T)]:poly [d(C-G)], 25 mM HEPES.NaOH pH 7.5, 100 mM NaCI, and various 
amounts of protein fractions, containing 50% glycerol, 1 mM DTT, 1 mM EDTA, 0.1% NP40, in a 
total reaction volume of 100 pi. Binding was allowed to proceed for 20 minutes at 20'^C then 0.5 
units of DNase I (Amersham) plus MgCl2 (to a final concentration of 4 mM) added and the reaction 
allowed to proceed for 60 seconds at 20®C after which time an equal volume of 0.6 M NaOAc, 20 mM 
EDTA was added. The DNA was then extracted once with phenol, once with chloroform, ethanol 
precipitated, washed with 70% ethanol, dried and redissolved in 10 pi formamide dyes (98% 
formamide, 20 mM NaOH, 1 mM EDTA with bromophenol blue and xylene cyanol FF). DNA was 
denatured at lOO^C for 2 minutes, cooled on ice and reaction products fractionated by 
electrophoresis in 6% or 8 % polyacrylamide gels containing 50% urea. Glass plates were treated 
with either SurfaSil siliconising agent (Pierce Chemical Company, Rockford, Illinois, USA) or Silane 
A-174 which covalently cross-links the acrylamide to the surface of the glass plate. After 
electrophoresis, gels were fixed in 10% acetic acid, baked dry onto the glass plates (Garoff and 
Ansgore, 1981) and exposed to X-ray film (Hyperfilm MP; Amersham) at -70®C in the presence of an 
intensifying screen. Sequence markers were prepared by subjecting end-labelled fragments to 
G+A or C+T specific cleavage reactions (Maxam and Gilbert, 1980).
18. Quantitation of protein
Protein concentrations were determined by the method of Bradford (1976). Protein 
samples, in a total volume of 10 pi, were mixed with 1 ml Bradford's reagent (100 mg Coomassie 
brilliant blue G250, 100 ml orthophosphoric acid and 50 ml ethanol made up to 1 litre with distilled 
HgO), incubated at room temperature for 5 minutes and the absorbance at 595 nm measured in an 
LKB Biochrom Ultrospec II spectrophotometer. Concentrations were calculated by comparison with
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a standard curve constructed using BSA (Sigma).
19. Méthylation protection
Binding reactions were carried out as described for DNase I protection assays. After 
equilibrium had been reached, 0.5 pi of DMS was added and the mixture incubated at 20°C for 2  
minutes. The reaction was stopped by the addition of two volumes of DMS “stop" buffer (0.3 M 
NaOAc, 1.5 M 8-mercaptoethanol, 50 pg/ml yeast tRNA). DNA was extracted once with phenol, 
once with chloroform, precipitated twice with ethanol, washed with 70% ethanol, dried and treated 
according to the “G greater than A" specific chemical cleavage method of Maxam and Gilbert (1980). 
DNA was denatured at 100®C for 2 minutes, cooled on ice and reaction products electrophoresed 
on 6 % or 8% polyacrylamide gels containing 50% urea. Gels were fixed in 10% acetic acid, dried 
and exposed to X-ray film (Hyperfilm MP; Amersham) at -70®C in the presence of an intensifying 
screen (Du Pont). Sequence markers were prepared by subjecting end-labelled fragments to G+A 
or C+T specific reactions (Maxam and Gilbert, 1980).
20. Méthylation interference
To -20 ng end-labelled DNA and 1 pg unlabelled poly[d(A-T)]: poly[d(C-G)] in 200 pi of 50 mM 
sodium cacodylate, 1 pi DMS was added and incubation continued for 10 minutes at 20®C. The 
reaction was terminated by the addition of 50 pi 1.5 M sodium acetate, 1.0 M 8 -mercaptoethanol 
containing 4 pg unlabelled poly[d(A-T)]: poly[d(C-G)] and the DNA isolated by two ethanol 
precipitations. Methylated DNA was resuspended in binding buffer and binding reactions carried 
out as described above. Specific DNA/protein complexes were separated from free DNA in 6% 
polyacrylamide gels containing 0.5 X TBE buffer. Electrophoresis was carried out at 2 0 0 V for one 
hour after which time bands corresponding to bound or free DNA were excised from the gels and 
the DNA eluted overnight at 37°C in 2 ml 0.5 M ammonium acetate, 1 mM EDTA, 0.1% SDS, 10% 
methanol, 50 pg/ml proteinase K, 10 pg yeast tRNA and 1 pg sonicated salmon sperm DNA. The 
DNA was filtered through glass fibre, and, after concentration with 2-butanol and organic extraction 
with phenol/chloroform, DNA was ethanol precipitated, resuspended in 10 mM Tris-HCI pH8.0, 1 
mM EDTA and reprecipitated by the addition of spermine to 1 mM. DNA was solubilised in 100 pi of
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2 mM EDTA pH8.0 and heated at 90'^C for 15 minutes in a sealed tube. NaOH was added to a final 
concentration of 100 mM and incubation at 90®C continued for a further 15 minutes. The solution 
was neutralised by the addition of acetic acid to 100 mM, sodium acetate to 400 mM and the DNA 
precipitated with ethanol. Samples were processed for electrophoresis as described in 
"Méthylation protection”.
21. Ethylation Interference
-20 ng end-labelled DNA in 100 pi of 50 mM sodium cacodylate pH8.0 was mixed with 100 pi 
of ethanol saturated with ethylnitrosourea and incubated at 50°C for 60 minutes. After addition of 5 
pg unlabelled poly [d{A-T)]: poly [d(C-G)] and ethanol precipitation, binding reactions containing the 
ethylated probe, 1.0 pg unlabelled poly [d(A-T)]: poly [d(C-G)] and 8 pi of affinity purified EBPl were 
carried out as described for the standard "Gel electrophoresis DNA binding assay". Specific 
DNA/protein complexes were separated from free DNA and the DNA eluted and processed as 
described for "Méthylation interference”.
22. Orthophenanthrollne/copper (OP/Cu+) chemical nuclease footprinting
Binding reactions containing -10 ng of labelled probe, 1.0 pg unlabelled poly [d(A-T)]; poly 
[d(C-G)] and 8  pi of affinity purified EBPl were carried out as described for the standard “Gel 
electrophoresis DNA binding assay”. Specific DNA/protein complexes were separated from free 
DNA in 6% polyacrylamide gels containing 0.5 X TBE. Electrophoresis was carried out for one hour 
at 200V. Footprinting reactions with OP/Cu+ were then carried out within the acrylamide matrix by 
immersion of the gels in 50 mM Tris.HCI pH8.0 (200 ml) and gentle shaking for 15 minutes at room 
temperature after which time 20 ml of solution A (equal volumes of 40 mM 1,10-phenanthroiine in 
ethanol and 9.0 mM CUSO4 were mixed and diluted 1:10 with water and 20 ml solution B 
(3-mercaptopropionic acid was diluted 1:200 with water to give 58 mM 3-mercaptopropionic acid) 
were added and digestion allowed to proceed at room temperature for 10 minutes (Kuwabara and 
Sigman, 1987). The reaction was quenched by the addition of 20 ml of 28 mM2,9-dimethyl-1,10- 
phenanthroline (Sigma) and the resulting solution allowed to stand at room temperature for 10 
minutes. Gels were washed with distilled water and bands corresponding to bound or free DNA
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excised and DNA eluted as described above. Eluted DNA was ethanol precipitated, spermine 
precipitated, resuspended in formamide dyes, electrophoresed and visualised as described in 
"Méthylation protection”.
23. Computer graphics
The three dimensional projection of the EBP1 binding site was modelled on the crystal structure of 
the B-DNA dodecamer 5 ’ -cgcgaattgcgc-S '
3 ’-GCGCTTAACGCG-5’
(Wing etal., 1980). This sequence is similar to the EBPl binding site and base pair changes, using 
the CHEMX programme, CHEM model application for molecular modeling, were incorporated to 
accomodate the sequence
5 ’-GTGGAAAGTCCCCA-3’
3 ’-CACCTTTCAGGGGT-5’
which contains the EBPl binding site that is present in the SV40 enhancer. Van der Waal's
surfaces of the nitrogen atoms of bases which interfered with binding when modified by DMS, and
phosphorus atoms in the phosphate groups of the DNA backbone whose oxygen atoms were
modified by ethylnitrosourea, were displayed on the EBPl binding site, using the CHEMX
programme run on a MicroVax with a Sigmex 85688 terminal. For the purposes of clarity, the van
der Waal's radius (which is the ratio of the size of the atoms) was set to 0.1. This was to ensure that
the non-highlighted atoms were so small as to appear invisible thus generating the skeletal DNA
sructure. Highlighted nitrogen and phosphorus atoms (coloured spheres) were assigned van der
Waal's radii of 10 thus distinguishing them from non-highlighted atoms.
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RESULTS
Chapter 1. Detection of a HeLa cell protein, EBP1, which interacts with the SV40 
enhancer.
1.1 Detection of celiular proteins which interact with the SV40 enhancer
Control of transcription in eukaryotes has been shown to be modulated by the interaction of 
trans- acting, sequence-specific DNA binding proteins with their cognate c/s- acting recognition 
sites on the DNA ( for review see N.C. Jones et at., 1988). Two distinct types of c/s- acting 
regulatory sequences, promoters and enhancers, govern eukaryotic gene expression. Within 
eukaryotic promoters, DNA sequences responsible for defining the mRNA start site and the rate of 
transcription initiation have been identified (Grosscheldl and Birnsteil, 1980; Myers etal., 1980; 
Dynan and Tjian, 1985) with efficient transcription being dependent on the correct spatial 
arrangement of the various promoter elements (Cochran and Weissman, 1984; McKnight and 
Kingsbury, 1982; Everett etal., 1983). Considerably more flexibility is exhibited by enhancer 
sequences in that they are able to activate transcription of linked genes essentially independent of 
position or orientation with respect to the responding promoter. This enhancing effect was first 
identified in DNA sequences present in SV40 (Banerji etal., 1981; Moreau et al., 1981) and since 
then the SV40 enhancer, which is regarded as the prototype enhancer element, has been the 
subject of intense investigation. It is now clear that it represents a transcriptional element of great 
complexity.
The SV40 early promoter is -300 bp long and can be subdivided into three distinct regions: the 
mRNA start site selection region, the upstream element containing the 21 bp repeats and the 
enhancer element containing the 72 bp repeats (Figure 1.1). The 21 bp repeats in the upstream 
region have been shown to contribute to the efficiency of the SV40 early promoter. Deletion of 
these elements decreases transcription by about 100-fold, with partial deletions having 
intermediate effects, suggesting that the repeated sequences can complement one another 
( Myers etal., 1981; Everett etal., 1983; Fromm and Berg, 1982). The GC motif, 5'-CCGCCC-3', is 
present as two copies in each 21 bp sequence, and is required for both promoter activity and 
binding of the transcription factor Spl (Barrera-Saldana etal., 1985; Kadonaga ef a/., 1986; 
McKnight and Tjian, 1986).
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Figure 1.1 The SV40 early promoter
The regions of the early promoter, including the transcription start site selection region, the 
upstream element (21 bp repeats) and the enhancer (72 bp repeats) are shown. The major 
early-early start sites (EES), late-early start sites (LES), A-T rich region (encompassing the TATA 
motif) and the coordinates of restriction sites are indicated.
%  CO
f  s— -F»*
O
eno
CT•o
NroO"*a
ro
CTTJm c  r  -a m ü) S H m 30 z  m -4 >
ro
or
TJ
nonoCTTJ
C /) c/3  
r  >  
O  H
O
enro
coZ
en
i
g
Figure 1.2 Organisation of the DNA sequence motifs present in the SV40 
enhancer
The DNA sequence of the top strand of the 72 bp repeat element and the 5’ flanking sequence is 
shown. The location of the sequence motifs which have been identified in the enhancer region 
{Zenke et al., 1986) is Indicated by the boxes as well as the positions of the A, B1 and B2 
enhancer domains. The SV40 nucleotide sequences present in the synthetic S V l, SV2 and 
SV3 oligonucleotides are indicated.
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The SV40 72 bp repeated sequence makes the largest contribution to the efficiency of the 
early promoter. Deletion of this element results in a 400-fold decrease in transcription (Zenke et al., 
1986). However, one copy of the 72 bp repeat can be deleted without having any substantial effect 
on virus viability (Gruss et a!., 1981). The minimum enhancer activity can thus be attributed to one 
copy of the 72 bp element plus an additional 30 bp of DNA located on the late side of the repeated 
element. Mutational analysis has identified short DNA segments, or motifs, within the SV40 
enhancer (Figure 1.2 ) which on their own have little enhancing effect but when multimerised, or 
combined with other motifs, can act in concert to generate enhancer activity (Zenke et a!., 1986; 
Herr and Clarke, 1986; Ondek eta!., 1988; Fromental etaL, 1988). Each of these sequence motifs 
represents the binding site for at least one trans -acting factor (Wildeman et al.. 1986) and it appears 
to be the interaction of the various trans - acting factors with the transcriptional machinery that is 
responsible for enhancer function. The multiplicity of protein binding sites within the SV40 
enhancer creates a situation whereby gene expression may be controlled by the binding of 
different combinations of interacting factors. In addition, cellular factors have been identified which 
bind to overlapping motifs within the SV40 enhancer (Xiao et al., 1987b) suggesting that 
transcriptional activity may also be modulated by the ability of bound proteins to exclude binding of 
other antagonistically-acting factors.
Since enhancer-mediated transcriptional activation has been shown to involve the interaction 
of cellular trans- acting factors with short segments of DNA (Zenke et al.. 1986), the objectives of 
this research project were (i) to identify and purify a cellular factor that bound to the "core" region of 
viral and cellular enhancers (which mutational studies have shown Is important in enhancement of 
transcription (Laimins etal.. 1982; Weiher etaL, 1983; Zenke etal., 1986)); (ii) to then characterise 
the interactions of this "core’ -binding protein with its sequence-specific binding site in DNA; (iii) to 
define the nucleotide sequence requirements necessary for formation of enhancer binding 
protein-DNA complexes, and (iv) to suggest possible models as to how interaction of this protein 
with its cognate site facilitates transcriptional activation.
In this study a plasmid. pUC1X72 (Figure 1M), which has one copy of the 72 bp element plus 
additional upstream SV40 DNA sequences extending to the Eco Rl site, was used as a source of
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enhancer containing DNA , and ,as a means of detecting cellular proteins which bind specifically to 
the SV40 enhancer, a modification of the gel electrophoresis DNA binding assay originally 
described by Fried and Crothers (1981), and Garner and Revzin (1981), was employed. This is a 
rapid and sensitive procedure for the detection of DNA binding proteins which Interact with specific 
and defined sites on DNA. It exploits the observation that complexes of proteins and DNA can 
jointly enter native polyacrylamide gels and remain stably associated during electrophoresis. The 
principal of this gel electrophoresis assay is that DNA-protein complexes have a lower 
electrophoretic mobility than free DNA through polyacrylamide gels. To eliminate interactions 
between the labelled DNA fragment, which contains the binding site of Interest, and cellular 
non-specific DNA binding proteins, a large excess of unlabelled carrier DNA is included in the 
reaction mixture (Strauss and Varshavsky, 1984).
A 173 bp [32p]-iabelled, Bam HI to Eco Rl, enhancer containing fragment was generated from 
pUC1X72 and incubated with nuclear extract from uninfected HeLa cells, which had been partially 
purified by ion-exchange chromatography over DEAE-Sepharose. Interactions between 
non-specific DNA binding proteins were minimised by the inclusion, in the binding reaction, of a 
large excess of an equimolar mixture of poly [d(C-G)] and poly [d(A-T)j. Native polyacrylamide gel 
electrophoresis of the binding reactions resolved free DNA from three distinct DNA-protein 
complexes labelled “a”, “b" and “c” in Figure 1.3B. To determine the sequence specificity of the 
proteins responsibie for the formation of the different DNA-protein complexes, double stranded 
oligonucleotides were synthesized which spanned a number of the motifs recognised in the SV40 
enhancer. SV1 contains the GT-I and part of the TC-II motifs, while SV2 contains the GT-II motif, and 
SV3 the Sph-1, Sph-ll, octamer and part of the P motif (Figure 1.2; Xiao etal., 1987a; for review see 
N.C. Jones et al., 1988). Competition analysis, in which an excess of the unlabelled double 
stranded oligonucleotide is included in the binding reaction, indicated that the formation of complex 
“a” was diminished in the presence of SV1 and to a lesser extent by SV2, whereas formation of 
complex "b" was unaffected by the presence of SV1, SV2 or SV3 (Figure 1.3B). Formation of 
complex "c" was abolished by inclusion of the SV1 oligonucleotide in the binding reaction, but was 
unaffected by the inclusion of the SV2 or SV3 oligonucleotides. The origin of complex “c” was 
investigated further by repeating these experiments using a shorter [32p]- labelled DNA fragment of
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Figure 1.3 Detection of enhancer binding proteins In HeLa cell nuclear extracts
(A) Organization of the SV40 transcriptional control region. Relevant restriction enzyme cleavage 
sites and important elements of the promoter and enhancer present in plasmid pMKD 231 are 
indicated. Shown below is the DNA sequence of the enhancer region. DNA sequences present in 
the double stranded synthetic oligonucleotides SV1, SV2 and SV3 are also indicated. [32p]-iabelled 
probes containing the 72bp enhancer element, Eco Rl-fîam HI (B) or Pvu W-Bam HI (C) digested 
pUC1X72, were incubated with 2 pg nuclear extract (partially purified over DEAE-Sepharose) in the 
standard gei electrophoresis DNA binding assay as described in "Materials and Methods" (lanes (-) 
contained no nuclear extract). Also included in the reaction mixture was 25 (lanes 1), 50 (lanes 2) or 
100 ng (lanes 3) of unlabelled SV1, SV2 or SV3 double stranded synthetic oligonucleotides.
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97 bp which extends from the Bam HI to the Pvu II site. Only one specific DNA-protein complex was 
resolved by polyacrylamide gel electrophoresis after incubation of the labelled probe with the 
nuclear extract (Figure 1.3C). Equivalence of this single DNA-protein complex with complex "c" 
observed previously was suggested by a similar electrophoretic mobility, and by the fact that 
formation of the complex was competed for by inclusion of the SV1 oligonucleotide, but not by the 
SV2 or SV3 oligonucleotides (Figure 1.3C).
1.2 DNase I protection of the SV40 enhancer by partially purified HeLa ceil 
factors
DNase I protection (or “footprinting”) experiments were employed to define the binding sites of 
the partially purified proteins on the SV40 enhancer. This technique allows the identification of the 
nucleotide sequences covered by sequence-specific DNA binding proteins (Galas and Schmitz, 
1978). DNase I footprinting involves incubating a DNA fragment, radioactively labelled at one end, 
with the protein, and digesting with limiting amounts of DNase I, sufficient to introduce, on average, 
one cut per DNA molecule. In the presence of a sequence-specific DNA binding protein, the DNA 
bound by the protein is less accessible to digestion with DNase I. Comparison of the DNase I 
cleavage products produced in the presence, and absence, of added DNA binding proteins after 
electrophoresis on a high resolution urea-polyacrylamide gel, identifies which phosphodiester 
bonds are protected from DNase I cleavage in the DNA binding protein (Figure 1.4). The presence 
of a sequence-specific DNA binding protein will alter DNase I cutting at the site of interaction, with 
respect to naked DNA, in that this region of the DNA will be protected from DNase I cleavage. This 
leads to weakening or disappearance of the corresponding bands detectable by gel elecrophoresis 
(Galas and Schmitz, 1978). The precise sequence can be identified by comparing the DNase I 
cleavage pattern with a DNA sequence ladder (Maxam and Gilbert, 1980). The identification of the 
limits of the “footprint", or protected region, is often facilitated by the observation that the 
phosphodiester bonds directly flanking the covered sequences are hypersensitive to DNase I, 
probably as a result of hydrophobic interactions between the enzyme and the DNA-bound protein.
A 5'-[32p]-|abelled DNA fragment containing SV40 enhancer sequences was incubated with 
the partially purified HeLa cell nuclear extracts , subjected to DNase I digestion, and the cleavage
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Figure 1.4 DNase I protection assay
The end-labelled DNA fragment is incubated with limiting amounts of DNase I (sufficient to 
introduce one cut per DNA molecule) in the presence (+) or absence (-) of a sequence-specific 
DNA binding protein (DBP). Cleavage by DNase I is Indicated by the vertical arrows. (For 
purposes of clarity, the non-labelled lower strand has not been shown). The corresponding 
sequencing gel is shown with the protected region indicated by the dotted line. The DNase I 
hypersensitive sites flanking the footprint are also indicated by the bold horizontal bars.
Figure 1.5. DNase I protection of the SV40 enhancer by partially purified enhancer 
binding factors
A Bam HI to Eco Rl fragment from pUC1X72, S’-end labeled at the Bam HI site, was incubated with 40 
ug of nuclear extract (DEAE-Sepharose fraction) and digested with DNase I as described in “Materials 
and Methods” (lane (-) contained no nuclear extract). Included in the reaction mixture was 100 ng of 
unlabeled double stranded oligonucleotides S V l, SVl .Ml, SVl .M2, SV2 or SV3. After treatment 
with DNase I, reaction products were electrophoresed in an 6% denaturing polyacrylamide gel and the 
cleavage products visualized by autoradiography. Oligonucleotides SVl.Ml and SVl.M2 are 
derivatives of SVl in which cytosines 244 and 245 have been altered to guanines (SVl.Ml) and 
thymine 241 has been altered to adenine (SVl .M2).
s  s
> > > > > - + (0 CO (0 CO (/>
r a w w w w
-A G G G
252 ---- ► X -  5* G
I  _f  -  r  5 “ ^  S MlG c  •  AA
A -► T M2
.  G233 ---- - ♦  — #  TC C
T T C  ^
products displayed (Figure 1.5). in the presence of HeLa cell protein, two areas of the SV40 
enhancer were protected from digestion by DNase I (Figure 1.5, lane +). The protected regions 
extended from position 233 to 253, which contains the GT-I motif (Figure 1.2), and position 262 to 
290, which contains the GT-II motif. Addition of a large excess of unlabelled SVl double stranded 
oligonucleotide to the binding reaction abolished protection between positions 233 and 252, but 
had no effect in the region from 262 to 290 (Figure 1.5, lane SVl). Conversely, addition of an 
excess of unlabelled SV2 double stranded oligonucleotide reduced the protection over the GT-II 
motif, whereas the footprint spanning the GT-I motif was unchanged (Figure 1.5, lane SV2). The 
pattern of DNase I protection was not significantly altered by the inclusion of excess SV3 double 
stranded oligonucleotide in the reaction mixture (Figure 1.5, lane SV3).
To investigate the sequence requirements for specific binding in the GT-I region, competition 
assays in which double stranded oligonucleotides corresponding to SVl with specific base pair 
alterations, were included in the binding reactions. Alteration of the two guanine residues at 
positions 244 and 245 to cytosines (SVl.M l) abolished the ability of the oligonucleotide to 
compete for binding of the nuclear factors (Figure 1.5, lane SVl.M l), whereas changing adenine 
241 to thymidine (SVl .M2) did not alter the ability of the oligonucleotide to compete for binding of 
the nuclear factors (Figure 1.5, lane SVl .M2).
1.3 Effects of SV40 enhancer sequences on transient gene expression in HeLa 
celis
Genetic evidence has demonstrated that the SV40 transcriptional enhancer is composed of 
multiple DNA sequence motifs that can act synergistically to stimulate transcription from the SV40 
early promoter (Zenke etal., 1986; Herr and Clarke, 1986; Schirm et a!., 1987; Davidson et al., 
1986; Fromental et al., 1988). In addition, it has been shown that multiple tandem copies of the 
“core” enhancer sequence function autonomously to activate transcription of a linked gene in a cell 
type-specific manner (Ondek etal., 1987; Schirm etal., 1987). Having identified a protein in HeLa 
cell nuclear extracts which binds in the GT-I region of the SV40 enhancer In vitro, we wished to 
determine whether or not the DNA sequences involved in the recognition event could activate 
transcription of a linked gene in vivo. To Investigate the in vivo activity of the factor binding site, we
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employed a strategy similar to that used by Veldman and coworkers (1985), in which tandem copies 
of DNA sequence elements were used to study redundant sequence elements of the polyomavirus 
enhancer that activate DNA replication and gene expression.
A powerful method for studying the role of a particular DNA sequence in transcription regulation 
is to combine the putative regulatory region with a “reporter" gene, to introduce the recombinant 
into appropriate tissue culture cells, and to measure expression of the reporter gene under various 
conditions. The reporter gene should encode an easily assayable protein readily distinguishable 
from endogenous cellular proteins. The bacterial gene for chloramphenicol 3-O-acetyltransferase 
(CAT) has proved to be extremely useful for this purpose because mammalian cells generally lack 
endogenous CAT activity (Gorman, efa/.,1982), and sensitive enzymatic assays for CAT are 
available. We have used the customary thin-layer chromatography (TLC) -based assay (Shaw, 1975; 
Gorman etal., 1982) in which [f 4C]-labelled chloramphenicol (CAM) is used as a substrate, and TLC 
followed by autoradiography is used to separate and locate the acetylated (3-Ac-CAM and 
1-Ac-CAM) and unacetylated CAM.
Recombinant expression vectors were constructed which contained 0,1, 2 or 3 copies of the 
SVl double stranded oligonucleotide, tandemly ligated in a head-to-tail orientation, upstream of the 
Adenovirus major late promoter (Ad MLP), linked to the bacterial CAT gene (Figure 4M). These 
recombinants were transfected into sub-confluent HeLa cell monolayers, harvested after 48 hours 
and CAT activity determined by TLC followed by autoradiography.
Transfection of the recombinant pSVI, which contains SV40 control sequences but no CAT 
gene, resulted In no detectable levels of CAT activity (Figure 1.6). In the case of plasmid pKTMPL 
(which does not contain any upstream enhancer sequences) a low basal level of CAT activity is 
observable which is probably a reflection of the promoter strength. When two copies of the SV40 
72 bp repeat are present upstream of the Ad MLP, as in plasmid pKTBMLP, a substantial increase 
in CAT activity is observed. However, this increase in activity is considerably less than expected 
when two copies of the 72 bp element are present since deletion of this element has been shown 
to decrease transcription, from a responding promoter, by 400-fold (Zenke et al., 1986). A similar 
increase in activity is also observed when two tandem copies of the SVl oligonucleotide are 
inserted upstream of the Ad MLP (plasmid pCATSV1/2). That approximately the same levels of
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Figure 1.6 CAT activity directed by SV40 enhancer-containing recombinants
HeLa cells were transfected with recombinant plasmids containing the Adenovirus major late promoter 
(Ad MLP) fused to the bacterial CAT gene (pKTMLP) and either two copies of the 72 bp repeat 
element (pKTBMLP) inserted upstream of the Ad MLP, or 1, 2 or 3 copies of the SV1 double 
stranded oligonucleotide (pCATSV1/1, 2 and 3 respectively). Plasmid pSV1 contains SV40 control 
sequences but no CAT gene. Cell extracts were prepared for CAT assay 48 hours after transfection 
and CAT activity determined by TLC followed by autoradiography. CAT activity was measured by 
determining the amount of acetylated chloramphenicol (3-Ac-CAM and 1-Ac-CAM) produced from 
[14C] chloramphenicol (CAM).
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CAT activity are observed for pKTBMLP and pCATSV1/2 may simply reflect differences in tissue 
culture. Insertion of only one copy of the SV1 oligonucleotide (plasmid pCATSVl/2) resulted in a 
similar basal level of CAT activity as observed using pKTMLP. However, when three tandem copies 
of SVl were present upstream of the MLP (plasmid pCATSV1/3) CAT activity was increased 
several-fold over that seen with pKTBMLP or pCATSV1/2. These results would therefore indicate 
that tandemly ligated copies of the SV1 oligonucleotide containing the GT-1 motif (Figure 1.2) can 
function as a transcriptional enhancer in vivo when Inserted into an appropriate expression vector.
Chapter 2, Purification and Characterisation of EBP1
2.1 Purification of a ceiluiar protein, EBPI, whicfi Ijinds to the "core" region of 
the SV40 enhancer
The factor which binds to the GT-I motif (Figure 1.2) of the SV40 enhancer, was also shown to 
bind to the SVl double stranded oligonucleotide (Figures 1.3 and 1.5). Thus as a means of 
monitoring the fractionation, and purification, of the GT-I binding fraction, [32p]-iabelled SVl double 
stranded oligonucleotide was used as probe in the gel electrophoresis DNA binding assay (Figures
2.1 and 2.2).
Uninfected HeLa cells (40 g wet weight) were fractionated into nuclei and cytosol and the nuclei 
extracted with 0.35 M NaCI. The crude nuclear extract, which contained the bulk of the specific DNA 
binding activity, was depleted of nucleic acids by passage over DEAE-Sepharose equilibrated with 
0.3 M NaCI. After reduction of the NaCI concentration to 0.5 M, the flow through from the first DEAE 
fractionation was applied to a second DEAE-Sepharose column and bound proteins eluted with a 
linear gradient from 0.05 to 0.4 M NaCI. individual fractions were monitored for DNA binding activity 
using the gel electrophoresis DNA binding assay. Using this procedure it was possible to resolve 
two distinct species which bound to the SVl double stranded oligonucleotide (Figure 2.1). The 
two species appear to have identical sequence specificities and bromodeoxyuracil cross-linking 
experiments (Figure 2.4) indicated that the cross-linked polypeptide is of identical molecular weight 
in each case.
Further purification of the enhancer binding species by conventional Ion-exchange 
chromatography was unsuccessful in that yields of active DNA binding protein were very poor, and
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Figure 2.1 Fractionation of HeLa nuciear extract
Dialysed nuclear extract was loaded onto a DEAE-Sepharose CL-6B column and bound proteins 
eluted with a linear gradient of 0.05 to 0.4M NaCI. Fractions were incubated with [32p] labelled SVl 
double stranded oligonucleotide under standard conditions employed in the gel electrophoresis DNA 
binding assay. DNA/protein complexes were resolved on 6% polyacylamide gels. Gels were either 
dried down and autoradiographed (A) or enhancer protein binding activity (n) quantified by excising 
bound species from the gels and determining the radioactivity present by Cerenkov counting (B). 
Protein concentration (g) was determined by the method of Bradford (1976). Fractions sampled are 
indicated below each panel. 0 represents cytoplasmic extract, E nuclear extract, FI material passing 
through the first DEAE- Sepharose CL-6B column and L, F2 and W representing column load, flow 
through and 0.05M NaCI wash from the second DEAE-Sepharose CL-6B column.
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preparations were somewhat heterogeneous. Since the enhancer binding species observed in the 
DEAE-Sepharose column eluates bound the SVl oligonucleotide, the next logical step to 
obtaining highly purified preparations of the protein would be to use the sequence-specific SV1 
oligonucleotide as an affinity ligand. Indeed, a number of DNA binding proteins, including various 
RNA and DNA polymerases, hormone receptors and repressors have in the past been purified by 
non-specific DNA-Cellulose and DNA-Agarose affinity chromatography (Alberts and Herrick, 1971; 
Arndt-Jovin etal., 1975). In this study, various types of affinity matrices were examined to enable 
the development of a rapid and sensitive method for purification of sequence-specific DNA binding 
proteins to near homogeneity. A DNA affinity resin was required which could maximise the recovery 
of the desired protein but which minimised contamination by other proteins. In addition, the DNA 
had to be accessible to the sequence-specific binding protein and to be stably bound to the 
protein.
Early attempts at generating an efficient affinity matrix were based on modifications of the 
schemes used to purify the HeLa cell factors Spl (Kadonaga and Tjian, 1986) and nuclear factor I 
(Rosenfeld and Kelly, 1986). Tandemly ligated double stranded SVl oligonucleotides were 
covalently coupled to aminophenylthioether- cellulose (APT-cellulose) via a diazo-linkage between 
the double stranded oligonucleotides and the APT-cellulose (Seed, 1982). The second 
DEAE-Sepharose fractions, shown in the gel electrophoresis DNA binding assay (Figure2.1) to 
contain enhancer binding activity, were pooled and further purified over this affinity matrix. 
However, very poor yields of specific SV40 enhancer binding protein were recoverable on this 
recognition site affinity matrix. In view of this, a second type of sequence-specific affinity matrix was 
prepared. This was generated by incorporating biotin-11-dUMP into the ends of double stranded 
SVl oligonucleotides and coupling them to Streptavidin- Agarose. Unfortunately, passage of the 
active DEAE-Sepharose fractions over this matrix did not improve the yields of specific enhancer 
binding activity above those obtained using APT-Ceilulose. Successful recognition site affinity 
matrices were finally prepared by covalently coupling tandemly ligated, double stranded SVl 
oligonucleotides, or double stranded SVl oligonucleotides containing a primary amine group at 
their 5'-ends (Aminolink- oligonucleotides), to CNBr-activated Sepharose, essentially as described 
by Kadonaga and Tjian (1986).
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Figure 2.2 Recognition site affinity chromatography of EBP1
A. Poly [d(G-C)] and poly [d(A-T)] were added to the DEAE-Sepharose fractions containing EBPI 
activity and passed over an affinity matrix composed of tandemly ligated SV1 oligonucleotides 
covalently linked to CNBr-activated Sepharose-4B. Bound proteins were eluted with 1 .OM NaCI and 
fractions assayed for EBPI activity . L, load; FT, flow though; W, wash; 1 -8, fractions from 1M NaCI 
elution.
B. Fractions from each stage of the EBP1 purification were precipitated with TCA and analysed by 
SDS-polyacrylamide gel electrophoresis and silver staining. Equivalent amounts (28 units) of each 
affinity column eluate were applied to each lane. The molecular weights of the marker proteins are 
indicated. D, DEAE-Sepharose fractions; 1, 2 and 3; first, second and third round affinity column 
eluates; M, protein molecular weight standards.
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Table 2.1 Purification of EBPI from HeLa ceii nuciear extracts
Fraction Protein
(mg)
Units
{*)
Yield
(%)
Specific activity 
(units/mg protein)
Fold purification
Nuclear extract 861 84378 100 98 1
DEAE pool 11 36400 43 473 5
1st dsSVl pool 1.3 25480 30 19600 210
2nd dsSVl pool 0.08 19110 22.6 238875 2560
3rd dsSVl pool 0.008 11275 13.4 1409375 15150
* One unit of activity represents the retention of 15 fmol specific DNA bound in the DNA/protein complexes in the gel 
electrophoresis DNA binding assay.
+ Estimate based on comparative silver staining.
Fractions from the second DEAE-Sepharose chromatography which contained the two 
enhancer binding species were pooled and further purified to near homogeneity by recognition site 
affinity chromatography (Rosenfeld and Kelly, 1986; Kadonaga and Tjian. 1986) on the SVI/CNBr- 
Sepharose resins. The pooled DEAE-Sepharose fractions were mixed with equimolar amounts of 
poly [d(A-T)] and poly [d(G-C)], as non-specific competitor DMAs, and applied to the DNA affinity 
resins. Whereas the bulk of the proteins in the DEAE fractions flowed through the affinity column, 
the SV1 binding activity was specifically retained on the column and could be eluted by raising the 
NaCI concentration to 1.0 M (Figure 2.2A). Two further rounds of affinity chromatography resulted 
in a preparation in which the specific binding activity had increased by 15,000-fold when compared 
to the crude nuclear extract (Table 2.1). (Yields of specific enhancer binding activity obtained by 
using tandemly ligated SVl oligonucleotides or Aminolink- SVl oligonucleotides were very similar).
This method of affinity chromatography exhibits some noteworthy differences to many 
previously published procedures. The most important feature is probably the addition of 
non-specific competitor DNA directly to the partially purified protein fraction prior to passage over 
the DNA-Sepharose resin (Kadonaga and Tjian, 1986). The inclusion of competitor DNA is to 
minimise the retention of non-specific DNA binding proteins on the affinity resin. In the past, 
plasmid DNA containing multiple binding sites has been used in generating sequence-specific 
resins (Rosenfeld and Kelly, 1986). Synthetic oligonucleotides were used In this study to maximise 
the specificity of the resins and also because they are more selective than plasmids containing 
multiple recognition sites. The oligonucleotides are quickly and easily prepared. In addition, affinity 
chromatography has generally been carried out using resins whereby DNA has been adsorbed to 
Cellulose (Alberts and Herrick, 1971; Rosenfeld and Kelly, 1986). In contrast, this method uses 
DNA-Sepharose resins prepared by covalent coupling of DNA to the solid support thus minimising 
loss of specific binding sites due to leaching of the DNA.
Another important feature of this method of protein purification is the inclusion of non-ionic 
detergents in the chromatography buffers. The high recovery of specific DNA binding activity was 
aided by the addition of 0.1% NP40 to both the loading and elution buffers. In addition, n-octyl-8-D- 
glucopyranoside (to a final concentration of 3 mM) was included in the buffers used during the 
recognition site affinity chromatography steps (Sorger and Pelham, 1987; Treisman, 1987). It is
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likely that these detergents inhibit the formation of protein aggregates which may accumulate during 
fractionation thereby releasing the sequence-specific DNA binding proteins for interaction with their 
binding sites.
To determine the purity at different stages during the course of fractionation, samples from 
various steps in the purification, which contained equivalent amounts of enhancer binding activity, 
were precipitated with TCA and analysed by SDS polyacrylamide gel electrophoresis followed by 
silver staining. The third round affinity fraction contained predominantly a 57,000 molecular weight 
polypeptide (Figure 2.2B). From 40 g of HeLa cells we obtained 8 |ig of purified protein with 13.4% 
recovery of specific DNA binding activity (Table 2.1). Since the purified protein bound to the SVl 
region of the SV40 enhancer, this protein has been designated EBPI.
2.2 Identification of ttre 57,000 moiecuiar weight poiypeptide (EBPI) as the 
specific DNA binding species
To confirm that the 57,000 molecular weight polypeptide (EBPI) contained the activity 
responsible for binding to the SVl oligonucleotide, DNA-bound protein was cross linked to 
bromodeoxyuracil- substituted, [32p]-iabelled DNA (Ogata and Gilbert, 1977). When the methyl 
group of thymidine is substituted with bromine, by incorporation of bromodeoxyuridine into DNA, 
the DNA remains functional, both in vivo and in vitro, although some changes can occur in the 
binding of proteins as demonstrated by lac repressor binding tenfold more tightly to 
bromine-substituted operator DNA than to unsubstituted operator (Lin and Riggs, 1972). UV 
irradiation of substituted DNA displaces the bromine and generates a free radical at the 5-position of 
the deoxyuridine. A covalent cross link between a protein bound specifically to this DNA can then 
form if an appropriate amino acid side chain is close to the free radical. After nuclease treatment of 
the complex, the molecular weights of the cross linked proteins can be determined by 
electrophoresis on SDS polyacrylamide gels. The extensive nuclease treatment ensures that only 
short oligonucleotides from the probe remain covalently cross linked to the proteins during 
electrophoresis (Chodosh etal., 1986).
The SVl double stranded oligonucleotide was first inserted into the Bam HI site of M13mp8 
and single stranded phage DNA prepared. A complementary strand was synthesized containing
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Figure 2.3 The binding of EBP1 to bromodeoxyuridine-substituted DNA
A. A bromodeoxyuridine-substituted, [32p].labelled, double stranded DNA fragment containing the 
SV1 sequence was incubated in the presence (+), or absence(-) of partially purified EBP1 under 
conditions employed in the standard gel electrophoresis DNA binding assay, DNA-protein 
complexes resolved on 6% polyacrylamide gels and visualised by autoradiography. Arrows depict the 
positions of the DNA-protein complexes (B) or free DNA (F).
B. Competition analysis of EBP1 binding. Reactions were prepared as in A but with the inclusion of 
10 (lane 1), 25 (lane 2), 50 (lane 3) or 100 ng (lane 4) of unlabelled, double stranded SVl 
oligonucleotide as competitor, in the binding mixture. Complexes were resolved and visualised as 
described in A.
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Figure2.4 Bromodeoxyuracil cross-linking of EBP1 to its binding site on the SV40 
genome
A bromodeoxyuridine substituted, [32p]-iabelled double stranded DNA fragment containing the 
EBPI binding site was prepared as described in “Materials and Methods". Probe DNA was incubated 
with affinity purified EBP1 under conditions empioyed in the gel electrophoresis DNA binding assay. 
Once equilibrium had been reached, samples were irradiated with UV light followed by treatment with 
DNase I and micrococcal nuclease as indicated. Reaction products were fractionated on 10% SDS 
polyacrylamide gels and visualised by autoradiography. The positions of the 66,000 and 45,000 
molecular weight protein standards are indicated by the arrows. UV irradiation, in the absence of 
competitor was for 0, 5,10 and 20 minutes. In the competition analysis EBPI was allowed to bind in 
the presence of 0.1 pg S V l, 0.5 pg S V l, 0.5 pg NFI or 0.5 pg NFIII double stranded oligonucleotides 
prior to UV irradiation for 10 minutes. Reaction productes which were UV irradiated for 10 minutes 
without subsequent DNase I or mirococcal nuclease digestion are also shown (-MNase,DNase).
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[32p]dGMP and bromodeoxyuridine (as a substitute for thymidine). Restriction enzyme cleavage 
with ECO Rl and Pst I released a small labelled fragment that contained the EBP1 binding site. 
Substitution of ^-32p]cieoxycytidine and bromodeoxyuridine for cytidine and thymidine did not 
affect the binding of EBP1 to the probe as determined in the standard gel electrophoresis DNA 
binding assay (Figure 2.3A). In addition, it was demonstrated that unlabelled SV1 double stranded 
oligonucleotide could successfully compete for EBP1 binding to the substituted DNA (Figure 
2.3B).
In the cross linking studies, probe DNA was incubated with affinity purified protein under 
conditions similar to those employed in the gel electrophoresis DNA binding assay. Once 
equilibration had been reached the samples were irradiated with UV light, digested with nucleases 
and analysed by autoradiography after SDS polyacrylamide gel electrophoresis. When the products 
of the cross-linking reactions were analysed without nuclease treatment it was evident that the 
labelled oligonucleotide had been cross-linked to a polypeptide present In the binding reaction 
(Figure 2.4). Treatment of the cross-linked products with DNase I and micrococcal nuclease, prior to 
gel electrophoresis, decreased the apparent molecular weight of the labelled species and identified 
a polypeptide with a molecular weight of ' 60,000 (Figure 2.4). The labelled species
accumulated with increased time of irradiation (Figure 2.4) but no cross-linking was observed if BSA 
was substituted for EBP1 in the DNA binding reaction (data not shown). Addition of an excess of 
unlabelled SV1 oligonucleotide to the binding reaction abolished cross-linking, whereas inclusion 
of double stranded oligonucleotides containing the binding sites for nuclear factor I (NFI) or nuclear 
factor III (NFIII) had little effect (Figure 2.4). These data indicate that a polypeptide of approximately 
60,000 is responsible for specific binding to the GT-I region of the SV40 enhancer and is the major 
component present in our most highly purified preparations.
2.3 DNA protected by EBPI from DNase I cleavage
To define more precisely the region of the SV40 enhancer that is bound by EBP1, DNase I 
protection experiments were employed. A 3'-[32p]-|abelled DNA fragment containing a single copy 
of the SV40 enhancer was incubated with 0,5, 10 or 20 p.1 of affinity purified EBPI (Figure 2.5), 
subjected to DNase 1 digestion and the cleaved DNA molecules fractionated by denaturing
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Figure 2.5. DNase I protection of the SV40 enhancer by affinity-purified EBPI
The Bam HI to Pvu II fragment from pUC1X72, 3'-[32p] lablled at the Bam HI site was incubated with 0, 
5,10 or 20 pi of affinity purified EBPI as described in “Materials and Methods". Competition assays 
were carried out in which 10 pi of EBPI was incubated with labelled probe in the presence of 500 ng 
unlabelled S V l, SVl .Ml or SVl .M2 double stranded oligonucleotide. After treatment with DNase I, 
reaction products were electrophoresed in a 6% denaturing polyacrylamide gel. C+T and A+G 
specific cleavage reactions of the labelled fragment were electrophoresed in parallel as markers.
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polyacrylamide gel electrophoresis. The purified protein protects the region from 230 to 250 on the 
SV40 enhancer from cleavage by DNase I (Figure 2.5). A similar region of protection is also seen 
between positions 233 and 252 on the opposite strand (Figure 1.5) with partially purified extracts, 
indicating that the protein we have purified is probably responsible for the binding activity observed 
in the nuclear extracts (Figures 1.3 and 1.5). This conclusion was strengthened by the finding that 
the SVl and SV1.M2 oligonucleotides can compete for binding of the enhancer binding factor, 
whereas the SVl.Ml oligonucleotide is ineffective at competing (Figure 2.5),
2.4 Characterisation of EBPI by proteolysis
To determine if EBP1 could be dissected into distinct functional domains, we subjected the 
purified protein to mild digestion with a variety of proteolytic enzymes. To identify a distinct DNA 
binding domain, EBP1 was incubated with [32p]-iabelled SVl double stranded oligonucleotide 
under conditions similar to those employed in the gel electrophoresis DNA binding assay. Once 
equilibrium had been reached, protease was added to the binding reactions and digestion allowed 
to proceed for 15 minutes at 20°C. Products of the reaction were fractionated on native 
polyacrylamide gels and the labelled species visualised by autoradiography. Addition of protease 
XIV from Streptomyces griseus had a dramatic effect on the formation of the EBPI-specific 
DNA-protein complex. A large Increase in the amount of labelled SVl double stranded 
oligonucleotide present in the DNA-protein complex was observed after addition of as little as 5 ng 
of protease XIV (each reaction contains 1 pg of BSA as carrier) (Figure 2.6). Incubation with larger 
amounts of protease XIV resulted in the appearance of a DNA-protein complex with increased 
electrophoretic mobility (Figure 2.6). This effect was also observed, but to a lesser extent, with 
proteinase K. Treatment of the DNA-protein complex with elastase had only a marginal effect on 
the amount of complex formed (Figure 2.6). The small increase in the electrophoretic mobility of the 
DNA-protein complex after treatment with protease XIV suggests that the DNA binding domain of 
the protein constitutes the bulk of the EBP1 polypeptide, but that the activity of this domain can 
apparently be "activated" by mild proteolytic digestion. It should be noted that material trapped at 
the top of the gel is removed by treatment with all three proteases. Although EBPI is purified in the 
presence of NP40, the material appears to result from the formation of aggregates of EBPI, since
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Figure 2.6 Proteolytic cleavage of EBPI
Reactions contained 0.5 ng [32p].|abelled, double stranded SV1 oligonucleotide, 1.0 |ig of 
unlabelled poly [d(A-T)] poly [d(G-C)] and 2 pi of affinity purified EBPI ; {-) indicates that EBPI was 
omitted from these reactions. In addition, reactions contained 0 (lanes 0), 5 (lanes 1), 10 (lanes 2), 20 
(Elastase and Type XIV lanes 3) or 5000 pg (Prot.K lane 3) of proteinase K, elastase or protease XIV. 
Proteolytic enzymes were added after the binding reactions had reached equilibrium and digestion 
was allowed to proceed for 15 minutes at 20°C. Reaction products were fractionated on native 6% 
polyacrylamide gels.
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they are removed by inclusion of the detergent n-octylglucopyranoside in the column buffer during 
the affinity chromatography steps (Treisman, 1987).
Chapter 3. EBPI binding to a variety of virai and ceiiular enhancers
3.1 Competition analysis o f EBPI binding to virai and ceiiuiar enfiancers
DNA sequences similar to the recognition site of EBPI in the SV40 enhancer are present in 
a variety of other viral and cellular transcriptional control regions, including the human 
immunodeficiency virus (HIV) enhancer (Nabel and Baltimore, 1987), human 8-interferon gene 
regulatory element (IRE) (Goodbourn etal., 1985), mouse immunoglobulin kappa chain gene 
enhancer (Sen and Baltimore. 1986) and mouse class 1 H2 major histocompatibility gene enhancer 
(Baldwin and Sharp. 1987). An additional sequence is also present in a region of the SV40 genome 
located on the "late" side of the enhancer. To determine if these DNA sequences also represent 
binding sites for EBPI, double stranded synthetic oligonucleotides containing these sites were 
assessed for their ability to compete with a labelled probe for binding of EBPI. EBPI was 
incubated with a [32p]-iabelled restriction enzyme fragment derived from the SV40 enhancer and 
binding monitored by DNase I footprinting. In the presence of EBP1 the region between 232 and 
251 on the SV40 enhancer is protected from digestion by DNase I (Figure 3.1 B),
Binding to the labelled probe is eliminated by inclusion of an excess of double stranded 
oligonucleotides containing the EBPI binding site in the SV40 enhancer (SVl) but not by inclusion 
of double stranded oligonucleotides containing mutations within the EBPI site in which guanines at 
positions 244 and 245 have been changed to cytosines (SVl .Ml), or cytosines at positions 237 
and 238 are changed to guanines (SVl .M3), thus identifying additional sequences lying outside 
the "core" region required to constitute a functional binding site for EBP1. This extends the EBPI 
binding site on the SV40 enhancer past the GT-I motif and into the TC-II motif (Figure 1.2) 
differentiating this factor from a number of previously identified proteins that bind to the SV40 
enhancer (Barrett etal., 1987; Johnson etal., 1987; Xiao etal., 1987a).
Inclusion of an excess of double stranded oligonucleotides containing the sequences from the 
immunoglobulin kappa chain enhancer (NF-kB) or the mouse class 1 H2 major histocompatibility 
gene enhancer (H2TF1) competed for binding of the labelled SV40 probe (Figure 3.1 B). Two
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Figure 3.1 Competition analysis of EBPI binding
A. Reactions contained 0.1 ng [32p]-iabelled double stranded SVl oligonucleotide, 0.5 jig of 
unlabelled poly[d{A-T)]: poly[d(G-C)] and 2 jil of affinity purified EBPI (dashes represent reactions 
which did not contain any EBPI). In addition reactions contained 0 (NC), 1,5,10,25 or 100 ng of 
unlabelled S V l, SVUP, IRE, SYM, HIV, HIV-L, HIV-R, NF-kB or H2TFI synthetic oligonucleotides. 
Binding reactions were fractionated on 6% polyacrylamide gels and products visualised by 
autoradiography.
B. A Bam HI to Pvu II fragment from pUC1X72, was 5'-[32p] labelled at the Bam HI site, incubated with 
0.5 pg of unlabelled poly[d(A-T)]:poly[d(G-C)], 20 pi of affinity purified EBPI (+) and digested with 
DNAse I as described in “Materials and Methods”. Also Included in the reactions were 100 ng of 
unlabelled double stranded SVl (1), SV1.M1 (2), SV1.M3 (3). NF-kB (4), H2TF1 (5), HIV (6), HIV-L (7) 
and HIV-R (8) oligonucleotides. DNA was isolated, fractionated by electrophoresis in 8% denaturing 
polyacrylamide gels and the cleavage products visualised by autoradiography. G+A (Pu) specific 
cleavage reactions of the labelled fragment were electrophoresed in parallel as markers.
C. DNA sequences which compete for binding of EBPI. Sequences thought to be important for 
EBP1 recognition are boxed.
Figure 3.1 Competition analysis of EBPI binding
A. Reactions contained 0.1 ng [32p]-iabelled double stranded SV1 oligonucleotide, 0.5 pg of 
unlabelled poly[d(A-T)]: poly[d(G-C)] and 2 pi of affinity purified EBPI (dashes represent reactions 
which did not contain any EBPI). In addition reactions contained 0 (NC), 1, 5,10,25 or 100 ng of 
unlabelled SVl, SVUP, IRE, SYM, HIV, HIV-L, HIV-R. NF-kB or H2TFI synthetic oligonucleotides. 
Binding reactions were fractionated on 6% polyacrylamide gels and products visualised by 
autoradiography.
B. A Bam HI to Pvu II fragment from pUCI X72, was 5'-[32p] labelled at the Bam HI site, incubated Wi 
0.5 pg of unlabelled poly[d(A-T)]:poly[d(G-C)], 20 pi of affinity purified EBP1 {+) and digested with 
DNAse I as described in "Materials and Methods". Also included in the reactions were 100 ng of 
unlabelled double stranded SV1 (1).SV1.M1 (2), SV l.M3 (3), NF-kB (4), H2TF1 (5), HIV (6), HIV-L (: 
and HIV-R (8) oligonucleotides. DNA was isolated, fractionated by electrophoresis in 8% denaturing 
polyacrylamide gels and the cleavage products visualised by autoradiography. G+A (Pu) specific 
cleavage reactions of the labelled fragment were electrophoresed in parallel as markers.
C. DNA sequences which compete for binding of EBP1. Sequences thought to be important for 
EBPI recognition are boxed.
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tandem copies of potential EBP1 binding sites are present in the HIV enhancer and It is apparent 
that each sequence separately (HIV-R, HiV-L) or together (HIV) can compete for binding (Figure
3.1 B). In addition, double stranded oligonucleotides containing the EBP1 binding site present in 
the IRE were also found to compete for binding of the labelled SV40 probe In DNase I footprint 
analysis (data not shown).
The relative affinity of the different sequences for EBP1 was determined by the addition of 
increasing amounts of each double stranded oligonucleotide to a binding reaction containing [32pj- 
labeiled SV1 oligonucleotide and purified EBP1 (Figure 3.1 A). It is apparent that the EBP1 binding 
sequence present in the immunoglobulin kappa chain enhancer, class 1 H2 genes, the HIV 
enhancer and a synthetic symmetrical sequence , Sym (Table 1), all compete for binding of EBP1 
with similar affinities (Figure 3.1 A). The IRE sequence also competes for binding of EBP1, but a 
tenfold higher concentration of this binding site is required to give a similar level of competition to 
that obtained with SV1. Competition by the additional SV40 sequence on the late side of the 
enhancer (SVUP) only takes place at very high concentrations of oligonucleotide Indicating that this 
sequence is a low affinity site for EBP1. The EBP1 recognition sites present in the aforementioned 
transcriptional control regions are shown In Figure 3.10 and comparison of the different EBP1 
binding sites indicates that each contains a conserved 10 bp sequence (as depicted by the boxed 
region ).
3.2 Binding of EBPI to the human 3-interferon response element (IRE)
The c/s- acting DNA sequences required for induction of the human 3-interferon gene have 
been identified as a 43 bp region located at position -77 to -35 with respect to the transcriptional 
start site. Within this region is a DNA sequence that is similar to the sequence present in the "core" 
region of the SV40 enhancer. In the previous section (Figure 3.1 A) it was been demonstrated,by 
competition analysis, that the IRE bound EBPi. The protein, purified by recognition site affinity 
chromatography, was therefore incubated with a restriction enzyme fragment p2p]_iabelled on 
either the top or bottom strand of the IRE, digested with DNase I and the cleavage products 
displayed on a denaturing polyacrylamide gel. On both the top and bottom strands a region of the 
IRE is protected by EBPI from DNase I digestion (Figure 3.2A). On the bottom strand the region of
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Figure 3.2 DNase I protection and OP/Cu+ cleavage of the IRE In the presence of 
EBP1
A. A HindWl to Bgl II fragment from pSPIRE, was 3'-[32p]-iabelled (top) or 5'-[32p] labelled (bottom) at 
the Hind\\\ site, incubated with 0, 5,10 or 20 pi of affinity purified EBPI and digested with DNase I as 
described in “Materials and Methods". DNA was isolated, fractionated by electrophoresis in 8% 
denaturing polyacrylamide gels and the cleavage products visualised by autoradiography. C+T (Py) 
and G+A (Pu) specific cleavage reactions of the labelled fragment were electrophoresed in parallel as 
markers.
B. The aforementioned labelled fragments were incubated with 20 pi of affinity purified EBPI and, 
after binding reactions had reached equilibrium, free DNA (F) was separated from EBPI-DNA 
complexes (B) by electrophoresis in a native polyacrylamide gel. Cleavage with OP/Cu+ was carried 
out within the acrylamide matrix and DNA eluted as described in “Materials and Methods”. DNA was 
fractionated, and products visualised as described in A. Deoxyribose residues within the bracketed 
region are protected from cleavage by OP/Cu+.
0. DNA sequence of the IRE containing the EBPI binding site. Phosphate bonds within the large 
brackets are protected from DNase I cleavage broken lines depict potential protected bonds). 
Deoxyribose residues within the small bracketed regions are protected from OP/Cu+ cleavage in the 
presence of EBPI.
Bottom Top Bottom
[ - I [
c.
5 ' -GAGAATGAAAGTGGGAAATTCCTCTGAATAGAGAGAGGACC-3' 
3 ' -CTCTTAÇTTTCACCCTTTAAGGAGACTTATCTCTCTCCTGG-5'
- 7 0 j ______________L i  I  j  - M  -40
protection extends from the phosphate bond 3' of base -51 to the phosphate bond 3' of base -69. 
The boundary of the DNase I footprint on the top strand Is not so well defined as DNase I cuts poorly 
in these regions. DNase I cleavage patterns are normally staggered by 2 bp which suggests that the 
protected region extends from the phosphate bond 3' of position -50 to the bond 3' of position -68.
To determine which deoxyribose residues in the DNA backbone are in the proximity of bound 
EBPI, we have subjected the EBPI-DNA complex to cleavage by hydroxyl radicals generated by 
the 1,10 orthophenanthroline/copper ion (OP/Cu+) complex. Restriction enzyme fragments p2p]_ 
labelled on either the top or bottom strand of the IRE were incubated with purified EBPI and 
EBPI- DNA complexes resolved from free DNA by electrophoresis in a non-denaturing 
polyacrylamide gel. OP/Cu+ cleavage was conducted in situ (Kuwabara and Sigman, 1987), DNA 
extracted from the gel and the cleaved products fractionated by denaturing polyacrylamide gel
Of-v Hva-^^àA-bc7vc-'iidi3-=>rv<E_electrophoresis. On each strand a total of eight deoxyribose jyvc>ida^y|are protected from OP/Cu+ 
cleavage by EBPI (Figure 3.2B). The region of protection extends from the deoxyribose residue 
attached to base -57 to base -64 on the bottom strand, and from -56 to -63 on the top strand. A 
summary of the DNase I and OP-Cu+ protection data is presented in Figure 3.2C.
3.3 Binding of EBPI to the human immunodeficiency virus (HiV) enhancer
The human immunodeficiency virus (HIV) can express its gene products when transfected into 
a number of cell lines, including HeLa cells (Levy et ai, 1985), suggesting that the virus is able to 
use general cellular transcription factors for expression of its genes. Genetic analysis of the HIV 
long terminal repeat (LTR) has revealed several cis -acting regions important for viral gene 
expression including a negative regulatory region, an enhancer element, SP1 ( Dynan and Tjlan, 
1983; Gidoni et ai., 1985; Briggs et ai., 1986) binding sites, TATA and untranslated regions 
(reviewed by Wu, et ai., 1988). Within the enhancer region are two direct repeats of a DNA 
sequence, -GGGAGTTTCC-, similar to that present in the "core" region of the SV40 enhancer 
(Nabel and Baltimore, 1987). Competition analysis (Figure 3.1 A and B) has demonstrated that 
EBPI binds to both of these sequences present in the HIV enhancer. To determine how EBPI 
bound to the HIV enhancer , the protein was incubated with a restriction enzyme fragment, 
[32.p]-iabelled on either the top or bottom strand of the HIV enhancer, digested with DNase I and
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Figure 3.3 DNase I protection of the HIV enhancer In the presence of EBPI
A Hind\\\ to Sac I fragment, or Eco RI to Pst I fragment, from pHIVEn was 3-end labelled at the Hind\\\ 
(Bottom: A) or Eco RI (Top; B) site, incubated in the absence (0) or presence of 5,10 or 20 pi of 
affinity purified EBPI and digested with DNase I as described in “Materials and Methods”. DNA was 
isolated and fractionated by electrophoresis in 8 % denaturing polyacrylamide gels and the cleavage 
products visualised by autoradiography.
C. DNA sequence of the HIV enhancer containing the EBPI binding sites (as depicted by the 
horizontal bars). Phosphate bonds within the bracketed regions are protected from DNase I 
cleavage in the presence of EBPI.
BOTTOM
^-7 5
-106
r5 ' -TCTACAAGGGACTTTCCGCTGGGGACTTTCCAGG-3 3'-AGATGTTCCCTGAAAGGCGACCCCTGAAAGGTCC-5'
i _________________________________________________ f
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the cleavage products fractionated on a denaturing polyacrylamide gel. On both the top and bottom 
strands a region of 34 bp of the HIV enhancer (Figure 3.3A and B) is protected from DNase 1 
digestion by EBPI. This region contains both the-GGGACTTTCC-direct repeats. On the bottom 
strand the region of protection extends from the phosphate bond 3' of base -75 to the phosphate 
bond 3' of base -108, and from the phosphate bond 3' of position -74 to the bond 3' of position 
-107 on the top strand. A summary of the DNase I data is presented In Figure 3.3C with the 
positions of the -GGGACTTTCC- repeats indicated by the horizontal bars.
Chapter 4. Mutational analysis of the EBPI binding site
4.1 DNA binding specificity of purified EBPI
To determine the bases involved in sequence-specific recognition by EBPI on the DNA, a 
detailed mutational analysis of sites present in the SV40 enhancer and IRE was carried out. Results 
of DNase I protection competition experiments revealed that guanines at positions 244 and 245, 
and cytosines at positions 236 and 237 (Figure 3.1 B, lanes 2 and 3) were an important component 
in the recognition event. This was also found to be the case by analysing the interaction of the 
purified protein with [32p]-iabelled SV1 double stranded oligonucleotide in the standard gel 
electrophoresis DNA-binding assay (Figure 4.1). Whereas unlabelled SV1 oligonucleotide could 
efficiently compete for binding of the purified factor , the SV1.M1 oligonucleotide (with G to C 
changes at positions 244 and 245) was unable to do so. This was also true of the SV1.M3 
oligonucleotide which contained C to G alterations at position 237 and 238 (Figure 4.1). Thus the 
purified protein requires interactions within the GT-I motif, at positions 244 and 245, and in the TC-ll 
motif at positions 237 and 238 for sequence-specific recognition, as determined by DNase I 
footprinting (Figure 3.1 B) and gel electrophoresis DNA binding assays (Figure 4.1)
4.2 Mutational analysis of the EBPi binding site in the IRE
Comparison of the naturally occurring binding sites for EBPI (Figure 3.10) suggest which base 
pairs within the recognition site are important for EBPI binding. To evaluate the contribution of 
individual base pairs to EBPI binding we have made use of a series of point mutants (Figure 4.2B) 
which span its binding site in the IRE (Goodbourn and Maniatis, 1988). [32p]-iabelled restriction
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Figure 4.1 DNA binding specificity of affinity purified EBP
Competition analysis of EBPI binding. Reactions contained 0.5 ng [32p].|abelled double stranded 
SV1 oligonucleotide, 1.0 pg of unlabeled poly [d(A-T)]: poly [d(C-G)] and 1.0 pi of affinity purified 
EBPI (lane (-) contained no EBPI). In addition, reactions contained 25 (lanes 1), 50 (lanes 2) or 100 
ng (lanes 3) of unlabelled double stranded SV1, SV1 .Ml or SV1 .M3 oligonucleotides. Reaction 
products were analysed on 6% polyacrylamide gels. The nucleotide sequence of the SV1 
oligonucleotide is shown -  the corresponding changes incorporated into SV1.M1 and SV1 .M3 are 
indicated.
SV1 
+ 1 2  3
SV1.M1 
1 2 3
SV1.M3 
1 2 3
SV1
Ml M3
CC GGtl It  ,5-AGGGTGTGGAAAGTCCC-3
Figure 4.2 Mutational analysis of the EBPI binding site present in the human 
B-interferon gene reguiatory eiement (iRE)
A. BglW to Nco I fragments were isolated from the p!F10 series of plasmids, which contain single point 
mutations throughout the IRE, and [32p]-iabelled at the Bgl II site. Labelled fragments (0.5 ng) were 
incubated with 0.5 pg of unlabelled poly[d(A-T)]: poly [d(G-C)] and 2 pi of affinity purified EBP1 in the 
standard gel electrophoresis DNA binding assay. Binding reactions were fractionated on 6% 
polyacrylamide gels and products visualised by autoradiography. The individual nucleotide changes 
incorporated into the mutant templates are indicated above the corresponding lanes. No EBPI was 
present in the reaction represented by the dash.
B. Nucleotide changes incorporated in the plF10 mutants used in this study. The top line 
represents the wild type (wt) IRE sequence together with the relevant nucleotide numbers. Arrows 
represent the bases which have been altered with the bottom line depicting the corresponding 
changes in these altered bases.
A.
-  WT 55T 56T 57C 60G GIT GIG G2A G3A 64A G5C
m
B.
W t  IRE
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enzyme fragments containing the mutated bases were incubated with EBP1 and free DNA 
separated from DNA-protein complexes on a native polyacrylamide gel. It is apparent from the 
autoradiograph shown in Figure 4.2A that mutations within the EBP1 binding site have widely 
differing effects on EBP1 binding. Mutations -65C, -60G and -57C have a negligable effect on 
EBP1 binding, unlike mutations -64A, -63A, -62A, -56T and -55T which have a severe deleterious 
effect on EBP1 binding. Changes at position -61 are of interest in that an A to T change reduces 
binding whereas an A to G change increases binding above the wild type level. Another interesting 
observation occurs when the guanine at position -62 is changed to an adenine. In this situation 
EBPI does not bind to the mutant IRE template. This is somewhat unexpected in that an adenine 
is permitted at this nucleotide position in the EBPI binding site on the SV40 enhancer, in addition, 
this base lies in the sequence between the conserved bases at positions 1 and 2, and 9 and 10 
(Figure 3.1 C). These centrai base pairs were originally thought to be mutable in that changes could 
be incorporated without having any severe effect on EBPI binding. Table 4.1 lists the DNA 
sequences which bind EBPI (A) and those which abolish EBPI binding (B).
4.3 Mutational analysis of the EBPI binding site in the SV4Q enhancer
Although the critical bases for EBPI binding in the SV40 enhancer were identified by analysis 
of double base pair mutations, it was not clear to what extent the base pairs between these critical 
residues contribute to EBPI binding since bases between these two conserved blocks of guanine 
and cytosine residues (Figure 3.1 C) appear to be mutable in the IRE (Figure 4.2). To address this 
question we have made use of the pA.. series (Figure 2M) of clustered triple point mutations in the 
SV40 enhancer (Zenke et ai, 1986) which have been used extensively to study enhancer function. 
These plasmids contain the SV40 enhancer region in which three neighbouring nucleotides have 
been mutated simultaneously in vitro by generating non-compiementary transversions (A e C,
G è T). The ability of EBPI to bind to a set of pA mutants that span the binding site was 
determined by the gel electrophoresis DNA binding assay and by DNase footprinting. 
[32p]-iabelied restriction enzyme fragments containing the mutations were incubated with EBPI 
and free DNA separated from DNA-protein complexes by electrophoresis in a native polyacrylamide 
gel. The extent of binding was quantitated by determining the [32p]-radloactivity in the bound
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Figure 4.3 Mutational analysis of the EBP1 binding site on the SV40 enhancer.
A. Bam HI to Pvu II fragments from pUC1 X72 and pA11 to pA16, were S'-[32p] labelled at the Bam HI 
site, and incubated with 2 pi of affinity purified EBP1, in the presence of 0.5 pg of unlabelled 
poly[d(A-T)]: poly[d(G-C)], in the standard gel electrophoresis DNA binding assay. Binding reactions 
were fractionated in a 6% polyacrylamide gel and products visualised by autoradiography. The relative 
binding of EBP1 to the various templates (as determined by Cerenkov radiation counting of bound 
species) is indicated.
B. DNase i protection of mutated SV40 enhancer sequences by EBP1. The [32p]-iabelled 
fragments described in A were incubated with 0 (-) or 20 pi (+) of affinity purified EBP1 and treated 
with DNase I as described in “Materials and Methods”. DNA was isolated and fractionated in 8% 
denaturing polyacrylamide gels and the cleavage products visualised by autoradiography. G+A (Pu) 
specific cleavage reactions of the labelled fragments were electrophoresed in parallel as markers. 
Sources of labelled fragments are indicated at the foot of the appropriate lanes.
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fraction by liquid scintillation counting. Examination of Figure 4.3A indicates that mutations pA11 
and 16, which lie on the boundary of the EBP1 recognition site, have only a marginal effect on 
EBP1 binding whereas mutations pA12,13,14 and 15, which lie within the recognition site, reduce 
binding by at least an order of magnitude. These results were confirmed by DNase I footprinting 
which also indicates that EBPI binding to pA II and 16 was unaltered by mutations on the 
boundary of the recognition site (Figure 4.3B).
4.4 DNA sequence requirement for EBPI binding
The mutational analysis of EBPI in the SV40 enhancer and the IRE is compiled in Table 4.1, 
where DNA sequences which bind EBPI (A) are compared with sequences that do not (B). An 
invariant feature of ail the DNA sequences that constitute high affinity binding sites for EBPI is that 
they possess the sequence 5'-G-G separated by six base pairs from the complementary sequence 
5'-C-C. Alteration of any one of these four bases reduces EBPI binding considerably. The 
absence of the two C residues in related naturally occurring sequences from the GT-ii motif of the 
SV40 enhancer (SV2) and two regions of the adenovirus type 2 El a enhancer (enhA, enhB) 
explain why these sequences fail to bind EBPI (Table 4.1 B). One T residue located between 
these essential sequences Is also conserved but is not absolutely required for binding since the 
H2TF1 sequence contains a C at this position (Figure 3.1 C). However, the SVUP sequence 
represents a low affinity binding site for EBPI and this may be explained by the absence of the 
conserved T residue. Single base pair changes between the conserved C's and G's can usually be 
tolerated, although this does not appear to be the case with the -62A mutant or the triple point 
mutations. The binding of EBPI to 34 different DNA sequences that are related to the binding site 
for EBPI on the SV40 enhancer were anaylsed. Nineteen different sequences bound EBPI 
(Figure 3.1; Table 4.1) and the information obtained was used to determine the DNA sequence 
requirement for EBPI binding. At each position in the sequence the frequency with which each 
base ocurrs has been determined and is presented graphically in Figure 4.4. As mentioned above, 
all sequences which bind EBPI have G's at positions 1 and 2 and C's at positions 9 and 10. What is 
aiso apparent is the strong preference for purines in positions 1 to 6, and the equally strong 
preference for pyrimidines in positions 7 to 10, on the top strand.
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Table 4.1 EBPI binding sites
DNA sequences of wild type and mutant templates which bind EBP1 (A) or those which do not bind EBP1 
(B). Nucleotide changes, with respect to the EBPI recognition site present in the SV40 enhancer, are 
underlined.
A
6
SVl 6 T 6 G A A A G T C C C G
SYM BS 6 6 6 G A A A T T C C C C A
SVl M2 6 T G G A A £ G T C C C G
SVl M4 Q T 6 G A A A G T C C C G
SV pAll Z T 6 G A A A G T C C C C A
SV pAl6 6 T G G A A A G T C C C C g
IRE 616 6 T 6 6 G fî A A T T C C T C
IRE 65C 6 Q 6 6 6 A A A T T C C T C
IRE 606 6 T 6 6 6 A Q. A T T C C T C
IRE 57C 6 T G 6 6 A A A T Q C C T C
IRE 54C 6 T G G G A A A T T C C g C
IRE 6IT 6 T G 6 6 I A A T T C C T C
SV pAl2 6 & I I A A A G T C C C C
IRE 64A 6 T A G G A A A T T C C T
IRE 63A 6 T G A G A A A T T C c T
SVl Ml 6 T Q G A A A G T C C c G
IRE 62A 6 T G G A A A A T T C c T
SV pAl3 6 T G G Q C Q G T C C c C
SV pAl4 6 T G G A A A £ g A C c C
SVl M3 6 T G 6 A A A G T g g c C
IRE 56T 6 T G G 6 A A A T T £ c T
IRE 55T 6 T G G 6 A A A T T C £ T
SV pAl5 6 T 6 6 A A A 6 T C A A A
SV2 6 T 6 6 A A T 6 T G T G
Enh A 6 T G G T A A A A 6 T G
Enh B 6 A G G A A G T G A A A
Figure 4.4 Frequency of base usage within EBP1 binding sites
Nineteen different EBPI binding sites, including naturally occurring sequences and mutated 
derivatives, were analysed and the frequency with which each base occurs at each position 
determined. A = adenine, C = cytosine, G = guanine, and T = thymine nucleotides respectively.
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Chapter 5. Contact point anaiysis of the EBPI binding site
Although the SV40 enhancer is oniy -100 bp long, it is an extremely complex transcriptional 
unit containing the binding sites for a large number of proteins (Wildeman et al., 1986; Davidson et 
al., 1986; for review see N.C. Jones et a!., 1988). Given the complexity of the situation in which a 
large number of proteins have the potential to interact with the same stretch of DNA, it is important to 
define precisely the recognition sequences for each of these proteins. To this end the points on 
the SV40 enhancer, IRE and HIV enhancer that are in close contact with EBPI have been 
examined using nuclease protection and a variety of chemical probing techniques.
5.1 DNA protected by EBPI from DNase / cleavage
In the presence of affinity purified EBPI, a total of nineteen phosphodiester bonds on both the 
top and bottom strands are protected by EBPI from cleavage with DNase 1. On the top strand 
(Figure 5.1 A), the phosphodiester bond 3' to base 250 is resistant to DNase I cleavage in the 
presence of EBPI and the protected region extends to the phosphodiester bond 3' to base 232. 
Partial protection of the bond 3' to base 231 is aiso apparent. The protected region on the bottom 
strand (Figure 5.1 B) includes the bond 3' to base 233 and extends to the bond 3' of base 251 (BBB 
system of numbering employed; Tooze, 1982). However, interpretation of DNase I cleavage 
patterns should take into account the large size of DNase i itself. Consideration of X-ray 
crystaiiographic data on the structure of a DNase l-oligonucleotide complex (Suck et a!., 1988 ) 
indicates that DNase 1 has an extended DNA binding surface with 6 bp on the 5'~side and 2 bp on 
the 3'-side of the cutting site being occupied by the enzyme. This would suggest that the area 
occupied by EBPI on the SV40 enhancer is in fact significantly smaller than that demonstrated by 
DNase I "footprint" analysis. Thus EBPI appears to occupy the DNA between bases 248 and 236 
on the top strand, and 235 (or 238) and 247 on the bottom strand.
5.2 Méthylation protection by EBPI on the SV40 enhancer
The exposure of double stranded DNA to DMS results in the méthylation of purines at the N-7 
position of guanine and the N-3 position of adenine with the introduction of a net positive charge 
onto the purine ring (Singer, 1975: Ogata and Gilbert, 1978). The reaction is set up under mild,
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Figure 5.1 DNase I protection of the SV40 enhancer by EBPI
A Bam HI to Eco RI fragment from pUCI X72, 3'-end labelled (A) or S’-end labeled (B) at the Bam HI 
site, was incubated in the absence (-) or presence (+) of 10 pi affinity purified EBPI and digested with 
DNase I as described in “Materials and Methods”. DNA was isolated and fractionated by 
electrophoresis in 6% denaturing polyacrylamide gels and the cleavage products visualised by 
autoradiography. G+A (Pu) specific cleavage reactions of the labelled fragments were 
electrophoresed in parallel as markers. Phosphate bonds within the brackets are protected from 
DNase I cleavage.
C. Organisation of the SV40 transcriptional control region. The 21 bp repeated elements of the early 
promoter, the origin of DNA replication (oh) and the enhancer, containing one copy of the 72 bp 
repeat, are indicated. Shown below is the DNA sequence of the enhancer region containing the 
EBPI binding site. Phosphate bonds within the brackets are protected from DNase I cleavage. DNA 
sequences present in the double stranded SVl oligonucleotide are also indicated.
T o p  
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5 ' -GTTAGGGTGTGGAAAGTCCCCAGGCTC-3' 
3 ' -CAATCCCACACCTTTCAGGGGTC|3GAG- 5 '
non-denaturing conditions such that they do not interfere with normal protein-DNA binding 
reactions. The destabilising effect of modification, due to méthylation, renders the DNA backbone 
susceptible to cleavage with alkali at the point of modification. The extent of méthylation at each 
purine in a given DNA fragment, in the presence and absence of a DNA binding protein, can be 
determined by fractionation of the cleaved molecules in denaturing polyacrylamide gels followed by 
autoradiography. Differences in the level of méthylation reflect the structure of the site of 
interaction on the DNA and identify the specific sites of purine-protein contact.
Binding of protein to the DNA can both decrease (protection) and increase (enhancement) the 
level of purine méthylation in the contact region. It is thought that protection is most likely caused by 
steric hindrance. Less is known about the mechanism of enhancement but it may represent a close 
approach of the protein to DNA in such a way as to produce a hydrophobic pocket that increases the 
local concentration of the methylating reagent, DMS. Since the N-7 position of guanine lies in the 
major groove of DNA and the N-3 of adenine in the minor groove, a perturbation of the méthylation 
reaction at guanine or adenine suggests a protein contact in the major or minor groove, 
respectively.
An end-labelled restriction fragment containing the cloned SV1 oligonucleotide, isolated from 
pSVI, was incubated with purified EBP1 and exposed to DMS. DNA was extracted and the 
backbone cleaved at modified G residues by treatment with piperidine. Analysis of the cleavage 
products by polyacrylamide gel electrophoresis (Figure 5.2A) revealed that guanines at positions 
240, 244 and 245 on the top strand and positions 237 and 236 on the bottom strand are protected 
from modification by DMS. Although the sites present in pSVI and the complete SV40 enhancer 
bind EBPI with equal affinity, we examined the region surrounding the binding site for changes in 
DMS sensitivity. Apparent in the fragment derived from the complete SV40 enhancer is a G residue 
at position 235 on the bottom strand that is hypersensitive to DMS méthylation in the presence of 
EBPi (Figure 5.2B ). A summary of this data is presented in Figure 5.2C.
5.3 Methy!ated bases that interfere with EBPI binding on the SV40 enhancer
A previously methylated guanine or adenine residue in DNA can interfere with the binding of 
protein (Siebenlist and Gilbert, 1980). Alkylation of either base creates a positive charge on the
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Figure 5.2 Méthylation protection of the EBPI binding site by EBPI
A. Hind ill to Kpn I, or Eco Ri to Pst I fragments from pSVI, 3'-end labelled at the HIndWl (top) or Eco 
RI (bottom) sites, were Incubated in the absence (-) or presence (+) of 10 |xl affinity purified EBP1 
and treated with DMS as described in "Materials and Methods”. DNA was cleaved at modified G 
residues by treatment with piperidine, reaction products were fractionated by electrophoresis in 8% 
denaturing polyacrylamide gels and the cleavage products visualised by autoradiography. Positions 
of protected bases are indicated by arrows.
B. A Bam Hi to Eco RI fragment from pUC1X72,3'-end labelled (top) or 5-end labelled (bottom), 
was incubated with 10 pi affinity pufiried EBPI, treated with DMS and free DNA (F) separated from 
EBPI - DNA complexes (B) in a native polyacrylamide gel. DNA was eluted from the gel, treated with 
piperidine and cleaved products fractionated by electrophoresis in 6% denaturing polyacrylamide 
gels. Positions of protected bases are indicated by arrows.
C. DNA sequence of the region of the SV40 enhancer containing the EBPI binding site. Filled 
squares represent guanines protected from DMS méthylation in the presence of EBP1 ; the open 
square represents a guanine hypersensitive to DMS méthylation, and the hatched square a 
guanine protected from DMS méthylation in pUC1X72, but not in pSVI.
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purine ring, rendering the modified residue base labile. Cleavage of the DNA at the point of 
modification and analysis of the products allows us to determine which N-7s of guanine and N-3s of 
adenine are critical for either the formation of the DNA-protein complex, or for its maintenance. 
Méthylation interference experiments require that the DNA is modified such that each molecule in 
the population contains no more than one methylated base. The protein under study is then 
allowed to bind to the modified DNA and free DNA is separated from DNA-protein complexes on 
non-denaturing polyacrylamide gels. Modification at a site that makes an essential contact with the 
protein will interfere with binding; as a result that molecule will not be represented as DNA-protein 
complexes. DNA molecules with modifications that do not interfere with binding will be present as 
DNA-protein complexes. After cleavage of the DNA molecule at the point of modification, 
comparison of DNA present in the free and bound fractions by denaturing polyacrylamide gel 
electrophoresis identifies functional groups on the DNA that are essential for complex formation.
Partially methylated, [32p]-iabelled DNA representing each strand of the cioned SV1 
oligonucleotide was incubated with purified EBPI and free DNA separated from DNA-protein 
complexes by electrophoresis in a native polyacrylamide gel. Bound and free DNA was purified, 
treated with NaOH, to cleave the strands at modified purine bases, and the cleavage products 
resolved on a sequencing gel. On the top strand the G residues at positions 240,244 and 245 that 
were protected from attack by DMS all interfere with binding (Figure 5.3A). Located between these 
interfering G residues, the A residues at positions 241, 242 and 243 also interfere with binding. On 
the bottom strand the two G residues at positions 236 and 237, which were protected from DMS 
modification, interfere with binding after modification Figure 5.3B). The two adjacent purine bases, 
G 238 and A 239, also interfere with binding of EBPI when modified. Guanine 235, which is 
hypersensitive to DMS attack and is not required for binding, does not interfere with binding when 
modified (data not shown). Assessment of this data indicates that the arrangement of interfering 
purine bases is highly strand specific; a string of four purine bases on the bottom strand followed by 
six purine bases on the top strand all interfere with binding (Figure 5.30). Dimethylsulphate 
introduces a methyl group onto the N-7 position of guanine, which projects into the major groove, 
and the N-3 position of adenine, which projects into the minor groove. The data presented above 
therefore suggest that EBPI makes contacts in both the major and minor grooves of the DNA
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Figure 5.3 Methylated bases that Interfere with EBP1 binding.
Hind III to Kpn I (A) or Eco RI to Pst I (B) fragments from pSV1, 3'-end labelled at the Hind III (top) or 
Eco RI (bottom) sites were treated with DMS and the methylated DNA incubated with 10 pi affinity 
purified EBPI. Free DNA (F) and EBP1-DNA complexes (B) were separated by electrophoresis in 
a native polyacrylamide gel. DNA was eluted from the gel and cleaved at modified purine bases by 
treatment with NaOH. Cleavage products were fractionated by electrophoresis in 8% denaturing 
polyacrylamide gels. Positions of interfering bases are indicated by arrows.
C. DNA sequence of the region of the SV40 enhancer containing the EBPI binding site. Filled 
circles depict modified bases which interfere with EBPI binding.
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double helix.
5.4 Base specific contacts of EBPi on the HiV enhancer
To determine which purine bases in the EBPI recognition sites of the HIV enhancer are in 
close contact with EBP1, méthylation protection and interference experiments were carried out. 
EBP1 was incubated with a restriction enzyme fragment containing the HIV enhancer, 
[32-p]-iabelled on either the top or bottom strand, and the resulting DNA-protein complexes treated 
with DMS. Guanine residues methylated at the N-7 position were identified by treating with 
piperidine to cleave the DNA at the point of DMS modification. The cleavage products were 
fractionated by electrophoresis in denaturing polyacylamide gels and visualised by autoradiography. 
X-ray film was allowed to expose for 15 hours, or 48 hours, for maximum resolution of 
protected/enhanced cieavages. Results indicate that guanines at positions -88, -89, -102 and -103 
are protected by EBPi from modification by DMS (Figure 5.4A). On the bottom strand, guanines at 
positions -80, -81, -85, -94, -95 and -99, are protected from DMS modification in the presence of 
EBP1 (Figure 5.4B). In addition, adenine residues at positions -86 and -104, guanine at position 
-87 and cytosine at position -85 on the top strand (Figure 5.4A) and adenines at positions -82 and 
-96 on the bottom strand (Figure 5.4B) are hypersensitive to DMS méthylation in the presence of 
EBPI. A summary of this data is presented in Figure 5.4C.
A compiementary series of experiments were carried out to determine which methylated purine 
bases interfered with the binding of EBPI. Specific binding of purified NF-kB to the HIV enhancer 
has been demonstrated by DNAse I protection and méthylation interfence analyses (Kawakami et 
al., 1988). In direct footprint anaiysis, NF-kB binding sites, which also correspond to EBPI binding 
sites (Figure 3.1), were protected from DNase I cleavage in the presence of affinity purified NF-kB. 
Méthylation interference studied revealed six guanine residues in the distal binding site which when 
methylated interfered with NF-kB binding. However, decreased signals indicative of méthylation 
interference were not clearly observed, suggesting that interference was only partial, in addition, no 
méthylation interference was observed in the proximal binding site in the presence of NF-kB. 
Kawakami and coworkers (1988) propose that the distal element can be occupied only by NF-kB, 
whereas the proximal element may be occupied by either a common cellular factor, for example
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Figure 5.4 Méthylation protection of bases In the HIV enhancer In the presence 
of EBP1
A Hind III to Sac I fragment, or Eco RI to Pst I fragment, from pHIVEn was 3'-end labelled at the Eco RI 
(Top; A) or Hind III (Bottom; B) site, was incubated in the absence (-) or presence of 20 pi of EBP1 
(+) and treated with DMS as described in “Materials and Methods”. DNA was cleaved at modified 
bases by treatment with piperidine and the reaction products fractionated by electrophoresis in 8 % 
denaturing polyacrylamide gels. Cleavage products were visualised by autoradiography after 15 
(Top, b; Bottom, a) or 48 hours (Top. a; Bottom, b) exposure to X-ray film. Positions with altered 
sensitivity to DMS are indicated by filled triangles, in the case of protected bases, or open triangles, 
in the case of bases hypersensitive to DMS méthylation.
C. DNA sequence of the HIV enhancer containing the two EBP1 binding sites. Positions of the 
bases with altered sensitivity to DMS are indicated as described above.
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H2TF1, or by NF-kB. In light of these findings, restriction fragments containing the proximal (right) or
distal (left) EBP1 binding sites on the HIV enhancer, [32_p].|abelled on either the top or bottom
strands, were treated with DMS to generate, on average, less than one methylated base per
labelled fragment. Partially methylated DNA fragments were incubated with EBPI and DNA-protein
complexes separated from free DNA in a non-denaturing polyacrylamide gel. DNA present in the
bound and free fractions was eluted from the gel and treated with NaOH to cleave N-7 methylated
guanines and N-3 methylated adenines at the point of modification. Comparing bound and free
DNA on a denaturing polyacrylamide gel revealed which purine bases, when methylated, interfered
with EBP1 binding. On the top strand of the distal site four consecutive purine bases, -100A,
-101G, -102G and -103G, all interfere with EBP1 binding when methylated. A similar situation is
evident on the bottom strand where six consecutive purines, -94G, -95G, -96A, -97A, -98A and
-99G, all interfere with EBP1 binding when methylated (Figure 5.5A). An identical pattern of
interfering bases is found for the proximal EBP1 binding site whereby four consecutive purine
bases, -86A, -87G, -88G and -89G, on the top strand, all interfere with EBP1 binding when
methylated and ^x consecutive purine bases on the bottom strand, at positions -80G, -82A, -83A, 
Coo O o*vpjrm .eS -
-84A and -85G, interfere with binding (Figure 5.5B)^ These data are summarised in Figure 5.5C and
show that all purine bases in the 10 bp stretches from -80 to -89, and -94 to -103, interfere with
EBP1 binding when methylated. The guanine nucleotides that were protected by EBP1 from
méthylation, all interfered with binding when methylated. The guanine residue at position -90,
which demonstrated a very pronounced increase in reactivity towards DMS, in the presence of
EBP1, did not interfere with EBP1 binding when methylated -  this nucleotide lies between the
two 10 bp stretches of interfering purines.
5.5 Base specific contacts of EBPi on the IRE
To establish which purine bases within the IRE are in close contact with EBP1, méthylation 
protection and interference experiments were performed. EBP1 was incubated with a restriction 
enzyme fragment containing the IRE, [32p]-iabelled on either the top or bottom strand, and the 
resulting DNA-protein complexes exposed to DMS. Guanine residues methylated at the N-7 
position were identified by treating with piperidine to cleave the DNA at the point of modification.
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Figure 5.5 Methylated bases on the HIV enhancer that Interfere with EBPI 
binding
A.A Hind III to Sac I fragment, or Eco RI to Pst I fragment from pHIV-R, was 3'-end labelled at the 
Eco RI (Top) or HindWl (Bottom) site, treated with DMS and the methylated DNA Incubated with 20 pi 
of affinity purified EBP1 as described in “Materials and Methods”. Free DNA (F) and EBP1-DNA 
complexes (B) were separated by electrophoresis In a native polyacrylamide gel. DNA was eluted 
from the gel and cleaved at modified purine bases by treatment with NaOH. Cleavage products 
were fractionated by electrophoresis in an 8 % denaturing polyacrylamide gel. Nucleotide positions 
of the Interfering bases are Indicated by arrows. The DNA sequence of HIV-R .containing the 
proximal EBPI binding site, is shown with the positions of the interfering bases depicted by the 
stars.
B. A HindWl to Sac I fragment, or Eco RI to Psf I fragment from pHlV-L, was 3'-end labelled at the Eco 
RI (Top) or HindWl (Bottom) site, treated with DMS, the methylated DNA incubated with EBP1 and 
processed as described in A. Nucleotide positions of the interfering bases are Indicated by arrows. 
The DNA sequence of HIV-L, containing the distal EBP1 binding site, is shown with positions of 
Interfering bases depicted by the stars.
Figure 5.5 Methylated bases on the HIV enhancer that Interfere with EBPI 
binding
A.A Hind 111 to Sac I fragment, or Eco RI to Pst I fragment from pHIV-R, was 3’-end labelled at the 
Eco RI (Top) or Hind III (Bottom) site, treated with DMS and the methylated DNA Incubated with 20 pi 
of affinity purified EBPI as described in “Materials and Methods". Free DNA (F) and EBP1-DNA 
complexes (B) were separated by electrophoresis in a native polyacrylamide gel. DNA was eluted 
from the gel and cleaved at modified purine bases by treatment with NaOH. Cleavage products 
were fractionated by electrophoresis in an 8 % denaturing polyacrylamide gel. Nucleotide positions 
of the interfering bases are indicated by arrows. The DNA sequence of HIV-R .containing the 
proximal EBP1 binding site, is shown with the positions of the interfering bases depicted by the 
stars.
B. A HindWl to Sac I fragment, or Eco RI to Psf I fragment from pHIV-L, was 3'-end labelled at the Eco 
RI (Top) or HindWl (Bottom) site, treated with DMS, the methylated DNA incubated with EBP1 and 
processed as described in A. Nucleotide positions of the interfering bases are indicated by arrows. 
The DNA sequence of HIV-L, containing the distal EBP1 binding site, is shown with positions of 
interfering bases depicted by the stars.
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On the top strand, G residues -63 and -64 are protected by EBP1 form modification by DMS. The G 
residue at -62 demonstrates the unusual property of being protected from méthylation at low 
concentrations of EBP1 but at high concentrations of EBP1 appears to be hypermethylated (Figure 
5.6A). On the bottom strand -55G and -56G are protected from méthylation by EBP1 whereas the 
reactivity of DMS to the G residue at -53 is increased by the presence of EBP1 (Figure 5.6A). In a 
complementary series of experiments the ability of methylated purine bases to interfere with binding 
of EBP1 was examined. A restriction enzyme fragment containing the IRE, p^pj-iabelled on either 
the top or the bottom strand, was treated with DMS to generate less than one methylated base per 
fragment. Partially methylated DNA fragments were incubated with EBP1 and DNA-protein 
complexes resolved from free DNA in a native polyacrylamide gel. DNA present in the bound and 
free fractions was eluted from the gel and treated with NaOH to cleave N-7 methylated G residues 
and N-3 methylated A residues at the point of modification. Comparison of the bound and free DNA 
on a denaturing polyacrylamide gel reveals that on the top strand the six consecutive purine bases, 
-59, -60 and -61 A, and -62, -63 and -64G, all interfere with EBP1 binding when methylated (Figure 
5.6B). A similar situation is apparent on the bottom strand where the four consecutive purine bases 
-55 and -56G, and -57 and -58A, all interfere with binding when methylated (Figure 5.6B). These 
data are summarised in Figure 5.60 and indicate that all purine bases in the 10 base pairs from -55 to 
-64 interfere with EBP1 binding when methylated. As expected the G residues that were protected 
by EBP1 from méthylation, interfered with binding when methylated, as did -62G which was 
hypermethylated at high concentrations of EBP1. Guanine residue -53, which demonstrated an 
increased reactivity towards DMS In the presence of EBP1, did not interfere with EBPI binding 
when methylated.
A summary of the bases in the SV40 enhancer, IRE and HIV enhancer that are in close contact 
with EBPI, as determined by DMS chemical probing, is presented in Figure 5.7. What is 
immediately apparent from the pattern of contacts Is that the protein binds homologously to its 
recognition sites in the aforementioned enhancers. In each instance, guanine residues at positions 
1 and 2 are protected from DMS méthylation -  these are separated by six bases from two protected 
guanines at positions 9 and 10 on the opposite strand. Assessment of the data indicates that the 
arrangement of purine bases, which when methylated interfere with EBPI binding, is highly strand
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Figure 5.6 Méthylation protection of the EBP1 binding site and methylated bases 
that interfere with EBPI binding on the IRE
A. A HindUl to Bgl II fragment from pSPlRE, 3’-[32p] labelled (top) of 5'-[32p] labelled (bottom) at 
the Hind ill site, was Incubated with 0,5,10 or 20 pi of affinity purified EBPI and treated with DMS as 
described in “Materials and Methods”. DNA was cleaved at modified guanine residues by treatment 
with piperidine and reaction products fractionated by electrophoresis in 8% denaturing 
polyacrylamide gels. Cleavage products were visualised by autoradiography. Positions of 
protected bases are indicated by arrows and the corresponding IRE nucleotide numbers.
B. The labelled fragments described in A were treated with DMS and the methylated DNA 
incubated with 20 pi of affinity purified EBPI. Free DNA (F) and EBP1-DNA complexes (B) were 
separated by electrophoresis in a native polyacrylamide gel. DNA was eluted from the gel and 
cleaved at modified purine bases by treatment with NaOH. Cleavage products were fractionated 
and visualised as described In A. C+T (Py) and G+A (Pu) specific cleavage reactions of the labelled 
fragments were electrophoresed in parallel as markers.
C. DNA sequence of the IRE containing the EBPI binding site. Filled circles represent guanines 
protected from DMS méthylation in the presence of EBPI with open circles depicting guanines 
hypersensitive to DMS méthylation. Open squares represent DMS- modified bases which interfere 
with EBPI binding.
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FIGURE 5.7 Summary of the EBP1/DNA DMS Méthylation protection and 
Interference analysis
The nucleotide sequences containing the EBP1 binding sites present in the SV40 enhancer, IRE 
and HIV (HIV-R and HIV-L) are shown. Filled circles represent bases which are protected from DMS 
méthylation in the presence of EBPI while open circles indicate bases with an increased reactivity 
towards DMS modification in the presence of EBP1. Purine bases which, when modified, interfere 
with EBP1 binding are depicted by the shaded boxes.
specific in that a string of four purine bases on one strand followed by six purine bases on the other 
strand all interfere with binding. Since DMS introduces a methyl group onto the N-7 position of 
guanine, which projects into the major groove of the DNA, and the N-3 position of Adenine, which 
projects into the minor groove, a straightforward interpretation of the data generated by DMS 
chemical probing studies, suggests that EBP1 makes sequence-specific contacts in both the major 
and minor grooves of the DNA double helix of the SV40 enhancer, IRE and HIV enhancer, in a 
similar manner.
5.6 Ethylated phosphates that interfere with EBPI binding
Modification of DNA with ethylnitrosourea creates a phosphotriester bond in the DNA 
backbone by the linkage of an ethyl group to one of the phosphate oxygens (Siebenlist and Gilbert, 
1980). These phosphotriester bonds are more alkali labile that the phosphodiester bonds. An 
interference experiment can then be carried out using essentially the same experimental design as 
that described for méthylation interference. Addition of the ethyl group removes the negative 
charge on the phosphate oxygen, thus blocking ionic interactions between protein and DNA. The 
bulky ethyl group may also stericaily hinder the close approach of a binding protein. [32p]-iabelied, 
ethylated DNA was Incubated with purified EBPI and DNA-protein complexes were separated from 
free DNA by native polyacrylamide gel electrophoresis. DNA from each fraction was purified, 
treated with NaOH, to cleave the alkali sensitive phosphotriester bonds, and the cleavage products 
fractionated on denaturing polyacrylamide gels. Cleavage at a particular phosphotriester is indicated 
by the presence of a corresponding band on the gel. Absence of a band from the bound fraction 
and its presence in the free fraction indicates that éthylation of the DNA backbone at this position 
blocks binding.
On the top strand it is evident that modification of any one of six contiguous phosphate groups, 
stretching from the phosphate 3' to base 245 to the phosphate 3' to base 240, can interfere with 
binding (Figure 5.8A). A similar situation is also apparent on the bottom strand where six contiguous 
phosphates, stretching from the phosphate 5' to base 236 to the phosphate 5' to 241, consistently 
interfere with binding (Figure 5.8B). Ethylation of phosphates 5' to bases 242 and 243 also leads to 
a reduction in binding but the effect observed is less pronounced and less reproducible. The
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Figure 5.8 Ethylated phosphotrlesters that Interfere with EBPI binding
A Bam HI to Eco RI fragment from pUC1X72, 3'-end labelled (A, top) or 5'-end labelled at the Bam HI 
site(B, bottom), was treated with ethylnitrosourea as described in “Materials and Methods”. Ethylated 
DNA was incubated with 10 pi affinity purified EBPI and free DNA (F) separated from EBP1-DNA 
complexes (B) in a native polyacrylamide gel. DNA was eluted and cleaved at phosphtriester bonds by 
treatment with NaOH. Reaction products were fractionated by electrophoresis in 6% denaturing 
polyacrylamide gels and cleavage products visualised by autoradiography. G+A (Pu) and C+T (Py) 
specific cleavage reactions of the labelled fragments were run in parallel as markers. Positions of 
modified phosphotriesters that interfere with binding are indicated by arrows.
C. DNA sequence of the region of the SV40 enhancer containing the EBPI binding site. Modified 
phosphate bonds within the bracket interfere with EBPI binding.
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strand specificity of the interfering ethylated phosphate groups (summarised in Figure 5.8C) is 
reminiscent of that observed for methylated bases which interfere with binding. On the top strand 
contacted phosphates are all located on the 3' side of purine bases which, when methylated, 
interfere with EBP1 binding.
5.7 Orthophenanthroline/copper (OP/Cu+) chemical nuclease “footprinting" of 
the EBPI binding site
To examine further the disposition of EBP1 on the DNA we have determined the susceptibility 
of backbone deoxyribose residues to attack by hydroxyl radicals generated by OP/Cu+ (Spassky 
and Sigman, 1985). The 1,10-phenanthrollne/ cuprous ion complex, together with 
mercaptopropionic acid as coreactant, nicks DNA in a reaction that requires the binding of the 
coordination complex to nucleic acid, it is thought that the OP/Cu+ ion binds in the minor groove of 
the DNA and generates a short-lived hydroxyl radical which can cause oxidative degradation of the 
deoxyribose ring. Since cleavage by OP/Cu+ produces predominantly 3'-phosphorylated and 
5'-phosphorylated ends, reaction products can be accurately calibrated using Maxam and Gilbert 
chemical sequencing reactions. Protein bound to a site on the DNA may protect against hydroxyl 
radical damage by blocking binding of OP/Cu+ in the minor groove, or by directly shielding the DNA 
from the hydroxyl radical.
Taking advantage of the stability of DNA-protein complexes in native polyacrylamide gels we 
combined either a 5'- or 3'- [32p]-iabeiled DNA fragment, containing an EBPI binding site, with 
purified EBPI. Once equilibrium had been reached free DNA and DNA-protein complexes were 
separated by electrophoresis in a native polyacrylamide gel. Free DNA and DNA-protein complexes 
within the gel matrix were treated with OP/Cu+ in situ (Kuwabara and Sigman, 1987) and the 
cleaved DNA purified and analysed by denaturing polyacrylamide gel electrophoresis (Figure 5.9). 
It is immediately apparent that a small region of the DNA on each strand is protected from attack by 
the hydroxyl radical. On the top strand the region of protection encompasses eight deoxyribose 
residues and extends from the deoxyribose attached to base 244, to the deoxyribose attached to 
base 237 (Figure 5.9A). A similar situation is apparent on the bottom strand with eight deoxyribose 
residues protected from cleavage, extending from the deoxyribose attached to base 238, to the
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Figure 5.9 1,10-orthophenanthrollne/copper cleavage of the SV40 enhancer In 
the presence of EBPI
A Bam HI to Eco RI fragment from pUC1 X72, 3'-end labelled (A, top) or S'-end labelled (B, bottom) at 
the Bam HI site, was incubated with 10 pi affinity purified EBPI and, after binding reactions had 
reached equilibrium, free DNA (F)was separated from EBP1-DNA complexes (B) by electrophoresis 
in a native polyacrylamide gel. Cleavage with OP/Cu+ was carried out within the acrylamide matrix and 
DNA eluted as described in “Materials and Methods”. DNA was fractionated by electrophoresis in 6% 
denaturing polyacrylamide gels and cleavage products visualised by autoradiography. G+A (Pu) 
specific reactions of the labelled fragments were electrophoresed in parallel as markers. Deoxyribose 
residues within the bracketed region are protected from cleavage by OP/Cu+.
C. DNA sequence of the region of the SV40 enhancer containing the EBPI binding site.
Deoxyribose residues within the bracketed region are protected from OP/Cu+ cleavage in the 
presence of EBPI.
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deoxyribose attached to base 244 (Figure 5.9B). A summary of the OP/Cu+ protection data is 
presented in Figure 5.9C. Hydroxyl radical footprinting, generated by an EDTA-Fe(ll) complex, 
which does not interact with the DNA (Tullius and Dombroski, 1986),was carried out in situ and 
gave very similar results to that observed with OP/Cu+ (data not shown).
5.8 Summary of contact point data
It has already been demonstrated using DMS chemical probing techniques that the pattern of 
contacts between EBPI and its binding site on the SV40 enhancer is typical of the patterns 
observed on the site present in the IRE and the two sites present on the HIV enhancer (Figure 5.7). 
In addition, the pattern of protection by EBPI on the IRE revealed by “footprinting” with hydroxyl 
radicals, generated by the OP/Cu+ complex (Figure 3.2B), Is identical to that seen in similar studies 
of EBPI on the SV40 enhancer (Figure 5.9). In view of this, results from the protection and 
interference data from the EBP1/SV40 enhancer interactions have been summarised In Figure 
5.10. Figure 5.1 OB represents a double helical projection of the contact point data. To gain an 
insight into the DNA surfaces that are contacted by EBPI, we have used computer graphics to 
display the data generated in the contact point analysis (Figure 5.11). What is evident from these 
studies is that within a 10 bp region every purine base interferes with EBPI binding when 
methylated and six phosphates on each strand interfere with binding when the attached oxygen 
groups are ethylated. The results suggest that EBPI makes sequence-specific contacts with the 
DNA over one complete turn of the double helix and has binding determinants in both the major and 
minor grooves.
In summary, a 57,000 molecular weight polypeptide, EBPI, was identified which bound to the 
“core” region of the SV40 enhancer. Analysis of DNA sequences required for specific EBPI 
binding distinguished this protein from a number of previously identified enhancer binding proteins. 
Multiple copies of the EBPI binding site could enhance transcription in vivo when inserted into an 
expression vector, in vivo transcriptional activity of wild type and mutant SV40 enhancers (Zenke et 
ai., 1986) correlated with EBPI binding. Mutations that abolish EBPI binding also have a severe 
deleterious effect on transcription, indicating that this protein may be important for SV40 enhancer 
activity.
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Figure 5.10 Summary of EBPi/DNA contact point analysis
A. Phosphodiester bonds within the large bracket are protected from cleavage with DNase I in the 
presence of EBP1. Deoxyribose residues within the smaller brackets are protected from cleavage 
with OP/CU+. Bold letters indicate that these bases interfere with EBPI binding when methylated. 
Filled squares indicate bases protected from méthylation while the open square indicates that this 
base was hypermethylated in the presence of EBPI. The shaded square indicates that this base was 
protected in the plasmid pUC1 X72 but not in pSVI. Open circles indicate the positions of 
phosphotriesters that interfere with EBPI binding.
B. Helical projection of the EBPI binding site. Modified bases {«) and phosphates (o) that interfere 
with binding are indicated, as are deoxyribose residues (*) that are protected from cleavage with 
OP/Cu+ in the presence of EBPI.
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Figure 5.11 Computer graphic analysis of the contacts between EBPI and its 
recognition site on the SV40 enhancer
A. Computer generated projection of the EBPI binding site. The van der Waal's radii of nitrogen 
atoms that interfere with binding are Indicated In blue while the modified phosphate groups that 
interfere with binding are indicated in red. The view in A Is rotated through 90®, 180® and 270® in B, 
0  and D respectively.
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Méthylation protection and alkylation interference studies Identified purine bases and 
backbone phosphate groups which participate in the formation of a specific EBP1/DNA complex. In 
addition, “footprinting" with hydroxyl radicals revealed deoxyribose residues in the binding site 
which are protected from cleavage by EBP1. This information was displayed using computer 
graphics and indicated that EBP1 made specific base and backbone contacts over one complete 
turn of the DNA double helix, supporting a model in which the protein makes sequence-specific 
contacts in the major groove, although binding may also be influenced by interactions in the minor 
groove.
Competition and contact point analyses revealed that EBP1 bound similarly to sites present in 
several other viral and cellular enhancers including those present in the IRE and HIV enhancer. 
Mutational analysis of EBP1 binding sites identified base pairs important for specific EBP1/DNA 
complex formation. All high affinity binding sites contained the sequence 5'-GG{N)6CC-3'. 
Although single base pair changes in the region between the conserved Gs and Os can generally 
be tolerated, it is clear that the central six base pairs contribute to binding affinity. Mutations in the 
recognition site which could lead to gross structural changes in the DNA abolish EPB1 binding.
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DISCUSSION
Onf\
In this study, the identification, purification and characterisation of^/ 57,000 molecular weight 
HeLa cell nuclear protein, EBP1, and its interactions with DNA are described. A considerable body 
of evidence suggests that this protein, which binds to the enhancer “core" region of SV40 and to 
similar sequences present in a variety of viral and cellular enhancers. Is involved in transcriptional 
activation.
1. The binding of EBP1 to the SV40 Enhancer and Its Role as a Transcriptional 
Activator
EBP1 was detected in nuclear extracts from HeLa cells in gel electrophoresis DNA binding 
assays (Figure 1.3B) and the region of the enhancer bound by the protein was estimated, from 
DNase I protection data, to extend from position 230 to position 250 on the SV40 genome (Figure 
1.5). This region includes the GT-l motif and spans the "core" sequence (5-GTGG A/T A/T A/T G-3') 
identified by comparison of DNA sequences from a number of different enhancers (Laimins et. a/., 
1982; Weiher et. al., 1983). However, this sequence alone does not constitute the binding site for 
EBPI since the SV2 double stranded oligonucleotide, which spans the GT-II motif and also 
contains the "core” sequence, fails to compete for EBPI binding ( Figures 1.3B and 1.5). While 
this sequence is clearly an important component in the recognition event, mutation of the G's at 
positions 244 and 245 abolishes binding (Figures 1.5; 2.5; 3.1; 4.1), additional sequences are 
required to constitute a functional binding site for EBPI. These additional sequences are identified 
by the mutations in the SV1.M3 oligonucleotide; C's at positions 237 and 238 are changed to G's 
with the result that the double stranded oligonucleotide can no longer be bound by EBP1 (Figures 
3.1; 4.1).
The extension of the binding site past the GT-l motif and into the TC-II motif differentiates this 
factor from a number of previously identified proteins which bind to the SV40 enhancer (Barrett et. 
a!., 1987; Johnson et. a!., 1987; Xiao et a!., 1987a). Purification of the transcription factors, AP-2 
and AP-3 from HeLa cells, which bind close to this region have recently been described (Imagawa 
et a!., 1987; Mitchell et. a/.,1987). However,EBPI can be distinguished from both these factors by 
virtue of the abilities of the different proteins to bind to mutated SV40 templates. The plasmid pA12
132
(Figure 2M) contains a mutated SV40 enhancer element in which the sequence 5'~TGG-3' 
(nucleotides 246-244) is altered to 5'-GTT-3' (Zenke et al., 1986). AP-2 binds normally to this 
fragment (Mitchell et al., 1987) whereas EBPI binding is abolished (Figure 4.3), indicating that 
EBPI and AP-2 have distinct recognition sites. EBPI binding is also abolished by the mutation 
present in pA15 (Figure 4.3), in which 5'-CCC-3' (nucleotides 237-235) is altered to 5'-AAA-3' 
(Zenke et al., 1986), whereas AP-3 binds normally to this template (Mitchell et al., 1987), thus 
distinguishing EBPI from AP-3.
The SV40 enhancer contains a number of DNA sequence motifs (Figure 1.1) that can be 
bound by a variety of trans- acting factors, and whose integrity is crucial for full enhancer activity 
(Zenke et ah, 1986; Herr and Clarke, 1986; Schirm eta l, 1987; Davidson et ai, 1986; Fromental et 
a i, 1988). Multiple tandem copies of the “core” enhancer sequence can function in a cell 
type-specific manner to activate transcription of a linked gene (Ondek et ai, 1987; Schirm et ai, 
1987). To ascertain whether or not the DNA sequences in the “core" region of the SV40 enhancer, 
which bound EBPI, play a role in transcriptional activation, the double stranded SV1 
oligonucleotide, present as 1, 2 or 3 copies, was introduced Into an expression vector and the 
effects of these sequences on transient gene expression in HeLa cells determined. Results of 
these studies (Figure 1.6) showed quite clearly that multimerisation of this sequence led to an 
increase in transcriptional activation demonstrating that the sequences which constitute the EBPI 
binding site on the SV40 enhancer can indeed function to activate transcription in vivo.
A role for EBP1 in transcriptional activation of the SV40 genome is also suggested by 
correlating the in vivo activity of wild type and mutated enhancers with EBPI binding in vitro. As 
previously demonstrated, tandemly ligated copies of an oligonucleotide containing the EBP1 
binding site can function to activate transcription when inserted into an appropriate expression 
vector (Ondek et ai, 1987 ; this study Figure 1.6). Mutation of the two G's at positions 244 and 245 
in the EBPI binding site abolished the enhancer activity of the ligated oligonucleotides (Ondek et 
ai, 1987) and also abolished binding of EBPI (Figures 1.5; 2.5; 3.1; 4.1). Nomiyama et ai (1987) 
have examined the activity of the pA series of triple point mutants in the SV40 enhancer (Zenke et 
ai, 1986) in a variety of cell types and correlated the activity of the various enhancer motifs with the 
presence of trans -acting factors. One cell type-specific protein, GT-IC (probably equivalent to
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AP-3), present in HeLa but not MCPil cells, binds to the GT-l motif in the SV40 enhancer (Xiao etaL, 
1987a). An additional cell type-specific protein TC-IIA and a ubiquitous protein TL-IIB are reported 
to bind to the TC-II motif (Nomiyama et a/., 1987). TC-IIA and TC-IIB appear to have very similar 
recognition sites to that of EBPI^ The mutation present in pA12 (described above) abolishes 
binding of all of these proteins and dramatically reduces transcription in all of the cell lines tested so 
far (Nomiyama etal., 1987). Mutations in the GT-l motif (pAIO and pA II), which eliminate GT-IC 
binding but which have no effect on the binding of TC-IIA, TC-IIB or EBPI (Figure 4.3), have no 
effect in MCPII cells where GT-IC is absent. In HeLa cells mutations pAIO and pAII have only a 
minimal effect on enhancer activity whereas mutation pA15, which abolishes binding of TC-IIA, 
TC-IIB and EBPI reduces transcription, in vivo, to 40-50% of wild type (Figure 1D). Since binding of 
GT-IC (AP-3) and EBP1 (TC-IIB) is eliminated by pA12, it suggests that in HeLa cells these proteins 
may compete for the same binding site. The minimal effect of mutations pA10 and pAi 1 in HeLa 
cells suggests that EBPI (TC-IIB) is bound preferentially to the template as opposed to GT-IC. 
Elimination of EBPI (TC-IIB) binding by mutant pA15 permits binding of GT-IC (AP-3) which also 
appears to stimulate transcription since a template which contains both the pA10 and pA15 
mutations gives only 5% enhancer activity in HeLa cells (Nomiyama etal., 1987). These data are 
summarised in Figure 1D, which shows the disposition on the SV40 enhancer of the transcription 
factors AP-2, AP-3 (Mitchell et. al., 1987) and EBPI.
The binding site for EBPI quite clearly overlaps the binding sites for both AP-2 and AP-3, as 
discussed above, and binding of EBPI may exclude binding of these transcription factors or vise 
versa . This poses the question of which proteins are bound to the enhancer in vivo in cell types 
other than HeLa. Answering this question is important since it has been shown that the regions 
bound by AP-3 and EBPI can act to mediate the transcriptional response to phorbol esters (Chiu 
et. al., 1987). Thus the multimerised C element described by Ondek et al. (1987), which is 
equivalent to the SV1 oligonucleotide used in this study, can act as a phorbol ester responsive 
element (Chiu et al., 1987). In addition, mutation of the two G's at positions 244 and 245 destroys 
the ability of the multimerised oligonucleotides to act as a phorbol ester inducible element (Chiu et 
al., 1987) and, as we have shown here, abolishes the ability of EBPI to recognize its binding site 
(Figures 1.5; 2.5; 3.1 ; 4.1). Correlation between the in vivo transcriptional activity of wild type and
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Figure 1.D Disposition of transcription factors AP-2, AP-3 and EBP1 on the SV40 
enhancer
The DNase I "footprint" boundaries for AP-2 and AP-3 on the SV40 enhancer DNA sequence are 
from Mitchell e ta l. (1987) and EBPI from this study. It should however be stressed that these 
boundaries probably represent an over estimate of the region occupied by the DNA binding 
proteins, since DNase I is a relatively large molecule and requires an extended binding surface for 
DNA cleavage (Suck et a!., 1988). The effect of mutations in this region on transcription in vivo are 
from Zenke e ta l.. 1986. Altered bases in the mutated SV1 oligonucleotides SV1.M1 and SV1.M3, 
that abolish EBPI binding, are underlined.
mutant enhancers with EBP1 binding in vitro, indicates that this protein may be important for SV40 
enhancer activity since mutations that abolish EBP1 binding also have a severe deleterious effect 
on transcription in vivo (Zenke etal., 1986).
The human 8-interferon gene regulatory element (IRE) (Goodbourn etal., 1985) consists of 
two genetically separable positive regulatory domains, PRDI and PRDII, both of which are required 
for maximal induction by virus or poly(l).poly(C), and a negative control region, NRDI, which overlaps 
PRDII (Goodbourn and f^aniatis, 1988). Interactions between the regulatory domains were 
investigated by analysing the effects of the IRE single base pair mutations on the expression of the 
8-Interferon gene (Goodbourn and Manlatis, 1988). Single point mutations in PRDII have the 
potential to affect binding of both negative and positive effectors such that the resulting 
phenotypes may be rather complex. PRDII was Identified as being crucial for Induction of 
8-interferon expression since mutations at positions -64 to -55 inclusive are all defective in their 
ability to respond to agents which activate 8-interferon transcription. This effect has been ascribed 
to the inability of a positive transcription factor to interact with mutant PRDils. EBPI binds to a 
region within PRDii which shows strong sequence similarity to the EBPI site on the SV40 enhancer 
(Figures 3.1; 4.2). Examination of the IRE point mutants which alter the conserved guanine and 
cytosine blocks in the EBP1 binding site, that is -64A, -63A, -56T and -55T, reveals that these 
mutations reduce EBPI binding to almost undetectable levels (Figure 4.2). in addition, the -64A 
and -56T mutations reduce induced transcription levels to virtually zero, whilst -63A and -55T 
mutations reduce transcription to approximately half that of wild type levels (Goodbourn and 
Manlatis, 1988). Mutant -61G, which increases EBPI binding to higher than wild type levels, shows 
an almost two-fold increase in relative transcription level after induction, whereas mutation -62A, 
which abolishes EBPI binding and becomes hypermethylated at high concentrations of EBPI, 
demonstrates a 50% reduction in induced transcription levels, it would therefore appear that 
mutations in PRDii of the IRE which Increase or decrease EBPI binding, show a corresponding 
increase or decrease in the relative transcriptional induction of 8-interferon mRNA lending support 
to the idea that EBPI does indeed function as a transcriptional activator In vivo.
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2. Nucleotide Sequence Requirements for Specific EBPI/DN A Complex 
Formation
To determine the DNA sequences required for specific EBPI binding, a detailed mutational 
analysis of the EBP1 binding sites in the IRE and SV40 enhancer has identified the nucleotide 
requirements necessary for specific EBP1/DNA complex formation. More that thirty DNA 
sequences related to the binding site for EBP1, including those present in the mouse Ig kappa light 
chain gene enhancer, mouse class 1 H2 major histocompatibility gene enhancer, HIV enhancer, 
IRE, SV40 enhancer and mutated derivatives thereof, were analysed for their ability to bind EBPI. 
A common feature in all the DNA sequences which bind EBP1 is that they possess the 10 bp 
sequence 5*-GG{N)6CC-3', within which every purine base interferes with EBP1 binding when 
methylated. Single base pair changes, as revealed in studies using mutant IRE templates (Figure 
4.2), between the conserved Gs and Os can generally be tolerated (Table 4.1), although it is clear 
that these bases contribute to binding affinity. This is exemplified at position -61 in the IRE where 
an A to T change reduces binding, but an A to G change increases binding.
Mutational analysis also reveals that alteration in the spacing between the conserved Gs at 
positions 1 and 2, and the conserved Cs at positions 9 and 10 (Figure 3.1 ; Table 4.1) abolish EBPI 
binding. The SV1 .M3 double stranded oligonucleotide alters this spacing to 7 bp, whilst the -64A 
IRE mutant alters it to 5 bp.; both of these are unable to bind EBPI (Figures 4.1 ; 4.2). Furthermore, 
binding studies revealed that mutants pA II and 16, which lie on the boundary of the SV40 EBPI 
recognition site have only a slight effect on EBPI binding (Figure 4.3) whereas mutations pA12, 
13,14 and 15, which lie within the recognition site, and also span the 10 bp region which, when 
methylated, interferes with EBPI binding (Figure 5.3), reduce binding by at least an order of 
magnitude (Figure 3.1). That no changes are tolerated within the EBPI recognition site in this 
instance may be due to the inability of the DNA to accommodate the gross structural changes which 
may arise as a result of the triple point mutations.
The importance of DNA structure in directing high affinity EBPI binding is suggested by the 
effect of mutations at -62, in which a G to A alteration abolishes EBPI binding. This was somewhat 
unexpected since an adenine is permitted at this position in the EBPI binding site in the SV40 
enhancer (Figures 1.5; 2.5). The -62A mutant creates a situation whereby four consecutive
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adenine residues are present in the binding site. The unusual structural features of an 
oligo(dA).oilgo{dT) tract and its biological implications have been described by Nelson etal., (1987). 
Their studies revealed that these sequences have an unusually high propeller twist of the bases 
along their longitudinal axis with a consequent narrowing of the minor groove. This in turn causes 
the major groove side of each base to point towards the 3'-end of its strand, thereby facilitating the 
formation of three-centred bifurcated hydrogen bonds. The inability of the -62A DNA template to 
bind EBPI may therefore be due to structural changes in the DNA in the region of the four 
consecutive adenine residues.
3. Contact Point Analysis of the EBPI Binding Site
The area of the SV40 enhancer occupied by affinity purified EBPI was estimated from the 
DNase i protection data (Figures 2.5; 5.1). Although 19 bp on each strand are protected from 
DNase i cleavage, the area occupied by EBPI is probably much smaller since DNase I has an 
extended DNA binding surface with 6 bp on the 5' side and 2 bp on the 3' side of the cutting site 
being occupied by the enzyme (Suck et al., 1988). This would indicate that EBPI occupies the 
DNA between bases 248 and 236 on the top strand and 235 (or 238) and 247 on the bottom 
strand.
Within the region occupied by EBPI a total of 8 deoxyribose moietïeson each strand^are 
protected from hydroxyl radical attack (produced by OP-CLI+) in the presence of EBPI. 
Comparison of the region of the DNA occupied by EBPI (as predicted from DNase I cleavage 
patterns and the structure of DNase i) with that protected from cleavage with OP-Cu+ indicates that 
the two are not symmetrically disposed (Figure 5.9). Neither is the OP-Cu+ "footprint" symmetrically 
arranged with respect to the G residues 236 and 237, and , 244 and 245 which are protected from 
DMS méthylation (Figure 5.2). Furthermore, EBP1 does not protect the sugar residues attached to 
G236, 237 and 245 from hydroxyl radical attack (Figure 5.9). Thus, even although EBPI Is 
interacting with bases in the major groove, the DNA backbone is still susceptible to attack by 
hydroxyl radicals generated by OP-Cu+, probably located in the minor groove.
On the top strand, the 5' boundary of the OP-Cu+ "footprint" coincides with the 5' boundary of 
the phosphate groups that interfere with binding when the attached oxygen atoms are ethylated
137
(Figure 5.8). However, at the 5' boundary of the binding site on the bottom strand, the situation is 
quite different. Modification of phosphate groups on the 3' side of bases 235 and 236 interferes 
with binding but the adjacent deoxyribose residues are not protected by EBP1 from hydroxyl radical 
attack. These data stress the asymmetry of the EBP1-DNA Interaction and suggest that, particuiariy 
at the 5' boundaries of the binding site, EBP1 makes contacts with the phosphate oxygens without 
completely covering the DNA backbone. On each strand six phosphate groups reproducibiy 
interfere with binding indicating that EBP1 makes backbone contacts on the SV40 enhancer over 
one complete turn of the DNA double helix.
The case for EBP1 making extensive major groove interactions is provided by the DMS 
protection data which indicate that on G residues 236, 237, 240, 244 and 245, the N-7 groups on 
the purine ring are protected from methyiation (Figure 5.2). In B-DNA these N-7 groups project into 
the major groove and protection of these groups from DMS modification implies that at these 
positions EBP1 makes ciose contact with the DNA. Guanine 235 has an interesting effect on the 
pattern of DMS modification. This residue is not required for EBP1 binding in that the piasmid 
pSV1, which has a C at this position, is bound by EBP1 with a similar affinity as that of the complete 
SV40 enhancer (Figure 3.1). in the presence of EBP1 the DMS modification rate of G235 is greatly 
increased. However, when G235 is present, G238, which is not protected in pSVI, is protected 
from DMS modification by EBPI (Figure 5.2). The increased rate of G235 méthylation could be 
explained by an increase in N-7 nucleophiiicity caused by bound EBPI. Alternatively, EBPI could 
create a hydrophobic pocket ciose to the recognition site resulting in a local increase in DMS 
concentration. A high local concentration of DMS near residue 235 may be accompanied by a 
correspondingly reduced DMS concentration near residue 238. it is worth noting that G235 is 
predicted, from DNase i protection data, to lie precisely on the boundary of the region occupied by 
EBPI (Figure 5.10).
Ail G residues which are protected from DMS modification also interfere with EBPI binding 
when methylated, in addition, methyiation of A residues 239, 241, 242 and 243 abolishes EBPI 
binding. Modification of A residues by DMS results in the addition of a methyl group at the N-3 
position. Since N-3 of adenine projects into the minor groove a straightforward interpretation of 
these results is that EBPI makes base-specific contacts in the minor groove, it should however be
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stressed that modification of the purine ring by DMS results in the addition of a positive charge to 
the ring which could have profound effects on specific DNA binding, quite distinct from the steric 
effects of introducing a bulky methyl group at the N-3 position, in particular, it has been shown that 
sequence-specific recognition of the operator sequence by the 434 bacteriophage repressor takes 
place by the formation of H-bonds between amino acid side chains and H-bond donors and 
acceptors arrayed along the edge of the bases that project into the major groove (Anderson et ai, 
1985). One of the potential H-bond acceptors is the imidazole nitrogen at position 7 of the purine 
ring. The effect of introducing a positive charge into the purine ring would be to withdraw electrons 
from this nitrogen thus reducing its ability to act as a hydrogen bond acceptor. Consequently the 
effect of N-3 methyiation on EBPI binding may be as a result of the inability of EBPI to make 
base-specific hydrogen bonds in the major groove and not of disruption of minor groove contacts, 
indeed a number of observations suggest that the latter alternative is more likely. Examination of 
the binding of EBP1 to a variety of related sequences has shown that EBPI binds with high affinity 
to sites that have guanine to adenine substitutions at positions 242 and 243(Tabie 4.1). 
Methyiation of these substituted G residues also blocks EBPI binding (Figure 5.3) suggesting 
sequence-specific contacts in the major groove.
To gain an insight into the DNA surfaces in the SV40 enhancer that are contacted by EBPI 
computer graphics were employed to display data generated by the contact point analysis (Figure 
5.11 ). What is apparent is that EBP1 makes contacts with each base pair over one complete turn of 
the DNA helix. Guanine residues 236 and 237, on the bottom strand, and 244 and 245 on the top 
strand, which are one turn of the helix apart, are crucial for EBP1 binding since their mutation 
reduces EBPI binding to undetectable levels. Phosphate backbone contacts made by EBPI also 
span one turn of the DNA helix which is unlike the pattern of contacts made by proteins which 
contain the well documented "helix-turn-heiix" motif exemplified by the bacteriophage 434 
repressor (Anderson et ai., 1985). EBPI binding is not reduced by exposure of the protein to 
chelating agents such as EDTA (10mM) and 1,10-orthophenanthroline (lOmM) and the pattern of 
contacts is unlike that made by "zinc finger" proteins such as TFIilA (Bogenhagen et al., 1980; Fairall 
et al., 1986). The observed contacts for EBPI are also arranged differently from other well 
characterised eukaryotic DNA binding proteins such as SV40 large T antigen (Jones and Tjian,
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1984), Drosophila heat shock transcription factor (Shuey and Parker, 1986) and human nuclear 
factor I (de Vries et ai., 1987).
EBP1 binds to sequences in the PRDii region of the human 6-interferon gene regulatory 
element (IRE). This study demonstrates, using nuclease protection, chemical probing techniques 
and mutational analysis, that EBPI binds to its sites in the IRE and SV40 enhancer In a very similar
manner. DNase 1 protection studies show that EBPI occupies a region of 19 bp on each strand of
ûL-ihe. b Ml\-bacici:>oyvpthe IRE and that, within this region, a total of eight deoxyribose rnmefi es on each strand^are 
protected from hydroxyl radical attack (generated by OP/Cu+) in the presence of EBPI (Figure 3.2).
EBPI protects guanine residues -64, -63, -56 and -55 in the IRE from methyiation by DMS 
(Figure 5.6) which suggests protein contacts in the major groove. All guanine residues which are 
protected from DMS modification also interfere with EBP1 binding when methylated. A total of 10 
purine bases within the 10 bp from -55 to -64 of the IRE interfere with EBPI binding when 
methylated. On the top strand the six consecutive purine bases -59, -60 and -61 A, and -62, -63 ands’
-64G all interfere with binding when methylated (Figure 5.6B). A similar situation is apparent on the 
bottom strand where the four consecutive purine bases -55 and -56G, and -57 and -58A also 
interfere with binding when methylated (Figure 5.6B).
Two EBPI binding sites are present in the HIV enhancer and DNase I "footprinting" has 
revealed that both these sites are protected from cleavage in the presence of EBPI (Figure 3.3).
Guanine residues -88, -89, -102 and -103 on the top strand (Figure 5.4A), and -80, -81, -85, -94,
-95 and -99 on the bottom strand (Figure 5.4B) are protected from DMS methyiation in the presence 
of EBP1. These residues include the conserved guanines shown to be essential components of 
the EBPI recognition site (Table 4.1; Figure 3.1). in addition, adenine residues at positions -82,
-86, -90 and -104, guanine at position -86, and cytosine at position -85 show increased reactivity to 
DMS methyiation in the presence of EBPI. This pattern of hypermethylated bases is somewhat 
unusual in that modified DNA due to adenine methyiation is not generally cleavable by the action of 
piperidine. An explanation of this observation is that methyiation probably occurs at a site other than 
N-3 of the purine ring, such as N-7. Alternatively perturbation of the DNA structure in this region 
may be responsible for the observed effects since it is known that DMS Methyiation of cytosine 
residues occurs at the imidazole N-3 in the pyrimidine ring directly involved in H-bonding to its
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complement on the DNA. Accessibility of this base to DMS methyiation therefore implies that either 
the DNA in this region was single stranded (see Boroweic and Hurwitz, 1988), or that the DNA was 
quite dramatically distorted. The pronounced increase in reactivity towards DMS shown by guanine 
at position -90 could also stem from perturbation of the DNA in this region since this residue lies 
between the two EBPI binding sites on the HiV enhancer.
it Is apparent from the pattern of contacts resulting from DMS chemical probing studies that 
EBP1 binds similarly to different viral and cellular enhancers. In each case a similar pattern of 
protection is observed within the 10 bp recognition sequence is preserved in that guanines at 
positions 1 and 2 are protected from DMS methyiation, as are the guanines at positions 9 and 10 on 
the opposite strand, in addition, the highly strand-specific pattern of purine bases which interfere 
with EBPI binding is evident in each case. Taken together, the methyiation protection and 
interference data indicates that EBPI binds homologously to its sites in the SV40 enhancer, IRE 
and HiV enhancer and in each case makes sequence-specific contacts over one complete turn of 
the DNA double helix.
4. The “Identity” of EBP1
The binding site for EBPI is similar to that described for the inducible factor NF-kB (Sen and 
Baltimore, 1986a,b) and the apparently ubiquitous factor H2TFI or KBFi (Baldwin and Sharp, 1987; 
1988; Israel et al, 1987; Yano etal., 1987). These proteins may constitute a family of related, but 
distinguishable, proteins which recognize similar DNA sequences. Synthetic oligonucleotides 
containing the NF-kB and H2TFI binding sites compete for EBPI binding with similar efficiency to 
the SVI oligonucleotide (Figure 3.1). However, EBPI can be distinguished from NF-kB and 
H2TFI/KBFI by a number of criteria. NF-kB binds to a site in the ig kappa light chain enhancer (Sen 
and Baltimore, 1986a) but, unlike EBPI which is constitutiveiy produced in HeLa cells, NF-kB 
binding activity is normally restricted to B ceils and its activity is only apparent in other cell types after 
stimulation with agents such as bacterial lipopolysaccharide and phorbol esters. This induction of 
NF-kB binding activity is evident even when the stimulation is carried out in the presence of 
inhibitors of protein synthesis. It therefore appears that prior to induction NF-kB exists in the cell in 
an inactive form that is converted to an active form by an as yet undefined post-translational
141
modification (Sen and Baltimore, 1986b). Preliminary data has shown that NF-kB, induced in mouse 
B cells, binds to the SV1 oligonucleotide, but the DNA-protein complex formed has an increased 
electrophoretic mobility when compared to the EBP1/SV1 complex (data not shown).
The distinguishing features of H2TFI/KBFI are its high affinity for the sequence 
-TGGGGATTCCCCA- which Is found in the enhancers of the mouse H-2 and B2-mircoglobuIin
-ACCCCTAAGGGGT-
genes, and its unique pattern of méthylation interference (Baldwin and Sharp, 1988; Israel et ai, 
1987). As mentioned previously, EBP1 binds the SV1 and H2TF1/KBFI sequences with equal 
affinities whereas H2TFI/KBF1 binds the sequence indicated above with a 20-fold higher efficiency 
(Baldwin and Sharp, 1988). Méthylation interference experiments with H2TFI/KBFI indicate that all 
of the G’s in the sequence interfere with binding when methylated (Baldwin and Sharp, 1988; Israel 
et ai, 1987). This is in contrast to the pattern obtained on the SV40 enhancer and EBP1, where the 
outermost G's In the sequence do not interfere with binding when modified (Figure 5.6). An 
attractive explanation of these differences is that EBP1, NF-kB and H2TFI/KBF1 represent the 
different modified forms of the same DMA binding protein.
Both the interleukin-2 receptor alpha (IL-2Fbi) gene and the long terminal repeat (LTR) of HIV-1 
can be activated by various T-cell mitogens, including PMA, PHA and the tax gene product of 
HTLV-1 (Nabel and Baltimore, 1987; Kaufman et ai, 1987). The HIV-I enhancer has been shown to 
interact with an inducible factor indistinguishable from NF-kB (Nabel and Baltimore, 1987). The 
binding of NF-kB to the tax responsive sequences in IL-2Roi suggest that NF-kB (or a protein with a 
similar DNA recognition sequence, such as EBP1) is involved in the tax- mediated trans- activation 
pathway. Bohnlein et al (1988) have investigated the trans- acting factor(s) and cis- acting 
sequences that regulate mitogen induclbility of the IL-2Ro  ^promoter and the potential interplay of 
the same factors with the HIV-1 LTR. They were able to demonstrate the binding of an NF-kB-like 
inducible factor to the sites in the HIV-I enhancer which bind EBP1 (Figure 3.3). These sites bear 
marked homology to a region in the IL-2RoC promoter. In addition, they could show that the 
inducible, host cell encoded, HIVEN86A protein could associate specifically with these sites in the 
lL-2RoLpromoter and HIV-i enhancer. Isolation of the IL-2Ro^Dromoter binding site , or single copies 
of the individual HIV-1 sites, were sufficient to impart mitogen induclbility to an unresponsive 
heterologous promoter. This suggests that the normal action of an inducible nuclear DNA binding
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protein(s) involved in the regulation of IL-2R<sC gene expression can be subverted by the HIV-1 
provirus to facilitate activation of retroviral gene transcription. This emphasises the important 
interplay of host cell factors, like NF-kB and probably EBP1, with this retrovirus In the regulation of 
latent versus lytic viral infection.
Kawakami and coworkers (1988) have demonstrated that purified NF-kB stimulates transcription 
from the HIV-1 promoter in HeLa cell extracts and that this stimulation is specific for templates 
containing NF-kB sites. However, their studies also showed that affinity purified NF-kB bound only 
to the distal site in the HlV-1 enhancer and suggest that this may reflect a steric problem due to the 
close proximity of the binding sites. Affinity purified EBP1, on the other hand, binds with high 
affinity to both these sites on the HIV-1 enhancer (Figure 3.3). Since the distal site can be occupied 
by NF-kB, the proximal site could, in principal, be occupied by a common cellular factor, such as 
EBP1 or H2TF1/KBF1, or by NF-kB itself. Binding and functional studies using the various purified 
factors will clearly be required to resolve the mechanisms involved in HIV-1 promoter activation.
Although we have no direct evidence for post-translational modification of EBP1, this 
phenomenon may account for the observation that two distinct DNA-protein complexes can be 
detected at early stages of purification (Figure 2.1). Both complexes have the same DNA-binding 
specificity and are cross-linked to polypeptides of identical molecular weight (Figure 2.4). After 
affinity purification however only the more slowly migrating complex is detected Figure 2.2). This 
may result from instability of the factor responsible for formation of the faster migrating DNA-protein 
complex, modification of the factor during extraction and purification or removal of associated factors 
during purification. An apparent "activation" of binding activity in vitro, by proteolytic cleavage, has 
also been demonstrated (Figure 2.6). An explanation for this observation could be that the increase 
in binding activity results merely in the release of active EBP1 that is otherwise trapped in 
aggregates. Both elastase and protease XIV remove the aggregates present at the top of the gel, 
but only protease XIV stimulates binding of EBP1 to the double stranded SV1 oligonucleotide 
indicating that the specificity of the proteolytic cleavage is important for the effects observed above. 
Whether proteolytic cleavage of EBP1 represents a post-translational modification of relevance in 
vivo remains to be determined.
The activation of DNA binding activity of what appears to be a cytoplasmic precursor of NF-kB
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has recently been reported (Baeuerle and Baltimore, 1988). Dissociating agents were used to 
effect this activation which resulted in the appearance of as much cytosolic NF-kB in unstimulated 
pre-B cells as is found in the nucleus when the same cells are activated with phorboi ester. The 
activation of specific DNA binding could be due to covalent modification of NF-kB, a conformational 
change in the protein, or by the release of an inhibitor which prevents specific binding to DNA. 
They suggest that the activation of binding activity is attributable to the release of an inhibitor, 
present in the cytosol, which blocks translocation of NF-kB to the nucleus and subsequent binding 
to its cognate site on the DNA. An attractive interpretation in vivo of these effects might be that 
protein kinase C, by phosphorylating the inhibitor (or another factor that can inactivate the inhibitor) 
would have the same effect as the denaturing agents in vitro. The data of Baeuerle and Baltimore 
(1988) help to explain how NF-kB is induced in immature B cells, Hela cells and other cells (such as T 
cells) but does not explain how B cells constitutively express NF-kB in an active state -  this requires 
further investigation.
EBP1, NF-kB and H2TF1/KBF1 may represent different modified forms of the same DNA 
binding protein which contains a conserved DNA binding domain, isolation and expression of 
cDNAs corresponding to each of these proteins, as well as a quantitative evaluation of their binding 
to the different templates, will be required to establish the relationship between this family of 
proteins which appear to recognise the same DNA sequence. The recent cloning of the gene 
coding for the DNA binding domain of a protein which binds to the NF-kB and H2TFI recognition 
sequences lends support to this idea (Singh et ai., 1988),
5. Models for enhancer-mediated transcriptional activation
The ability of the individual sequence modules of enhancer elements to bind different transcription 
factors yet activate transcription in essentially the same way, suggest that these trans- acting factors 
exert their effects via a common mechanism. Of central importance in the scheme of enhancer 
action is the observation from the laboratories of Schaffner (Weber and Schaffner, 1985) and 
Maniatis (Treisman and Maniatis, 1985) that enhancers function by increasing the RNA polymerase 
density over a linked gene, i.e., they increase the rate of transcription.
In the first of these models, the polymerase entry site, or scanning model, the enhancer has a
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very high affinity for RNA polymerase II. The polymerase binds to enhancer sequences and slides, 
in either direction, aiong the DNA, until it reaches promoter initiation signals where it begins to 
transcribe RNA (Moreau et al., 1981). Additional support for this model came from the experiments 
of Brent and Ptashne (1984) in which the lexA repressor DNA binding site was inserted between 
the promoter and UAS of a yeast B-galactosidase expression vector. This construct was introduced 
into yeast ceils, together with a lexA expression vector, which resulted in reduction of 
B-galactosidase activity. The same result was obtained when the lexA operator was replaced by a 
transcription termination signal. These results were interpreted as being due to RNA polymerase II 
binding at the UAS and sliding along the DNA to the promoter unless prevented from doing so by 
operator-bound lexA or a transcription terminator. Support for this model also comes from the 
observation that enhancers and tandem promoters in mammalian cells preferentially activate 
proximal promoters (reviewed by Muiler et a!., 1988). Certain mechanistic problems, however could 
arise from this type of model. In particular, on activation from a 3' position, collisions would be 
expected between the sliding polymerase and polymerase actually involved in active transcription. 
Even so, in vitro experiments have demonstrated that a prokaryotic RNA polymerase can transcribe 
through a 5S RNA gene, displacing neither the specific 5S RNA transcription complex, nor the 
nucleosome cores (reviewed by Muller et ai., 1988). In this way it is feasible that two polymerases 
could pass each other without releasing from the DNA. (It should be stressed however, that this is 
still a highly controversial area since it is not known what actually controls the directionality of sliding, 
it is probably not the enhancer region since this can be moved 5' or 3' of the gene and maintained in 
the same orientation, resulting in an enhancer effect.)
The second model for enhancer action, and the more favourable of the two, is the looping 
model in which a remote enhancer and a promoter interact with one another via proteins bound to 
the DNA (Figure 2D). In prokaryotic systems, such DNA loops have been extensively investigated 
(reviewed by Ptashne, 1986c). There exists in prokaryotes examples of gene regulation by 
repressor binding sites on the same face of the DNA double helix. This effect is highly sensitive to 
the length of intervening DNA in that insertion of even one half turn of the helix can virtually abolish 
cooperativity (Dunn et ai., 1984). Hochschild and Ptashne (1986) examined cooperativity between 
two binding sites for lambda repressor and found that a variable number of full helical turns of the
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Figure 2D. Looping model of enhancer mechanism
A. A remote enhancer with a single binding site for a transcription factor cannot easily form a 
functional transcription complex, nor are there sufficient factors present in the promoter region to 
allow high transcriptional activity.
B. A larger number of factor binding sites are present in the enhancer which facilitates formation of 
a functional complex via protein-protein contacts (including the TATA box binding factor and RNA 
polymerase II) which leads to initiation of transcription. (Muller etal., 1988).
DNA were required for cooperativity, but not if the binding sites were positioned on opposite sides 
of the helix. Indeed, the proposed Intervening looped out structure resulting from protein-protein 
interactions has been visualised by electron microscopy (Griffith etal., 1986). Whether this looping 
model for enhancer-promoter interaction actually exists remains to be determined but preliminary 
data on loop formation induced by the progesterone receptor lends some support to the idea 
(reviewed by Muller etal, 1988).
Whether or not insertion of half helical turns into intervening DNA as a rule affects the activity of 
eukaryotic promoter-enhancer interactions is not clear, neither is the problem of long-range 
enhancer-promoter interactions since half helical turns often have little or no effect on eukaryotic 
transcriptional activity. This difference between prokaryotic and eukaryotic promoters could be 
attributable to the nature of the DNA binding proteins themselves, e.g., in eukaryotes it is feasible 
that two disinct domains on the transcription factor could be connected by long, flexible arms. 
Nevertheless, the looping model accommodates a method of activation over large distances and 
the orientation independence of enhancers, as does the preferential transcription of 
enhancer-proximal promoters versus distal promoters. There is no evidence to suggest that EBP1 
acts via looping but the plethora of factors which have the ability to bind to the SV40 enhancer 
suggest that protein-protein interactions probably play a major role in transcription activation and 
one could easily envisage a situation whereby distantly bound proteins could interact with each 
other. In addition, it has been shown that EBP1 has a distinct, cleavable DNA binding domain 
(Figure ). It is therefore possible that a component of the protein not involved In binding to DNA 
could be some sort of activation domain involved in direct binding to other proteins possibly via a 
negatively charged region (for review see Sigler, 1988). Transcription factor Spl has a region of the 
protein not associated with binding to DNA . This region has a very high glutamine content (Jones 
et al, 1987) and it is feasible that these residues could be involved in protein-protein interactions. 
Similarly, the proline rich regions of the CTF/NF-I family of proteins (Santoro et al, 1988) could 
provide the sites for interaction with other oppositely charged protein domains. Whether or not 
domain(s) of EBP1 are involved in such interactions will require detailed sequence information on 
the protein.
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6. The interplay of cellular factors in transcriptional control and DNA replication
It is well established that eukaryotic cells can generate alternative messages from one gene using 
devices such as alternative promoters, terminators and splice sites. A factor has been described, 
CTF, which stimulated transcription from various viral and cellular promoters, and which can mediate, 
in part, some of the Increased transcription caused by transforming growth factor-13 (reviewed by 
Short, 1988). During the purification of this factor, it became apparent that it was identical to the 
factor NF-I, shown previously to stimulate adenovirus DNA replication (Jones etal., 1987). This NF-I, 
purified from HeLa cells, was able to bind to and stimulate DNA replication from the adenovirus origin 
of DNA replication and also bind to several promoters to activate transcription in vitro. However, 
preparations of the protein were inherently heterogeneous -  repeated rounds of affinity 
chromatography failed to produce preparations with a single molecular mass. The reason for this 
heterogeneity has now been established by Santoro et al., (1988) whereby they carried out a 
detailed molecular analysis of CTF/NF-I cDNA clones and demonstrated the presence of multiple 
mRNA species containing alternative coding regions, resulting from differential splicing. Expression 
of these cloned genes and analysis of there functions in vivo established that the individual gene 
products could bind to the GOOAAT recognition site common to both CTF and NF-I, and act as both 
promoter-selective transcriptional activators and as initiation factors for DNA replication. The 
functional differences between the three forms of CTF/NF-I isolated by Santoro and coworkers 
(1988) still remains somewhat obscure but it is conceivable that each form could have subtly 
different effects on transcription or DNA replication, perhaps mediated by their interaction, in 
different ways, with some other factor involved in these processes.
All three of the CTF/NF-I proteins have a C-termlnal portion fairly similar to the C-termlnal portion 
of the yeast RAP1 factor (Shore and Nasmyth, 1987) which binds to the silencer sequence In the 
HMR locus In yeast. This adds yet another degree of complexity to the CTF/NF-I story in that these 
silencer regions are the inverse of enhancers in that they repress transcription in both directions 
over long distances. RAP1 also influences the transmission of plasmids at mitosis, as well as 
binding to yeast telomeres. These findings lend support to the multifunctional nature of CTF/NF-I.
The association of transcription factors with origins of DNA replication may provide us with a 
mechanism for coordinate regulation of transcription and replication, it is possible that replication is
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dependent on a template that requires activation by RNA polymerase ll-mediated initiation of 
transcription, but this situation does not appear to be necessary for adenovirus, SV40 and polyoma 
DNA replication where RNA polymerase II activity is dispensable (reviewed by Santoro et al., 1988). 
Alternatively, binding of the transcription factors to the template could directly alter the chromatin 
structure tQ facilitate DNA replication. A model favoured by Santoro and coworkers (1988) involves 
specific interaction between transcription factors bound to the DNA template and components of 
the replication machinery.
Does EBP1 have such a multifunctional role? There Is no evidence to suggest such a role at 
present. However, it does appear that EBP1 belongs to a family of related DNA binding proteins, 
i.e., NF-kB and H2TF1/KBF1, all of which have similar molecular weights (Kawakami etal., 1988; 
Singh et al„ 1988). To determine the relationship between these proteins will require a detailed 
molecular and functional analysis.
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Figure 2.3 The binding of EBP1 to bromodeoxyuridine-substituted DNA
A. A bromodeoxyuridine-substituted, p^p].labelled, double stranded DNA fragment containing the 
SV1 sequence was incubated in the presence (+), or absence(-) of partially purified EBP1 under 
conditions employed in the standard gel electrophoresis DNA binding assay, DNA-protein 
complexes resolved on 6% polyacrylamide gels and visualised by autoradiography. Arrows depict the 
positions of the DNA-protein complexes (B) or free DNA (F).
B. Competition analysis of EBP1 binding. Reactions were prepared as in A but with the inclusion of 
10 (lane 1), 25 (lane 2), 50 (lane 3) or 100 ng (lane 4) of unlabelled, double stranded SV1 
oligonucleotide as competitor, in the binding mixture. Complexes were resolved and visualised as 
described in A.
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Figure2.4 BromodeoxyuracM cross-linking of EBP1 to Its binding site on the SV40 
genome
A bromodeoxyuridine substituted, [32p]-iabelled double stranded DNA fragment containing the 
EBP1 binding site was prepared as described in “Materials and Methods". Probe DNA was incubated 
with affinity purified EBP1 under conditions employed in the gel electrophoresis DNA binding assay. 
Once equilibrium had been reached, samples were irradiated with UV light followed by treatment with 
DNase I and micrococcal nuclease as indicated. Reaction products were fractionated on 10% SDS 
polyacrylamide gels and visualised by autoradiography. The positions of the 66,000 and 45,000 
molecular weight protein standards are indicated by the arrows. UV irradiation, in the absence of 
competitor was for 0, 5,10 and 20 minutes. In the competition analysis EBP1 was allowed to bind in 
the presence of 0.1 pg SV1, 0.5 pg SV1, 0.5 pg NFI or 0.5 pg NFIII double stranded oligonucleotides 
prior to UV irradiation for 10 minutes. Reaction productes which were UV irradiated for 10 minutes 
without subsequent DNase I or mirococcal nuclease digestion are also shown (-MNase,DNase).
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Figure 2.5. DNase I protection of the SV40 enhancer by affinity-purified EBP1
The Bam HI to Pvu II fragment from pUC1X72, 3'-[32p] lablled at the Bam HI site was incubated with 0, 
5,10 or 20 pi of affinity purified EBP1 as described in “Materials and Methods". Competition assays 
were carried out in which 10 pi of EBP1 was incubated with labelled probe in the presence of 500 ng 
unlabelled SV1, SV1 .Ml or SV1 .M2 double stranded oligonucleotide. After treatment with DNase I, 
reaction products were electrophoresed in a 6% denaturing polyacrylamide gel. C+T and A+G 
specific cleavage reactions of the labelled fragment were electrophoresed in parallel as mariners.
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Figure 2.6 Proteolytic cleavage of EBP1
Reactions contained 0.5 ng [32p].|abelled, double stranded SV1 oligonucleotide, 1.0 pg of 
unlabelled poly [d(A-T)] poly [d(G-C)] and 2 pi of affinity purified EBP1 ; {-) indicates ttiat EBP1 was 
omitted from these reactions. In addition, reactions contained 0 (lanes 0), 5 (lanes 1), 10 (lanes 2), 20 
(Elastase and Type XIV lanes 3) or 5000 pg (Prot.K lane 3) of proteinase K, elastase or protease XIV. 
Proteolytic enzymes were added after the binding reactions had reached equilibrium and digestion 
was allowed to proceed for 15 minutes at 20°C. Reaction products were fractionated on native 6% 
polyacrylamide gels.
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Figure 3.2 DNase I protection and OP/Cu+ cleavage of the IRE In the presence of
EBP1
A. A HindWl to Bgl II fragment from pSPIRE, was 3'-[32p].|abelled (top) or 5'-[32p] labelled (bottom) at 
the Hind\\\ site, incubated with 0, 5,10 or 20 pi of affinity purified EBP1 and digested with DNase I as 
described in “Materials and Methods". DNA was isolated, fractionated by electrophoresis in 8% 
denaturing polyacrylamide gels and the cleavage products visualised by autoradiography. C+T (Py) 
and G+A (Pu) specific cleavage reactions of the labelled fragment were electrophoresed in parallel as 
markers.
B. The aforementioned labelled fragments were incubated with 20 pi of affinity purified EBP1 and, 
after binding reactions had reached equilibrium, free DNA (F) was separated from EBP1-DNA 
complexes (B) by electrophoresis in a native polyacrylamide gel. Cleavage with OP/Cu+ was carried 
out within the acrylamide matrix and DNA eluted as described in “Materials and Methods". DNA was 
fractionated, and products visualised as described in A. Deoxyribose residues within the bracketed 
region are protected from cleavage by OP/Cu+.
0. DNA sequence of the IRE containing the EBP1 binding site. Phosphate bonds within the large 
brackets are protected from DNase I cleavage broken lines depict potential protected bonds). 
Deoxyribose residues within the small bracketed regions are protected from OP/Cu+ cleavage in the 
presence of EBP1.
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Figure 3.3 DNase I protection of the HIV enhancer In the presence of EBP1
A Hind\\\ to Sac I fragment, or Eco RI to Pst I fragment, from pHIVEn was 3-end labelled at the Hind\\\ 
(Bottom; A) or Eco RI (Top; B) site, incubated in the absence (0) or presence of 5,10 or 20 pi of 
affinity purified EBP1 and digested with DNase I as described in “Materials and Methods”. DNA was 
isolated and fractionated by electrophoresis in 8 % denaturing polyacrylamide gels and the cleavage 
products visualised by autoradiography.
C. DNA sequence of the HIV enhancer containing the EBP1 binding sites (as depicted by the 
horizontal bars). Phosphate bonds within the bracketed regions are protected from DNase I 
cleavage in the presence of EBP1.
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Figure 4.1 DNA binding specificity of affinity purified EBP
Competition analysis of EBP1 binding. Reactions contained 0.5 ng [32p].|abelled double stranded 
SV1 oligonucleotide, 1.0 pg of unlabeled poly [d(A-T)]: poly [d(C-G)] and 1.0 pi of affinity purified 
EBP1 (lane (-) contained no EBP1). In addition, reactions contained 25 (lanes 1), 50 (lanes 2) or 100 
ng (lanes 3) of unlabelled double stranded SV1, SV1 .Ml or SV1 .M3 oligonucleotides. Reaction 
products were analysed on 6% polyacrylamide gels. The nucleotide sequence of the SV1 
oligonucleotide is shown -  the corresponding changes incorporated into SV1.M1 and SV1 .M3 are 
indicated.
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Figure 4.2 Mutational analysis of the EBP1 binding site present in the human 
B-interferon gene regulatory element (IRE)
A. BglW to Nco I fragments were isolated from the plF10 series of plasmids, which contain single point 
mutations throughout the IRE, and [32p]-iabelled at the Bgl II site. Labelled fragments (0.5 ng) were 
incubated with 0.5 pg of unlabelled poly[d(A-T)]: poly [d(G-C)] and 2 pi of affinity purified EBP1 in the 
standard gel electrophoresis DNA binding assay. Binding reactions were fractionated on 6% 
polyacrylamide gels and products visualised by autoradiography. The individual nucleotide changes 
incorporated into the mutant templates are indicated above the corresponding lanes. No EBP1 was 
present in the reaction represented by the dash.
B. Nucleotide changes incorporated in the plF10 mutants used in this study. The top line 
represents the wild type (wt) IRE sequence together with the relevant nucleotide numbers. Arrows 
represent the bases which have been altered with the bottom line depicting the corresponding 
changes in these altered bases.
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Figure 4.3 Mutational analysis of the EBP1 binding site on the SV40 enhancer.
A. Bam HI to Pvu II fragments from pUC1 X72 and pA11 to pA16, were S'-[32p] labelled at the Bam HI 
site, and incubated with 2 pi of affinity purified EBP1, in the presence of 0.5 pg of unlabelled 
poly[d(A-T)]: poly[d(G-C)], in the standard gel electrophoresis DNA binding assay. Binding reactions 
were fractionated in a 6% polyacrylamide gel and products visualised by autoradiography. The relative 
binding of EBP1 to the various templates (as determined by Cerenkov radiation counting of bound 
species) is indicated.
B. DNase I protection of mutated SV40 enhancer sequences by EBP1. The [32p]-iabelled 
fragments described in A were incubated with 0 (-) or 20 pi (+) of affinity purified EBP1 and treated 
with DNase I as described in “Materials and Methods”. DNA was isolated and fractionated in 8% 
denaturing polyacrylamide gels and the cleavage products visualised by autoradiography. G+A (Pu) 
specific cleavage reactions of the labelled fragments were electrophoresed in parallel as markers. 
Sources of labelled fragments are indicated at the foot of the appropriate lanes.
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Figure 4.4 Frequency of base usage within EBP1 binding sites
Nineteen different EBP1 binding sites, including naturally occurring sequences and mutated 
derivatives, were analysed and the frequency with which each base occurs at each position 
determined. A = adenine, C = cytosine, G = guanine, and T = thymine nucleotides respectively.
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Figure 5.1 DNase I protection of the SV40 enhancer by EBP1
A Bam HI to Eco RI fragment from pUCI X72, 3'-end labelled (A) or S’-end labeled (B) at the Bam HI 
site, was incubated in the absence (-) or presence (+) of 10 pi affinity purified EBP1 and digested with 
DNase I as described in “Materials and Methods”. DNA was isolated and fractionated by 
electrophoresis in 6% denaturing polyacrylamide gels and the cleavage products visualised by 
autoradiography. G+A (Pu) specific cleavage reactions of the labelled fragments were 
electrophoresed in parallel as markers. Phosphate bonds within the brackets are protected from 
DNase I cleavage.
C. Organisation of the SV40 transcriptional control region. The 21 bp repeated elements of the early 
promoter, the origin of DNA replication (oh) and the enhancer, containing one copy of the 72 bp 
repeat, are indicated. Shown below is the DNA sequence of the enhancer region containing the 
EBP1 binding site. Phosphate bonds within the brackets are protected from DNase I cleavage. DNA 
sequences present in the double stranded SV1 oligonucleotide are also indicated.
T o p  
Pu -  ♦
B B o t t o m  
P u  — +
I I
Pvull BamHI
I 72bp H  21 I 21 I 22
5 ' -GTTAGGGTGTGGAAAGTCCCCAGGCTC-3' 
3 ' -CAATCCCACACCTTTCAGGGGTC|3GAG- 5 '
245^1244^
240^
P S V I  p U C t X 7 2A T o p  B o t t o m  B T o p  B o t t o m
B  F  8  F
B r  3
C5'-GTTAGGGTGTGGAAAGTCCCCAGGCTC-3' 3'-CAATCCCACACCTTTCAGGGGTCCGAG-5'
I I " ' °  I
250 240 230
Figure 5.3 Methylated bases that Interfere with EBP1 binding.
Hind III to Kpn I (A) or Eco RI to Pst I (B) fragments from pSV1, 3'-end labelled at the Hind III (top) or 
Eco RI (bottom) sites were treated with DMS and the methylated DNA incubated with 10 pi affinity 
purified EBP1. Free DNA (F) and EBP1-DNA complexes (B) were separated by electrophoresis in 
a native polyacrylamide gel. DNA was eluted from the gel and cleaved at modified purine bases by 
treatment with NaOH. Cleavage products were fractionated by electrophoresis in 8% denaturing 
polyacrylamide gels. Positions of interfering bases are indicated by arrows.
C. DNA sequence of the region of the SV40 enhancer containing the EBP1 binding site. Filled 
circles depict modified bases which interfere with EBP1 binding.
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Figure 5.4 Méthylation protection of bases In the HIV enhancer In the presence 
of EBP1
A Hind III to Sac I fragment, or Eco RI to Pst I fragment, from pHIVEn was 3'-end labelled at the Eco RI 
(Top; A) or Hind III (Bottom; B) site, was incubated in the absence (-) or presence of 20 pi of EBP1 
(+) and treated with DMS as described in “Materials and Methods”. DNA was cleaved at modified 
bases by treatment with piperidine and the reaction products fractionated by electrophoresis in 8 % 
denaturing polyacrylamide gels. Cleavage products were visualised by autoradiography after 15 
(Top, b; Bottom, a) or 48 hours (Top. a; Bottom, b) exposure to X-ray film. Positions with altered 
sensitivity to DMS are indicated by filled triangles, in the case of protected bases, or open triangles, 
in the case of bases hypersensitive to DMS méthylation.
C. DNA sequence of the HIV enhancer containing the two EBP1 binding sites. Positions of the 
bases with altered sensitivity to DMS are indicated as described above.
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FIGURE 5.7 Summary of the EBP1/DNA DMS Méthylation protection and 
interference analysis
The nucleotide sequences containing the EBP1 binding sites present in the SV40 enhancer, IRE 
and HIV (HIV-R and HIV-L) are shown. Filled circles represent bases which are protected from DMS 
méthylation in the presence of EBP1 while open circles indicate bases with an increased reactivity 
towards DMS modification in the presence of EBP1. Purine bases which, when modified, interfere 
with EBP1 binding are depicted by the shaded boxes.
Figure 5.8 Ethylated phosphotrlesters that Interfere with EBP1 binding
A Bam HI to Eco Rl fragment from pUC1X72, 3'-end labelled (A, top) or 5'-end labelled at the Bam HI 
site(B, bottom), was treated with ethylnitrosourea as described in “Materials and Methods”. Ethylated 
DNA was incubated with 10 pi affinity purified EBPIand free DNA (F) separated from EBP1-DNA 
complexes (B) in a native polyacrylamide gel. DNA was eluted and cleaved at phosphtriester bonds by 
treatment with NaOH. Reaction products were fractionated by electrophoresis in 6% denaturing 
polyacrylamide gels and cleavage products visualised by autoradiography. G+A (Pu) and C+T (Py) 
specific cleavage reactions of the labelled fragments were run in parallel as markers. Positions of 
modified phosphotriesters that interfere with binding are indicated by arrows.
C. DNA sequence of the region of the SV40 enhancer containing the EBP1 binding site. Modified 
phosphate bonds within the bracket interfere with EBP1 binding.
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Figure 5.9 1,10-orthophenanthrollne/copper cleavage of the SV40 enhancer In 
the presence of EBPI
A Bam HI to Eco Rl fragment from pUC1 X72, 3'-end labelled (A, top) or S'-end labelled (B, bottom) at 
the Bam HI site, was incubated with 10 pi affinity purified EBPI and, after binding reactions had 
reached equilibrium, free DNA (F)was separated from EBP1-DNA complexes (B) by electrophoresis 
in a native polyacrylamide gel. Cleavage with OP/Cu+ was carried out within the acrylamide matrix and 
DNA eluted as described in “Materials and Methods”. DNA was fractionated by electrophoresis in 6% 
denaturing polyacrylamide gels and cleavage products visualised by autoradiography. G+A (Pu) 
specific reactions of the labelled fragments were electrophoresed in parallel as markers. Deoxyribose 
residues within the bracketed region are protected from cleavage by OP/Cu+.
C. DNA sequence of the region of the SV40 enhancer containing the EBPI binding site.
Deoxyribose residues within the bracketed region are protected from OP/Cu+ cleavage in the 
presence of EBPI.
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Figure 5.10 Summary of EBPI/DNA contact point analysis
A. Phosphodiester bonds within the large bracket are protected from cleavage with DNase I in the 
presence of EBP1. Deoxyribose residues within the smaller brackets are protected from cleavage 
with OP/Cu+. Bold letters indicate that these bases interfere with EBP1 binding when methylated. 
Filled squares indicate bases protected from méthylation while the open square indicates that this 
base was hypermethylated in the presence of EBP1. The shaded square indicates that this base was 
protected in the plasmid pUC1X72 but not in pSVI. Open circles indicate the positions of 
phosphotriesters that interfere with EBPI binding.
B. Helical projection of the EBPI binding site. Modified bases (#) and phosphates (o) that interfere 
with binding are indicated, as are deoxyribose residues (*■) that are protected from cleavage with 
OP/CU+ in the presence of EBP1.
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Figure 1.D Disposition of transcription factors AP-2, AP-3 and EBP1 on the SV40 
enhancer
The DNase I "footprint" boundaries for AP-2 and AP-3 on the SV40 enhancer DNA sequence are 
from Mitchell e ta l . (1987) and EBPI from this study. It should however be stressed that these 
boundaries probably represent an over estimate of the region occupied by the DNA binding 
proteins, since DNase I is a relatively large molecule and requires an extended binding surface for 
DNA cleavage (Suck et al., 1988). The effect of mutations in this region on transcription in vivo are 
from Zenke eta l.. 1986. Altered bases in the mutated SV1 oligonucleotides SV1.M1 and SV1.M3, 
that abolish EBPI binding, are underlined.
